≡ Risteys
R14

Documentation Changelog GitHub Contact & Feedback

Paraplegia, diplegia of upper limbs

DOID EFO Endpoint Browser PheWeb

G6_PARDIPLE

paraplegia: Complete paralysis of the lower half of the body including both legs, often caused by damage to the spinal cord. [database_cross_reference: NCIT:P378]

Suggest a new description

Endpoint definition

↥

Report an error or suggest an improvement for this endpoint codes

Endpoint definition steps

FinnGen

Phenotype data

519870

1. Apply sex-specific rule

None

519870

2. Check conditions

None

519870

3. Check pre-conditions, main-only, mode, registry filters

Registry filters:

2 out of 7 registries used, show all original rules.

856

4. Check minimum number of events

None

856

5. Include endpoints

None

856

6. Filter based on genotype QC (FinnGen only)

834

Control definitions (FinnGen only)

Control exclude
G6_CPETAL

Extra metadata

Level in the ICD hierarchy
3
First used in FinnGen datafreeze
DF2

Case counts by codes

↥

FinnGen case counts by registry codes:

generic upset plot

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

Key figures

All Female Male
Number of individuals
Whole population 7688 3418 4167
Only index persons 6093 2826 3267
Unadjusted period prevalence (%)
Whole population 0.11 0.10 0.12
Only index persons 0.12 0.10 0.12
Median age at first event (years)
Whole population 56.92 57.26 56.41
Only index persons 54.02 54.33 53.75

-FinnGen-

Key figures

All Female Male
Number of individuals 834 380 454
Unadjusted period prevalence (%) 0.17 0.13 0.21
Median age at first event (years) 55.93 49.43 61.36

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.

Matched cohort

Matched cases
856
Matched controls
8560
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
G82.2
ICD-10 Finland
Paraplegia, unspecified
16384.0
307.7
639
*
M03BX01
ATC
baclofen; systemic
38.1
272.8
174
57
L89
ICD-10 Finland
Decubitus ulcer and pressure area
25.1
198.0
145
69
N18
ICPC
Paralysis/weakness
25.6
193.0
140
65
G82.1
ICD-10 Finland
Spastic paraplegia
+∞
171.8
159
*
XKC03
NOMESCO Finland
Water cystometry
16.7
151.7
134
94
N31.9
ICD-10 Finland
Neuromuscular dysfunction of bladder, unspecified
40.6
148.1
91
25
XKD06
NOMESCO Finland
Physiologic investigation of micturition
14.2
146.8
143
119
G82.0
ICD-10 Finland
Flaccid paraplegia
+∞
134.0
125
*
N31.2
ICD-10 Finland
Flaccid neuropathic bladder, not elsewhere classified
35.7
132.1
84
26
T91.3
ICD-10 Finland
Sequelae of injury of spinal cord
483.0
128.5
125
*
NA7DG
NOMESCO Finland
Spine and spinal cord very extensive MRI examination with high intensity magnet
24.4
126.6
92
42
NA2BG
NOMESCO Finland
Thoracal spine MRI examination with high intensity magnet
13.4
112.0
111
94
NA7CG
NOMESCO Finland
Spine and spinal cord extensive MRI examination with high intensity magnet
23.1
110.8
82
39
Z46.8
ICD-10 Finland
Fitting and adjustment of other specified devices
13.1
106.9
107
92
R33
ICD-10 Finland
Retention of urine
6.2
102.8
209
424
G95.8
ICD-10 Finland
Other specified diseases of spinal cord
543.1
99.6
97
*
SPAT1229
SPAT
Assessment of need for aid
6.8
96.4
172
306
N10
ICD-10 Finland
Acute tubulo-interstitial nephritis
4.9
87.8
244
645
KH1AE
NOMESCO Finland
Urinary tract ultrasound examination
6.6
86.0
155
277
N03AX16
ATC
[U] pregabalin
4.0
80.4
343
1237
R29.8
ICD-10 Finland
Other and unspecified symptoms and signs involving the nervous and musculoskeletal systems
5.6
79.0
172
367
L28
ICPC
Limited function/disability (L)
4.0
76.8
301
1019
TKC10
NOMESCO Finland
Percutaneous puncture of bladder
17.8
76.1
63
38
N03AE01
ATC
clonazepam; systemic
6.9
75.8
128
213
N28
ICPC
Limited function/disability (N)
14.0
75.1
71
55
TKC20
NOMESCO Finland
Catheterisation of bladder
5.6
70.5
151
316
N39.0
ICD-10 Finland
Urinary tract infection, site not specified
4.0
68.7
248
785
GD1QA
NOMESCO Finland
Supine thorax X-ray examination
3.8
68.6
291
1029
UKC02
NOMESCO Finland
Cystoscopy
3.9
68.3
269
905
NA2CG
NOMESCO Finland
Thoracal spine extensive MRI examination with high intensity magnet
17.8
63.0
52
31
NA1BG
NOMESCO Finland
Cervical spine MRI examination with high intensity magnet
6.0
62.7
120
225
N31.8
ICD-10 Finland
Other neuromuscular dysfunction of bladder
25.7
62.5
44
18
N03AX12
ATC
[U] gabapentin; oral
3.8
61.8
243
810
SPAT1230
SPAT
Aid fitting and borrowing and monitoring of use
3.7
60.1
240
807
NA2AA
NOMESCO Finland
Thoracal spine X-ray examination without contrast
8.2
59.1
82
109
N31.1
ICD-10 Finland
Reflex neuropathic bladder, not elsewhere classified
26.2
57.2
40
16
R26.8
ICD-10 Finland
Other and unspecified abnormalities of gait and mobility
9.8
56.7
68
75
A28
ICPC
Limited function/disability NOS
3.4
55.7
263
980
NA3AD
NOMESCO Finland
Lumbar spine and sacrum CT examination
8.5
55.3
74
94
S97
ICPC
Chronic ulcer skin
4.9
55.1
136
319
R1250
NOMESCO Finland
Evaluation of functional capability
8.4
54.8
74
95
J01EA01
ATC
trimethoprim; systemic
3.2
54.4
306
1265
KCV12
NOMESCO Finland
Urinary bladder endoscopic botulin therapy
16.1
53.2
46
30
NA3AA
NOMESCO Finland
Lumbar spine X-ray examination without contrast
4.1
53.1
170
487
TAB00
NOMESCO Finland
Lumbar puncture
5.9
51.9
100
188
A06AD11
ATC
lactulose; oral
3.5
51.6
217
748
N99
ICPC
Neurological disease other
14.1
51.4
48
36
J01MA12
ATC
levofloxacin; systemic
3.2
48.6
254
997
XKD03
NOMESCO Finland
Urethral pressure profilometry
9.9
48.5
57
61
N32.82
ICD-10 Finland
Instability of the detrusor vesicae muscle
11.2
48.4
52
49
SPAT1231
SPAT
Assessment of adjustments needed in living environment
10.1
48.2
56
59
S22.0
ICD-10 Finland
Fracture of thoracic vertebra
9.0
45.2
57
67
SPAT1148
SPAT
Treatment of chronic ulcer or burn
3.4
44.0
192
672
G35
ICD-10 Finland
Multiple sclerosis
12.9
43.8
43
35
R4120
NOMESCO Finland
Occupational therapy
4.5
43.3
117
293
N02AE01
ATC
buprenorphine; parenteral, sublingual, transdermal
3.4
43.3
193
684
G82.5
ICD-10 Finland
Tetraplegia, unspecified
+∞
43.1
41
*
SPAT1167
SPAT
Insertion of urinary catheter
6.4
42.7
74
125
Z50.8
ICD-10 Finland
Care involving use of other rehabilitation procedures
4.2
42.5
124
329
NA3BG
NOMESCO Finland
Lumbar spine MRI examination with high intensity magnet
3.6
42.4
161
514
U07
ICPC
Urine symptom/complaint other
4.0
42.4
134
377
N30.9
ICD-10 Finland
Cystitis, unspecified
4.6
41.8
108
261
N30.0
ICD-10 Finland
Acute cystitis
3.2
41.5
204
765
QBG10
NOMESCO Finland
Excision and repair of bedsore of trunk
92.7
40.2
44
5
R5110, ,
SPAT
3.8
39.8
135
399
ABB00
NOMESCO Finland
Excision of lesion of spinal canal
209.5
39.2
40
*
ZXD05
NOMESCO Finland
Urgent procedure
2.6
39.1
342
1735
N02AA05
ATC
oxycodone; systemic
2.9
38.9
244
1045
AA1AD
NOMESCO Finland
CT of head and brain
2.6
38.7
342
1741
QBB05
NOMESCO Finland
Revision of wound of skin of trunk
9.7
38.6
46
50
J01MA02
ATC
ciprofloxacin; systemic
2.5
38.4
424
2395
M48.0
ICD-10 Finland
Spinal stenosis
3.2
38.3
177
637
T91.1
ICD-10 Finland
Sequelae of fracture of spine
75.2
38.3
43
6
KA1AE
NOMESCO Finland
Kidney ultrasound examination
6.8
38.0
61
95
WX408
NOMESCO Finland
General anesthesy, balanced
2.7
37.9
298
1431
Z50.9
ICD-10 Finland
Care involving use of rehabilitation procedure, unspecified
5.3
37.8
80
163
U05
ICPC
Urination problems other
4.6
37.4
95
226
WYA30
NOMESCO Finland
Treatment of a patient needing special arrangements
3.9
37.2
119
337
SPAT1215
SPAT
Assessment of need for medical rehabilitation
5.5
36.5
74
145
A46
ICD-10 Finland
Erysipelas
3.0
35.8
200
801
WX700
NOMESCO Finland
Respiratory and circulatory monitoring
2.9
35.3
204
831
L97
ICD-10 Finland
Ulcer of lower limb, not elsewhere classified
5.4
35.2
72
142
G99.2*M47.1
ICD-10 Finland
Spondylogenic compression of spinal cord
14.4
34.9
32
23
JN3AA
NOMESCO Finland
Abdominal X-ray examination without contrast
5.1
34.8
77
163
N29
ICPC
Neurological sympt/complt other
8.2
34.8
47
60
C03CA01
ATC
furosemide; systemic
2.5
34.3
340
1805
A12AX
ATC
Calcium, combinations with vitamin D and/or other drugs
2.4
34.2
354
1916
N06AX21
ATC
duloxetine; oral
3.2
34.0
153
540
NA3CG
NOMESCO Finland
Lumbar spine extensive MRI examination with high intensity magnet
5.0
33.6
76
164
N06AA09
ATC
amitriptyline; systemic
3.5
32.8
126
402
Z3226
NOMESCO Finland
Physiotherapist
2.7
32.6
215
936
N02AX02
ATC
tramadol; systemic, rectal
2.3
32.3
447
2729
G04BD08
ATC
solifenacin; oral
3.9
32.2
102
286
G83.4
ICD-10 Finland
Cauda equina syndrome
328.7
32.1
32
*
SPAT1262
SPAT
Handing over of treatment supplies
2.7
31.9
209
905
G95.1
ICD-10 Finland
Vascular myelopathies
171.4
31.9
33
*
U29
ICPC
Urinary symptom/complaint other
5.5
31.6
64
125
A49.9
ICD-10 Finland
Bacterial infection, unspecified
3.0
31.3
156
583
QBG00
NOMESCO Finland
Debridement of bedsore of trunk
324.2
31.0
31
*
GD1UA
NOMESCO Finland
Thorax X-ray examination outside radiological department
2.7
31.0
212
937
SPAT1222
SPAT
Counselling/guidance promoting independent living
2.8
30.9
184
757
N05BA01
ATC
diazepam; systemic, rectal
3.0
30.9
162
622
G82.4
ICD-10 Finland
Spastic tetraplegia
+∞
30.4
29
*
NA1CG
NOMESCO Finland
Cervical spine extensive MRI examination with high intensity magnet
7.8
30.4
43
58
J01XE01
ATC
nitrofurantoin; oral
9.0
30.3
38
44
XF400
NOMESCO Finland
ECG with 12 standard connections
2.7
30.0
192
819
S24.0
ICD-10 Finland
Concussion and oedema of thoracic spinal cord
313.0
30.0
30
*
R4110
NOMESCO Finland
Physiotherapy
2.4
30.0
300
1581
W17
ICD-10 Finland
Other fall from one level to another
4.7
29.7
71
160
U04
ICPC
Incontinence urine
3.9
29.3
91
251
N81
ICPC
Injury nervous system other
45.5
28.9
35
8
SPAT1137
SPAT
Taking care of patient’s/customer’s hygiene
3.9
28.8
92
259
A41.9
ICD-10 Finland
Sepsis, unspecified
4.8
28.5
66
145
PH2AE
NOMESCO Finland
Ultrasound examination of lower leg veins
3.0
28.4
145
547
AA1CG
NOMESCO Finland
Extensive MRI examination of brain with high intensity magnet
3.3
28.1
115
381
SPAT1216
SPAT
Assessment of functional ability
2.7
28.1
180
767
G04AC01, ,
ATC
6.2
28.0
49
83
TKC22
NOMESCO Finland
Catheterisation instruction
6.3
27.9
48
80
N02BF02
ATC
pregabalin; oral
3.7
27.6
95
281
K59.00
ICD-10 Finland
Constipation caused by slow bowel passage (SCT)
6.2
27.1
47
79
Z00.4
ICD-10 Finland
General psychiatric examination, not elsewhere classified
3.2
26.9
115
391
U71
ICPC
Cystitis/urinary infection other
3.8
26.6
86
244
TPH04
NOMESCO Finland
Cathetrisation of vein
2.4
26.5
247
1251
J01CA08
ATC
pivmecillinam; oral
2.2
26.3
346
2022
J18.9
ICD-10 Finland
Pneumonia, unspecified
2.3
26.2
295
1618
34401
ICD-8 Finland
Other cerebral paralysis, Diplegia NUD
+∞
26.2
25
*
G95.9
ICD-10 Finland
Disease of spinal cord, unspecified
96.4
25.8
28
*
QDB10
NOMESCO Finland
Major dressing of wound of skin of lower limb
3.9
25.7
79
216
ZXD35
NOMESCO Finland
Usual procedure
4.9
25.3
57
122
ABD40
NOMESCO Finland
Implantation of spinal injection device
+∞
25.1
24
*
U08
ICPC
Urinary retention
6.6
25.0
41
65
Z2446
NOMESCO Finland
Social worker
3.5
24.9
94
295
SPAT1255
SPAT
Intravenous administration of medicine
3.6
24.9
89
270
GD1PA
NOMESCO Finland
X-ray examination of the lungs in one projection
2.8
24.6
139
552
X59
ICD-10 Finland
Exposure to unspecified factor
2.4
24.6
213
1041
W01
ICD-10 Finland
Fall on same level from slipping, tripping and stumbling
2.1
24.2
327
1917
M47.1
ICD-10 Finland
Other spondylosis with myelopathy
8.7
24.1
31
37
R5110
NOMESCO Finland
Evaluation of the need for aids, the testing, fitting and choice of the aid, instruction in use and delivery of it
2.7
24.1
151
633
NA2AD
NOMESCO Finland
Thoracic spine CT examination
23.5
24.1
34
15
D32.1
ICD-10 Finland
Benign neoplasm: Spinal meninges
246.6
23.8
24
*
W19
ICD-10 Finland
Unspecified fall
2.9
23.6
125
479
Z43.5
ICD-10 Finland
Attention to cystostomy
22.1
23.6
34
16
S32.0
ICD-10 Finland
Fracture of lumbar vertebra
4.5
23.6
59
138
R20.2
ICD-10 Finland
Paraesthesia of skin
3.4
23.4
92
296
R52.2
ICD-10 Finland
Other chronic pain
4.3
23.1
62
153
G83.0
ICD-10 Finland
Diplegia of upper limbs
+∞
23.0
22
*
N06AX16
ATC
venlafaxine; oral
2.6
22.9
154
667
G61.0
ICD-10 Finland
Guillain-Barré syndrome
31.0
22.9
30
10
N02BF01
ATC
gabapentin; oral
2.8
22.3
122
475
NAJ22
NOMESCO Finland
Posterior reduction of fractrue of thoracic spine
53.5
22.2
26
5
L98.4
ICD-10 Finland
Chronic ulcer of skin, not elsewhere classified
5.5
22.0
43
81
G04BD04
ATC
oxybutynin; oral, transdermal
3.5
22.0
79
240
XKD00
NOMESCO Finland
Uroflowmetry
2.4
21.8
183
878
G81.9
ICD-10 Finland
Hemiplegia, unspecified
225.5
21.7
22
*
308
Kela drug reimbursment
Alprostadil, sildenafil and combination product containing aviptadil and phentolamine
6.0
21.7
39
68
N39.4
ICD-10 Finland
Other specified urinary incontinence
3.0
21.6
106
389
J01MA06
ATC
norfloxacin; oral
2.6
21.6
140
595
ZXE15
NOMESCO Finland
Procedure duration 120 to 149 minutes
6.6
21.5
35
55
G95.0
ICD-10 Finland
Syringomyelia and syringobulbia
44.6
21.5
26
6
SPAT1220
SPAT
Assessment of need for rehabilitation and/or rehabilitation plan
3.4
20.8
80
254
JN3AE
NOMESCO Finland
Abdominal ultrasound examination
2.5
20.6
149
666
K59.09
ICD-10 Finland
Constipation, unspecified
3.2
20.3
88
300
N03AX09
ATC
lamotrigine; oral
3.8
20.3
64
178
NA7BG
NOMESCO Finland
Spine and spinal cord MRI examination with high intensity magnet
19.4
20.1
30
16
R31
ICD-10 Finland
Unspecified haematuria
2.6
20.0
133
571
NAG53
NOMESCO Finland
Posterior or lateral fusion of thoracic spine with fixation, more than 3 vertebraea
59.0
20.0
23
*
G80.1
ICD-10 Finland
Spastic diplegic cerebral palsy
+∞
19.9
19
*
U13
ICPC
Bladder symptom/complaint other
4.8
19.8
46
101
N03AF02
ATC
oxcarbazepine; oral
4.5
19.5
49
115
109
Kela drug reimbursment
Multiple sclerosis
16.0
19.4
31
20
NH1AA
NOMESCO Finland
Ankle X-ray examination without contrast
3.1
19.4
87
303
NE1CG
NOMESCO Finland
Pelvic, hip and femur extensive MRI examination with high intensity magnet
5.5
19.3
38
72
ZXE10
NOMESCO Finland
More than one and less than three hours
2.0
19.0
334
2111
B01AB05
ATC
enoxaparin; parenteral
2.0
19.0
299
1821
WX002
NOMESCO Finland
Sedation and analgesia
2.2
18.9
192
992
M86.9
ICD-10 Finland
Osteomyelitis, unspecified
8.3
18.8
25
31
TQW11
NOMESCO Finland
Vacuum treatment of wound
5.0
18.6
41
86
G99.2
ICD-10 Finland
Myelopathy in diseases classified elsewhere
39.4
18.6
23
6
TPH15
NOMESCO Finland
Insertion of central venous catheter through external or internal jugular vein
3.2
18.6
79
266
AWB00
NOMESCO Finland
Reoperation for superficial infection in surgery of the nervous system
194.1
18.6
19
*
N12
ICD-10 Finland
Tubulo-interstitial nephritis, not specified as acute or chronic
6.4
18.6
31
50
TPH20
NOMESCO Finland
Insertion of central venous catheter through subclavian or brachiocephalic vein
4.4
18.5
47
111
A41.5
ICD-10 Finland
Sepsis due to other Gram-negative organisms
4.0
18.5
54
142
N06AB04
ATC
citalopram; systemic
2.1
18.4
204
1090
R60.0
ICD-10 Finland
Localized oedema
2.4
18.4
136
613
S82.1
ICD-10 Finland
Fracture of upper end of tibia
6.1
18.3
32
54
J01FF01
ATC
clindamycin; systemic
2.0
18.3
263
1546
ZXE13
NOMESCO Finland
Procedure duration 90 to 119 minutes
4.1
18.2
51
130
ABC60
NOMESCO Finland
Decompression of cervical spinal cord
14.8
18.2
30
21
SPAT1254
SPAT
Administration of medicine
2.3
18.2
153
730
KC1EE
NOMESCO Finland
Ultrasound measurement of residual urine
2.3
18.1
155
745
JN3BD
NOMESCO Finland
Extensive abdominal CT
2.7
18.1
110
451
N86
ICPC
Multiple sclerosis
27.4
17.9
24
9
ZXE20
NOMESCO Finland
More than three and less than five hours
2.3
17.8
147
695
M51.1
ICD-10 Finland
Lumbar and other intervertebral disc disorders with radiculopathy
2.3
17.7
156
758
J96.1
ICD-10 Finland
Chronic respiratory failure
4.9
17.7
39
82
Y83
ICD-10 Finland
Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure
3.0
17.6
85
308
ABB10
NOMESCO Finland
Resection of lesion of spinal canal
97.1
17.6
19
*
T81.4
ICD-10 Finland
Infection following a procedure, not elsewhere classified
2.5
17.6
121
527
C79.5
ICD-10 Finland
Secondary malignant neoplasm of bone and bone marrow
5.2
17.5
36
71
N21.0
ICD-10 Finland
Calculus in bladder
7.2
17.5
26
37
OAB50, ,
SPAT
2.8
17.3
96
375
SPAT1156
SPAT
Guidance concerning treatment of rash and skin
2.3
17.3
142
669
J01XX05
ATC
methenamine; oral
15.2
17.2
28
19
Z03.3
ICD-10 Finland
Observation for suspected nervous system disorder
3.1
17.2
76
262
N31.0
ICD-10 Finland
Uninhibited neuropathic bladder, not elsewhere classified
19.8
16.9
25
13
G04BE03
ATC
sildenafil; oral
5.8
16.9
31
55
A82
ICPC
Secondary effect of trauma
64.7
16.8
19
*
V49.9
ICD-10 Finland
Car occupant [any] injured in unspecified traffic accident
3.7
16.8
55
157
QXB99
NOMESCO Finland
Other procedure to treat skin wound, unspecified location
5.6
16.8
32
59
TPH07
NOMESCO Finland
Cathetrisation of artery
2.4
16.7
124
558
JN3AD
NOMESCO Finland
Abdominal CT examination
2.3
16.7
140
665
SPAT1083
SPAT
Initiation and monitoring of IV fluid therapy
3.7
16.6
54
153
Z3231
NOMESCO Finland
Registered nurse
1.9
16.6
260
1568
9072A
ICD-9 Finland
Late effects of injuries to the nervous system, Late effect of spinal cord injury
173.2
16.5
17
*
D43.4
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Spinal cord
173.2
16.5
17
*
WX882
NOMESCO Finland
High dependency care
4.5
16.5
41
95
K59.0
ICD-10 Finland
Constipation
3.1
16.5
72
246
WX404
NOMESCO Finland
Intravenous generell anesthesy
2.1
16.4
193
1050
S72.4
ICD-10 Finland
Fracture of lower end of femur
14.6
16.4
27
19
R50.9
ICD-10 Finland
Fever, unspecified
2.2
16.3
160
811
A41.0
ICD-10 Finland
Sepsis due to Staphylococcus aureus
4.9
16.2
36
76
A08
ICPC
Swelling
3.0
16.1
73
255
WX000
NOMESCO Finland
Monitoring vital functions without anesthesy
3.5
16.1
56
166
Z03.80
ICD-10 Finland
Observation for other suspected diseases and conditions
4.2
16.0
43
106
UJD10
NOMESCO Finland
Esophagoscopy, gastroscopy and duodenoscopy
1.9
15.9
272
1683
NE1BG
NOMESCO Finland
Pelvic, hip and femur MRI examination with high intensity magnet
4.0
15.9
46
120
R35
ICD-10 Finland
Polyuria
2.8
15.9
86
332
ABC36
NOMESCO Finland
Decompression of lumbar nerve roots
3.1
15.8
69
236
G04BD12
ATC
mirabegron; oral
2.3
15.8
131
619
WX892
NOMESCO Finland
Monitored bed care
2.7
15.7
88
346
NAJ32
NOMESCO Finland
Posterior reduction of fractrue of lumbar spine
26.9
15.6
21
8
QX2XE
NOMESCO Finland
Ultrsound examination of soft tissue not elsewhere classified
3.9
15.4
46
123
L29
ICPC
Musculoskeletal sympt/complt other
2.6
15.4
99
417
N03AF01
ATC
carbamazepine; oral, rectal
3.2
15.3
63
208
Z3229
NOMESCO Finland
Other healthcare associate professional
2.7
15.3
89
356
ZZR10
NOMESCO Finland
Flap of skin and muscle
13.4
15.3
26
20
QBB10
NOMESCO Finland
Major dressing of wound of skin of trunk
3.6
15.2
51
148
A01
ICPC
Pain general/multiple sites
2.4
15.2
111
496
ABC63
NOMESCO Finland
Decompression of thoracic spinal cord
45.9
15.1
18
*
JN4AD
NOMESCO Finland
Body CT examination
2.3
15.0
124
584
T36
ICD-10 Finland
Poisoning by systemic antibiotics
3.5
15.0
53
159
WX725
NOMESCO Finland
Noninvasive ventilation
3.0
15.0
68
238
SPAT1234
SPAT
Support of social functional capacity
3.1
14.9
65
222
XA402
NOMESCO Finland
ENMG
4.4
14.9
38
90
S76
ICPC
Skin infection other
3.0
14.9
68
239
NG4AA
NOMESCO Finland
Lower leg X-ray examination
3.7
14.8
47
131
AA1DG
NOMESCO Finland
Very extensive MRI examination of brain with high intensity magnet
4.0
14.8
42
108
AA1BG
NOMESCO Finland
Standard MRI examination of brain with high intensity magnet
2.4
14.8
106
469
T90.5
ICD-10 Finland
Sequelae of intracranial injury
6.3
14.7
25
41
B01AA03
ATC
warfarin; systemic
2.0
14.7
187
1043
S34.0
ICD-10 Finland
Concussion and oedema of lumbar spinal cord
+∞
14.6
14
*
G11.4
ICD-10 Finland
Hereditary spastic paraplegia
+∞
14.6
14
*
N05CF01
ATC
zopiclone; oral
1.8
14.5
292
1892
QDB05
NOMESCO Finland
Revision of wound of skin of lower limb
3.8
14.5
44
119
NE1AA
NOMESCO Finland
Pelvis X-ray examination
2.6
14.4
90
373
G37.9
ICD-10 Finland
Demyelinating disease of central nervous system, unspecified
17.3
14.3
22
13
NF3AA
NOMESCO Finland
Femur X-ray examination
4.4
14.2
36
85
G62.9
ICD-10 Finland
Polyneuropathy, unspecified
3.6
14.1
47
136
F45.4
ICD-10 Finland
Persistent somatoform pain disorder
5.0
13.9
30
62
EBA15
NOMESCO Finland
Extraction of multiple teeth
3.4
13.7
51
158
N05AA02
ATC
levomepromazine; systemic
3.4
13.7
50
153
NA1AA
NOMESCO Finland
Cervical spine X-ray examination without contrast
3.6
13.6
46
134
QDG10
NOMESCO Finland
Excision and repair of bedsore of lower limb
76.4
13.6
15
*
ZX120
NOMESCO Finland
Intravenous
2.4
13.6
97
428
G83.1
ICD-10 Finland
Monoplegia of lower limb
+∞
13.6
13
*
G81.1
ICD-10 Finland
Spastic hemiplegia
+∞
13.6
13
*
F44.4
ICD-10 Finland
Dissociative motor disorders
142.2
13.5
14
*
F43.22
ICD-10 Finland
Adaptation disorder with mixed anxiety and depression
3.3
13.5
51
160
SPAT1223
SPAT
Implementation of physical therapy rehabilitation plan
1.8
13.4
253
1602
Z04.3
ICD-10 Finland
Examination and observation following other accident
4.7
13.4
31
68
R56.8
ICD-10 Finland
Other and unspecified convulsions
3.0
13.3
62
220
303
Kela drug reimbursment
Dimethyl fumarate, interferon beta, glatiramer acetate and teriflunomid (Multiple sclerosis)
14.1
13.3
22
16
ZXE00
NOMESCO Finland
One hour or less
1.7
13.3
333
2290
V89
ICD-10 Finland
Motor- or nonmotor-vehicle accident, type of vehicle unspecified
40.8
13.2
16
*
NA1AD
NOMESCO Finland
Cervical spine CT examination
3.0
13.1
61
217
IAZ97
NOMESCO Finland
Psychiatric consultation in another specialty
5.3
13.0
26
50
R10.4
ICD-10 Finland
Other and unspecified abdominal pain
1.7
13.0
311
2107
WF049
NOMESCO Finland
Radiotherapy of metastasis
3.5
12.9
45
134
S14.0
ICD-10 Finland
Concussion and oedema of cervical spinal cord
50.8
12.9
15
*
G04BD07
ATC
tolterodine; oral
3.0
12.8
57
197
RS222, ,
NOMESCO Finland
5.9
12.8
23
40
N02AB03
ATC
fentanyl; nasal, sublingual, transdermal
3.1
12.7
54
182
R15
ICD-10 Finland
Faecal incontinence
3.9
12.7
38
102
R4190
NOMESCO Finland
Nutritional therapy
3.3
12.7
49
156
NA7DM
NOMESCO Finland
Spine and spinal cord very extensive MRI examination with 3 Tesla magnet
70.9
12.6
14
*
G40.9
ICD-10 Finland
Epilepsy, unspecified
3.4
12.6
46
141
NA2DG
NOMESCO Finland
Thoracal spine very extensive MRI examination with high intensity magnet
32.6
12.6
16
5
ZXE30
NOMESCO Finland
More than five and less than seven hours
3.1
12.6
54
183
R53
ICD-10 Finland
Malaise and fatigue
1.8
12.6
236
1487
G82
ICD-10 Finland
Paraplegia and tetraplegia
+∞
12.5
12
*
NA3DG
NOMESCO Finland
Lumbar spine very extensive MRI examination with high intensity magnet
13.4
12.5
21
16
3499X
ICD-9 Finland
Other and unspecified disorders of the nervous system, Unspecified disorders of nervous system
131.9
12.5
13
*
NF1AA
NOMESCO Finland
Hip X-ray examination
2.4
12.5
94
425
SPAT1301
SPAT
No procedures
1.8
12.4
272
1793
JN4BD
NOMESCO Finland
Extensive body CT
2.3
12.4
105
499
111
Kela drug reimbursment
Epilepsy and comparable convulsive disorders
2.9
12.4
60
218
NA7EA
NOMESCO Finland
Scoliosis X-ray examination
5.5
12.4
24
45
204
Kela drug reimbursment
Leukemia lymphatica
3.8
12.3
38
104
G99.2*M47.9
ICD-10 Finland
Myelopathy in spondylosis
14.6
12.3
20
14
M47.2
ICD-10 Finland
Other spondylosis with radiculopathy
2.7
12.3
69
271
S30.0
ICD-10 Finland
Contusion of lower back and pelvis
3.1
12.3
52
175
SPAT1125
SPAT
Stoma care and guidance
5.0
12.2
26
53
M05BA04
ATC
alendronic acid; oral
2.5
12.2
80
339
XPX99
NOMESCO Finland
Other diagnostic examination of periferal vessel
2.6
12.1
71
285
ZXM10
NOMESCO Finland
Intraoperative use of conventional X-ray imaging
2.6
12.1
71
285
N32.83
ICD-10 Finland
Nozzle synergy in the bladder neck
21.6
12.0
17
8
NK6QA
NOMESCO Finland
Measurement of bone density from two or more locations with X-ray
2.7
12.0
68
268
NAG63
NOMESCO Finland
Posterior fusion of lumbar spine with fixation, more than 3 vertebraea
13.6
12.0
20
15
R39.1
ICD-10 Finland
Other difficulties with micturition
3.5
11.9
42
126
GD1AA
NOMESCO Finland
Thorax X-ray examination
1.7
11.9
417
3110
Z76.9
ICD-10 Finland
Person encountering health services in unspecified circumstances
2.3
11.9
97
454
R13
ICD-10 Finland
Dysphagia
2.5
11.9
77
325
R52.1
ICD-10 Finland
Chronic intractable pain
6.0
11.8
21
36
R1240
NOMESCO Finland
Social assessment of need and possibilities of rehabilitation
9.8
11.8
23
24
UJH02
NOMESCO Finland
Anoscopy
3.2
11.7
47
153
R32
ICD-10 Finland
Unspecified urinary incontinence
4.0
11.6
33
85
G83.9
ICD-10 Finland
Paralytic syndrome, unspecified
65.9
11.6
13
*
QBG20
NOMESCO Finland
Operation for chronic ulcer or fistula of skin of trunk
23.3
11.6
16
7
A41.8
ICD-10 Finland
Other specified sepsis
4.4
11.6
29
68
Z50.1
ICD-10 Finland
Other physical therapy
2.8
11.5
58
215
TAW99
NOMESCO Finland
Other minor neurosurgical procedure
13.8
11.5
19
14
157
Kela drug reimbursment
Dimethyl fumarate, glatiramer acetate, interferon beta and teriflunomid (Multiple sclerosis)
13.8
11.5
19
14
C72.00
ICD-10 Finland
Malignant tumor of the spinal cord without histology
+∞
11.5
11
*
G04BD09
ATC
trospium; oral
4.1
11.5
31
77
N39.9
ICD-10 Finland
Disorder of urinary system, unspecified
4.8
11.5
26
56
G80.2
ICD-10 Finland
Spastic hemiplegic cerebral palsy
121.6
11.5
12
*
U28
ICPC
Limited function/disability (U)
5.5
11.4
22
41
J96.0
ICD-10 Finland
Acute respiratory failure
5.5
11.4
22
41
R5599
NOMESCO Finland
Other rehabilitation service
3.4
11.3
40
120
M03BX02
ATC
tizanidine; oral
1.7
11.3
506
3996
ZXE11
NOMESCO Finland
Procedure duration 60 to 89 minutes
2.8
11.2
58
218
S22.1
ICD-10 Finland
Multiple fractures of thoracic spine
17.3
11.2
17
10
N30.2
ICD-10 Finland
Other chronic cystitis
12.9
11.2
19
15
R5130, ,
SPAT
20.3
11.2
16
8
M05BX04
ATC
denosumab; parenteral
2.7
11.1
59
225
A04
ICPC
Weakness/tiredness general
2.0
11.1
145
810
D64.9
ICD-10 Finland
Anaemia, unspecified
2.1
11.1
110
556
SPAT1127
SPAT
Enema
11.3
11.1
20
18
U70
ICPC
Pyelonephritis/pyelitis
5.8
11.0
20
35
H01BA02
ATC
desmopressin; nasal, systemic, sublingual
4.5
11.0
27
62
SPAT1263
SPAT
Sampling
1.6
10.9
344
2480
NA1CM
NOMESCO Finland
Cervical spine extensive MRI examination with 3 Tesla magnet
43.9
10.9
13
*
N06AX11
ATC
mirtazapine; oral
1.7
10.9
297
2063
S82.3
ICD-10 Finland
Fracture of lower end of tibia
4.4
10.8
27
63
L03AB07
ATC
interferon beta-1a; parenteral
18.1
10.8
16
9
G99.2*M51.0
ICD-10 Finland
Lumbar and other intervertebral disc disorders with myelopathy
28.4
10.7
14
5
FB1BD
NOMESCO Finland
Extensive CT examination of arteria pulmonalis
2.4
10.7
77
341
G04AA01, ,
ATC
13.1
10.7
18
14
Y96.9
ICD-10 Finland
Unspecified type of accident
4.2
10.7
28
68
SPAT1149
SPAT
Suture or treatment of traumatic wound
2.0
10.5
117
617
Z01.8
ICD-10 Finland
Other specified special examinations
1.8
10.5
193
1201
XA800
NOMESCO Finland
Neuropsychological investigation
2.9
10.4
49
175
M41.4
ICD-10 Finland
Neuromuscular scoliosis
111.3
10.4
11
*
AEA30
NOMESCO Finland
Replacement of implanted pump of injection device in the nervous system
+∞
10.4
10
*
80691
ICD-8 Finland
Fracture and fracture dislocation of vertebral column with spinal cord lesion, Thoracica, Sequelae
+∞
10.4
10
*
G80.0
ICD-10 Finland
Spastic quadriplegic cerebral palsy
+∞
10.4
10
*
G83.8
ICD-10 Finland
Other specified paralytic syndromes
+∞
10.4
10
*
R51.80
ICD-10 Finland
Headache
1.9
10.4
140
790
Z2445
NOMESCO Finland
Psychologist
3.0
10.4
46
159
L99
ICPC
Musculoskeletal disease other
4.0
10.4
29
74
F32.9
ICD-10 Finland
Depressive episode, unspecified
2.0
10.4
113
592
NH3AA
NOMESCO Finland
Foot and toes X-ray examination
2.2
10.3
87
412
SPAT1295
SPAT
Other function in accordance with physical therapy nomenclature
2.8
10.3
51
188
SPAT1294
SPAT
Other function in accordance with health social work nomenclature
4.2
10.2
27
66
Z71.3
ICD-10 Finland
Dietary counselling and surveillance
2.9
10.1
47
167
ZXE04
NOMESCO Finland
Procedure duration 30 to 39 minutes
2.6
10.1
61
249
WX872
NOMESCO Finland
Intensive care
2.6
10.1
59
237
SPAT1226
SPAT
Implementation of occupational therapy rehabilitation plan
3.7
10.0
32
90
G99.2*M47.0
ICD-10 Finland
Anterior spinal and vertebral artery compression syndromes
40.6
10.0
12
*
M51.3
ICD-10 Finland
Other specified intervertebral disc degeneration
2.3
9.9
77
352
J69.0
ICD-10 Finland
Pneumonitis due to food and vomit
4.0
9.9
28
72
SPAT1221
SPAT
Guidance concerning rehabilitation services and livelihood
4.3
9.9
25
59
M50.1
ICD-10 Finland
Cervical disc disorder with radiculopathy
2.9
9.8
46
164
J01CE08
ATC
benzathine benzylpenicillin; parenteral
8.9
9.8
20
23
WZC00
NOMESCO Finland
Treatment plan or consultation
1.6
9.8
307
2197
UJF32
NOMESCO Finland
Coloscopy
1.7
9.8
223
1472
UGC12
NOMESCO Finland
Flexible bronchoscopy
2.3
9.7
80
375
OAB43, ,
SPAT
0.5
9.7
90
1667
X69
ICD-10 Finland
Intentional self-poisoning by and exposure to other and unspecified chemicals and noxious substances
3.4
9.7
35
107
TNX34
NOMESCO Finland
Major custom molded cast, unspecified region
5.4
9.7
19
36
G04BD11
ATC
fesoterodine; oral
3.8
9.7
29
78
R60.9
ICD-10 Finland
Oedema, unspecified
2.6
9.6
56
224
L81
ICPC
Injury musculoskeletal NOS
3.6
9.6
31
88
ABD30
NOMESCO Finland
Implantation of spinal stimulation device
9.2
9.6
19
21
A09
ICD-10 Finland
Other gastroenteritis and colitis of infectious and unspecified origin
1.8
9.5
157
943
R4130
NOMESCO Finland
Speech therapy
3.4
9.5
34
103
X58
ICD-10 Finland
Exposure to other specified factors
1.9
9.5
137
789
R52.9
ICD-10 Finland
Pain, unspecified
2.1
9.5
98
503
K62.5
ICD-10 Finland
Haemorrhage of anus and rectum
2.6
9.5
57
232
L17
ICPC
Foot/toe symptom/complaint
1.6
9.5
255
1755
NH1BA
NOMESCO Finland
Ankle extensive X-ray examination
3.7
9.4
30
84
S24.1
ICD-10 Finland
Other and unspecified injuries of thoracic spinal cord
101.1
9.4
10
*
6BA02, ,
NOMESCO Finland
30.4
9.4
12
*
NA1EA
NOMESCO Finland
Cervical spine X-ray examination with flexion
5.2
9.4
19
37
G83.2
ICD-10 Finland
Monoplegia of upper limb
+∞
9.4
9
*
A211_, ,
NOMESCO Finland
+∞
9.4
9
*
Z03.9
ICD-10 Finland
Observation for suspected disease or condition, unspecified
1.8
9.4
160
972
N45.9
ICD-10 Finland
Orchitis, epididymitis and epididymo-orchitis without abscess
3.7
9.3
29
80
J01EE01
ATC
sulfamethoxazole and trimethoprim; systemic
2.5
9.3
57
234
SPAT1217
SPAT
Assessment of need for services (elderly/care support)
2.3
9.3
71
323
KCE02
NOMESCO Finland
Transluminal endoscopic extraction of calculus from bladder
7.4
9.3
21
29
Z02.7
ICD-10 Finland
Issue of medical certificate
2.3
9.2
75
350
L03.9
ICD-10 Finland
Cellulitis, unspecified
4.0
9.2
26
67
A03FA01
ATC
metoclopramide; systemic, rectal
1.7
9.2
190
1219
D12
ICPC
Constipation
2.9
9.1
43
154
GBB00
NOMESCO Finland
Tracheostomy
5.1
9.1
19
38
I63.9
ICD-10 Finland
Cerebral infarction, unspecified
2.0
9.1
101
532
N05BA04
ATC
oxazepam; oral
1.7
9.0
225
1516
I26.9
ICD-10 Finland
Pulmonary embolism without mention of acute cor pulmonale
2.5
9.0
58
244
M81.9
ICD-10 Finland
Osteoporosis, unspecified
2.9
9.0
42
150
TJF80
NOMESCO Finland
Ostomy education
7.6
9.0
20
27
N30.1
ICD-10 Finland
Interstitial cystitis (chronic)
7.6
9.0
20
27
L03AX13
ATC
glatiramer acetate; parenteral
18.8
8.9
13
7
X50
ICD-10 Finland
Overexertion and strenuous or repetitive movements
3.8
8.9
27
73
G95.2
ICD-10 Finland
Cord compression, unspecified
24.3
8.9
12
5
G04.9
ICD-10 Finland
Encephalitis, myelitis and encephalomyelitis, unspecified
24.3
8.9
12
5
TPH30
NOMESCO Finland
Insertion of central venous catheter through periferal vein
4.0
8.9
25
64
M80.0
ICD-10 Finland
Postmenopausal osteoporosis with pathological fracture
4.6
8.9
21
47
Y83.9
ICD-10 Finland
Surgical procedure, unspecified as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure
3.0
8.9
38
129
F10.1
ICD-10 Finland
Mental and behavioural disorders due to use of alcohol, Harmful use
2.2
8.9
72
336
WX730
NOMESCO Finland
Conventional respirator
4.7
8.9
20
43
Z73.6
ICD-10 Finland
Limitation of activities due to disability
8.7
8.8
18
21
F32.2
ICD-10 Finland
Severe depressive episode without psychotic symptoms
2.4
8.8
60
259
ZXD10
NOMESCO Finland
Scheduled procedure
1.6
8.8
304
2214
K07
ICPC
Swollen ankles/oedema
2.7
8.8
48
186
AA1CM
NOMESCO Finland
Extensive MRI examination of brain with 3 Tesla magnet
4.2
8.8
23
56
R5140
NOMESCO Finland
Monitoring the use of the aid
2.0
8.7
105
569
N17.9
ICD-10 Finland
Acute renal failure, unspecified
2.8
8.7
44
164
Z71.8
ICD-10 Finland
Other specified counselling
1.6
8.7
278
1988
JN1AE
NOMESCO Finland
Ultrasound examination of upper part of abdomen
2.1
8.7
85
428
JN2AE
NOMESCO Finland
Ultrasound examination of lower part of abdomen without contrast
4.8
8.6
19
40
M47.9
ICD-10 Finland
Spondylosis, unspecified
3.2
8.6
33
105
D17
ICPC
Incontinence of bowel
7.0
8.6
20
29
ABD99
NOMESCO Finland
Other operation on spinal cord or nerve for pain or impaired function
16.5
8.6
13
8
SPAT1260
SPAT
Consultation of another employee
1.8
8.6
146
885
KF8AE
NOMESCO Finland
Ultrasound examination of scrotum
3.3
8.6
31
95
NG1AA
NOMESCO Finland
Knee X-ray examination without contrast
1.9
8.5
110
610
M54.9
ICD-10 Finland
Dorsalgia, unspecified
1.9
8.5
112
626
M79.2
ICD-10 Finland
Neuralgia and neuritis, unspecified
3.7
8.5
26
71
NA7AD
NOMESCO Finland
Spine CT
27.8
8.5
11
*
RS142, ,
NOMESCO Finland
27.8
8.5
11
*
ABC53
NOMESCO Finland
Decompression of thoracic spinal canal and nerve roots
27.8
8.5
11
*
R69
ICD-10 Finland
Unknown and unspecified causes of morbidity
4.0
8.5
24
62
GD1AD
NOMESCO Finland
Thorax CT examination
2.3
8.4
64
290
D33.4
ICD-10 Finland
Benign neoplasm: Spinal cord
90.9
8.4
9
*
R06.0
ICD-10 Finland
Dyspnoea
1.6
8.4
236
1634
3430A
ICD-9 Finland
Infantile cerebral palsy, Diplegic
+∞
8.3
8
*
Q82.2
ICD-10 Finland
Mastocytosis
+∞
8.3
8
*
ABB20
NOMESCO Finland
Drainage of intra- or extramedullary cyst of spinal canal
+∞
8.3
8
*
G37.3
ICD-10 Finland
Acute transverse myelitis in demyelinating disease of central nervous system
+∞
8.3
8
*
G83.3
ICD-10 Finland
Monoplegia, unspecified
+∞
8.3
8
*
AEA40
NOMESCO Finland
Removal of implanted pump of injection device in the nervous system
+∞
8.3
8
*
R1410
NOMESCO Finland
Drawing up a rehabilitation plan
8.6
8.3
17
20
NA3EA
NOMESCO Finland
Lumbar spine X-ray examination with flexion
3.2
8.3
33
107
A03
ICPC
Fever
1.8
8.3
145
884
N30
ICD-10 Finland
Cystitis
2.2
8.3
72
345
J01CF05
ATC
flucloxacillin; systemic
2.2
8.3
74
359
SPAT1172
SPAT
Guidance concerning hydration
3.9
8.3
24
63
NFQ20
NOMESCO Finland
Amputation of femur
7.2
8.3
19
27
D50.9
ICD-10 Finland
Iron deficiency anaemia, unspecified
2.1
8.2
75
367
A06AC01
ATC
ispaghula (psylla seeds); oral
1.6
8.2
217
1479
Z98.8
ICD-10 Finland
Other specified postsurgical states
4.6
8.1
19
42
N05AF03
ATC
chlorprothixene; systemic
3.5
8.1
27
78
F43.29
ICD-10 Finland
Adaptation disorder UNS
3.5
8.1
27
78
RJ630, ,
NOMESCO Finland
33.7
8.1
10
*
J15.9
ICD-10 Finland
Bacterial pneumonia, unspecified
2.0
8.1
85
439
J01EE02
ATC
sulfadiazine and trimethoprim; systemic
1.6
8.1
227
1570
S29
ICPC
Skin symptom/complaint other
1.7
8.0
168
1077
ZXE05
NOMESCO Finland
Procedure duration 40 to 49 minutes
2.6
8.0
47
189
KCW98
NOMESCO Finland
Other transluminal endoscopic operation on bladder
22.3
8.0
11
5
H05BA01
ATC
calcitonin (salmon synthetic); nasal, parenteral
3.2
8.0
31
99
ZXE40
NOMESCO Finland
More than seven and less than nine hours
3.6
8.0
26
74
NB1AA
NOMESCO Finland
Shoulder X-ray examination without contrast
2.2
8.0
69
330
D07BA04
ATC
hydrocortisone and antiseptics; topical
2.0
8.0
84
434
SPAT1245
SPAT
Provision of support and information to patient’s family members
2.7
8.0
43
166
A29
ICPC
General symptom/complaint other
1.8
7.9
125
739
L02.3
ICD-10 Finland
Cutaneous abscess, furuncle and carbuncle of buttock
3.5
7.9
26
75
E87.1
ICD-10 Finland
Hypo-osmolality and hyponatraemia
2.7
7.8
41
156
SPAT1211
SPAT
Application of soft bandage
2.1
7.8
76
382
NE1AD
NOMESCO Finland
Pelvis and hip bones CT examination
3.2
7.7
30
96
SPAT1144
SPAT
Treatment of reopened or infected surgical wound
2.2
7.7
65
308
Y85.0
ICD-10 Finland
Sequelae of motor-vehicle accident
45.4
7.7
9
*
N05AH04
ATC
quetiapine; oral
1.7
7.7
157
1000
F10.00
ICD-10 Finland
Alcohol-related acute intoxication uncomplicated
3.8
7.7
23
62
L03.0
ICD-10 Finland
Cellulitis of finger and toe
2.1
7.6
78
399
KDV20
NOMESCO Finland
Submucous urethral injection
18.5
7.6
11
6
H02AB09
ATC
hydrocortisone; systemic
3.5
7.6
25
72
L03AB08
ATC
interferon beta-1b; parenteral
25.3
7.6
10
*
JFF27
NOMESCO Finland
Laparoscopic sigmoidostomy
25.3
7.6
10
*
ZXM20
NOMESCO Finland
Intraoperative use of computerised tomography
6.2
7.6
19
31
ZZA00
NOMESCO Finland
Split skin graft
2.9
7.5
35
125
J01DB01
ATC
cefalexin; oral
1.6
7.5
676
5984
TNX50
NOMESCO Finland
Removal of cutom molded cast and internal stretch
2.6
7.4
44
178
ZZR00
NOMESCO Finland
Flap of skin
3.5
7.4
25
73
V29.9
ICD-10 Finland
Motorcycle rider [any] injured in unspecified traffic accident
6.5
7.4
18
28
T09.3
ICD-10 Finland
Injury of spinal cord, level unspecified
80.8
7.4
8
*
G80.9
ICD-10 Finland
Cerebral palsy, unspecified
80.8
7.4
8
*
80621
ICD-8 Finland
Fracture and fracture dislocation of vertebral column with spinal cord lesion, Thoracica, Non complicata (sive NUD)
80.8
7.4
8
*
QBA10
NOMESCO Finland
Incision of skin of trunk
6.0
7.4
19
32
M54.5
ICD-10 Finland
Low back pain
1.5
7.4
294
2192
F60.30
ICD-10 Finland
Emotionally unstable personality disorder, impulsive
4.1
7.4
20
50
U06
ICPC
Haematuria
3.1
7.4
30
99
N05CD07
ATC
temazepam; oral
1.9
7.4
102
579
I69.3
ICD-10 Finland
Sequelae of cerebral infarction
2.0
7.4
77
397
H53.2
ICD-10 Finland
Diplopia
2.9
7.3
34
121
L95
ICPC
Osteoporosis
2.8
7.3
37
138
WX402
NOMESCO Finland
General anaesthesia
1.6
7.3
181
1210
Y86
ICD-10 Finland
Sequelae of other accidents
11.0
7.3
13
12
YN7AD
NOMESCO Finland
CT examination of spine for dose design of radiotherapy
11.0
7.3
13
12
5965X
ICD-9 Finland
Other disorders of bladder, Other functional disorders of bladder[ALIA FUNCTIO LAESA VESICAE URINARIAE]
+∞
7.3
7
*
D33.41
ICD-10 Finland
Myxopapillary epndymoma of the spinal cord (grade I)
+∞
7.3
7
*
M81.2
ICD-10 Finland
Osteoporosis of disuse
+∞
7.3
7
*
J01XX08
ATC
linezolid; systemic
9.5
7.3
14
15
379
Kela drug reimbursment
Apixaban, dabigatran, edoxaban and rivaroxaban for the long-term prevention of recurrent deep veinthrombosis and pulmonary embolism
3.0
7.3
31
105
RS221, ,
NOMESCO Finland
4.4
7.2
18
42
TNH33
NOMESCO Finland
Custom moulded brace, ankle or foot
4.4
7.2
18
42
3459X
ICD-9 Finland
Epilepsy, unspecified
15.9
7.2
11
7
A02BC01
ATC
omeprazole; systemic
1.6
7.2
216
1511
R1210
NOMESCO Finland
Medical assessment of need and possibilities to rehabilitation
4.5
7.2
17
38
ZY000
NOMESCO Finland
Hospital inpatient
4.5
7.2
17
38
X57
ICD-10 Finland
Unspecified privation
3.2
7.2
28
90
J09
ICD-10 Finland
Influenza due to identified zoonotic or pandemic influenza virus
3.0
7.2
31
106
T81.0
ICD-10 Finland
Haemorrhage and haematoma complicating a procedure, not elsewhere classified
2.2
7.2
59
277
D50.0
ICD-10 Finland
Iron deficiency anaemia secondary to blood loss (chronic)
2.9
7.2
33
117
XG466
NOMESCO Finland
Sleep oxymetry
2.9
7.2
33
117
U72
ICPC
Urethritis
3.5
7.2
24
70
D33.40
ICD-10 Finland
Benign glioma of the spinal cord (grade I)
30.3
7.2
9
*
NA7FT
NOMESCO Finland
Labeling lesion in spinal area with X-ray guidance
30.3
7.2
9
*
M86.4
ICD-10 Finland
Chronic osteomyelitis with draining sinus
30.3
7.2
9
*
G06.1
ICD-10 Finland
Intraspinal abscess and granuloma
30.3
7.2
9
*
M54.4
ICD-10 Finland
Lumbago with sciatica
1.7
7.1
147
937
Z93.5
ICD-10 Finland
Cystostomy status
20.2
7.1
10
5
RK112, ,
NOMESCO Finland
20.2
7.1
10
5
A81
ICPC
Multiple trauma/injuries
20.2
7.1
10
5
G99.2*M50.0
ICD-10 Finland
Cervical disc disorder with myelopathy
8.0
7.1
15
19
RK110, ,
NOMESCO Finland
8.0
7.1
15
19
NA3CM
NOMESCO Finland
Lumbar spine extensive MRI examination with 3 Tesla magnet
12.1
7.1
12
10
ABC66
NOMESCO Finland
Decompression of lumbal spinal channel
12.1
7.1
12
10
H02AB07
ATC
prednisone; oral
1.8
7.1
116
694
F61.0
ICD-10 Finland
Mixed personality disorders
4.4
7.0
17
39
JF1AB
NOMESCO Finland
Passage examination of small bowell with X-ray
4.4
7.0
17
39
J01DA01
ATC
[U] cefalexin
1.5
7.0
491
4090
SPAT1296
SPAT
Other function in accordance with occupational therapy nomenclature
6.4
7.0
17
27
J45.9
ICD-10 Finland
Asthma, unspecified
1.7
6.9
156
1017
S82.2
ICD-10 Finland
Fracture of shaft of tibia
3.8
6.9
21
57
G57.3
ICD-10 Finland
Lesion of lateral popliteal nerve
3.8
6.9
21
57
XF600
NOMESCO Finland
Bloodpressure measurement
2.2
6.9
57
268
KH1AD
NOMESCO Finland
CT of urinary organs
2.7
6.9
35
131
NAU20
NOMESCO Finland
Removal of internal fixation device from spine or neck
13.9
6.9
11
8
ZXA05
NOMESCO Finland
Left side
1.6
6.9
195
1346
S70.0
ICD-10 Finland
Contusion of hip
2.5
6.9
41
167
ZX114
NOMESCO Finland
Intramuscular
4.2
6.8
18
44
A04.7
ICD-10 Finland
Enterocolitis due to Clostridium difficile
3.1
6.8
28
93
KH1AT
NOMESCO Finland
Urinary tract cathetrisation with ultrasound guidance
11.0
6.8
12
11
SPAT1293
SPAT
Other function in accordance with rehabilitation guidance nomenclature
11.0
6.8
12
11
NAW10
NOMESCO Finland
Reoperation for superficial infection in in surgery of spine or neck
40.4
6.8
8
*
N32.89
ICD-10 Finland
Other specified disorders of bladder
40.4
6.8
8
*
Q28.8
ICD-10 Finland
Other specified congenital malformations of circulatory system
40.4
6.8
8
*
M41.5
ICD-10 Finland
Other secondary scoliosis
16.8
6.8
10
6
RS314, ,
NOMESCO Finland
16.8
6.8
10
6
R10.3
ICD-10 Finland
Pain localized to other parts of lower abdomen
1.6
6.7
170
1141
TKC20, ,
SPAT
7.3
6.7
15
21
TAA40
NOMESCO Finland
Cathetrisation of cerebrospinal fluid through skin
22.7
6.7
9
*
TNX00
NOMESCO Finland
Puncture and needle biopsy of soft tissue, unspecified region
3.8
6.7
20
54
XX3DW
NOMESCO Finland
Time consuming IT work
1.8
6.6
93
530
XQ858
NOMESCO Finland
Oxygen partial pressure measurement
6.0
6.6
17
29
Z93.3
ICD-10 Finland
Colostomy status
7.9
6.6
14
18
M05BB03
ATC
alendronic acid and colecalciferol; oral
3.6
6.6
21
59
R11
ICD-10 Finland
Nausea and vomiting
1.9
6.6
78
420
NB1AE
NOMESCO Finland
Shoulder ultrasound examination
3.5
6.6
22
64
G61.9
ICD-10 Finland
Inflammatory polyneuropathy, unspecified
12.4
6.6
11
9
ZXE06
NOMESCO Finland
Procedure duration 50 to 59 minutes
2.3
6.6
47
208
Y88.3
ICD-10 Finland
Sequelae of surgical and medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure
2.9
6.6
30
106
R5140, ,
SPAT
3.9
6.6
19
50
SPAT1299
SPAT
Other function in accordance with podiatry nomenclature
3.9
6.6
19
50
WX213
NOMESCO Finland
Lower leg blockade
6.9
6.5
15
22
JAH01
NOMESCO Finland
Laparoscopy
2.5
6.5
40
165
T78.4
ICD-10 Finland
Allergy, unspecified
2.6
6.5
36
141
AA1BD
NOMESCO Finland
Extensive CT of head and brain
3.2
6.5
25
80
TNX33
NOMESCO Finland
Custom moulded cast, unspecified region
2.3
6.5
48
216
G40.22
ICD-10 Finland
Complex partial epileptic seizure with secondary generalization
3.4
6.5
22
65
Z43.0
ICD-10 Finland
Attention to tracheostomy
70.4
6.4
7
*
9222
FHL
Surgery for a fresh back injury
70.4
6.4
7
*
D33.43
ICD-10 Finland
Spinal cord
70.4
6.4
7
*
H02AB06
ATC
prednisolone; systemic
1.4
6.4
379
3036
WX704
NOMESCO Finland
Intubation
2.0
6.4
70
367
ZXD40
NOMESCO Finland
Procedure on patient requiring isolation
14.4
6.4
10
7
I50.0
ICD-10 Finland
Congestive heart failure
2.0
6.4
69
360
SPAT1256
SPAT
Intramuscular and subcutaneous injection
1.5
6.4
319
2476
Z00.0
ICD-10 Finland
General medical examination
1.6
6.4
158
1055
R5130
NOMESCO Finland
Repair work or maintenance done on the aid
2.5
6.4
38
155
M96.1
ICD-10 Finland
Postlaminectomy syndrome, not elsewhere classified
8.2
6.3
13
16
7819X
ICD-9 Finland
Symptoms involving nervous and musculoskeletal systems, Other symptoms involving nervous and musculoskeletal systems[SYMPTOMATA ALIA SYSTEMATIS NERVORUM ET MUSCULOSCEL]
8.2
6.3
13
16
E87.5
ICD-10 Finland
Hyperkalaemia
3.6
6.3
20
56
RK220, ,
NOMESCO Finland
11.1
6.3
11
10
NAG41
NOMESCO Finland
Anterior fusion of cervical spine with fixation
9.3
6.3
12
13
TNX39
NOMESCO Finland
Other orthopedic bandage, unspecified region
3.9
6.3
18
47
L02.2
ICD-10 Finland
Cutaneous abscess, furuncle and carbuncle of trunk
2.4
6.3
43
187
T93.1
ICD-10 Finland
Sequelae of fracture of femur
18.2
6.3
9
5
Y83.8
ICD-10 Finland
Other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure
2.8
6.3
30
109
OAA67, ,
SPAT
0.4
6.3
38
830
C72.09
ICD-10 Finland
Malignant tumor of the spinal cord other histology
+∞
6.3
6
*
C41.20
ICD-10 Finland
Malignant tumor of the spine without histology
+∞
6.3
6
*
L04AA31
ATC
[U] teriflunomide
+∞
6.3
6
*
ABB50
NOMESCO Finland
Decompression of spinal canal for lesion of spinal cord or nerve root
+∞
6.3
6
*
3BX01, ,
NOMESCO Finland
+∞
6.3
6
*
C41.29
ICD-10 Finland
Malignant tumor of the spine other or unspecified histology
+∞
6.3
6
*
T91.8
ICD-10 Finland
Sequelae of other specified injuries of neck and trunk
26.9
6.2
8
*
J46
ICD-10 Finland
Status asthmaticus
3.1
6.2
25
82
E04.9
ICD-10 Finland
Nontoxic goitre, unspecified
4.0
6.2
17
43
R52.0
ICD-10 Finland
Acute pain
2.6
6.2
35
139
Z04.8
ICD-10 Finland
Examination and observation for other specified reasons
1.7
6.2
106
642
M01AE03
ATC
ketoprofen; systemic, rectal
1.5
6.2
289
2211
I84.9
ICD-10 Finland
Unspecified hemorrhoids without complication
2.4
6.1
40
170
T81.3
ICD-10 Finland
Disruption of operation wound, not elsewhere classified
3.1
6.1
24
78
N07BC02
ATC
methadone; systemic
8.7
6.1
12
14
DM1QA
NOMESCO Finland
Paranasal sinuses X-ray examination in one projection
2.4
6.1
40
171
KCV04
NOMESCO Finland
Distension of bladder with fluid
6.8
6.0
14
21
R2130
NOMESCO Finland
Counselling and guidance which enhance independent living
1.9
6.0
71
382
UJF45
NOMESCO Finland
Flexible sigmoidoscopy with biopsy
1.9
6.0
70
375
G04BE01
ATC
alprostadil; parenteral, urethral
3.3
6.0
22
68

TimeCodeWAS

↥

TODO / Current known limitations:

  • Only showing the top 300 codes, because showing all (sometimes 20k) makes the page too slow.
  • Legend / how to read the glyphs.
  • Show details (e.g. Fisher or Chi-square test, LR+, etc.) when clicking on a row.
  • Explanation on the underlying data / how the TimeCodeWAS is done (e.g. matched cases / controls, eligibility).
  • Download CSV.
  • No filters and sorters.
  • Limited amount of endpoints (~400) having TimeCodeWAS data.
  • Cross-links to Risteys lab test pages for lab test codes.
OMOP concept
ln(OR)
%cases with code / %controls with code
2×2 table
Inpatient Hospital
21 [8717]
8.2e-01
1.6e+00
2.8e+00
6.9e+00
3.2e+00
2.0e+00
1.2e+00
cases:51.50%
controls:31.86%
cases:36.22%
controls:10.41%
cases:20.10%
controls:1.49%
cases:36.82%
controls:0.06%
cases:29.72%
controls:1.77%
cases:43.69%
controls:9.90%
cases:55.66%
controls:27.36%
428
2644
403
5656
301
864
530
7436
167
124
664
8176
306
5
525
8295
244
147
577
8140
329
805
424
7323
364
1991
290
5287
Neurosurgery
14 [38004459]
1.7e+00
2.5e+00
3.7e+00
1.0e+50
4.3e+00
3.4e+00
2.2e+00
cases:9.87%
controls:1.89%
cases:9.15%
controls:0.78%
cases:4.45%
controls:0.12%
cases:5.42%
controls:0.00%
cases:9.26%
controls:0.13%
cases:18.19%
controls:0.71%
cases:16.67%
controls:2.07%
82
157
749
8143
76
65
755
8235
37
10
794
8290
45
0
786
8300
76
11
745
8276
137
58
616
8070
109
151
545
7127
baclofen; oral, parenteral
M03BX01 [21604115]
3.8e+00
4.0e+00
—
—
—
4.0e+00
4.3e+00
cases:4.21%
controls:0.10%
cases:3.97%
controls:0.07%
—
—
—
—
—
—
cases:8.90%
controls:0.17%
cases:13.61%
controls:0.21%
35
8
796
8292
33
6
798
8294
—
—
—
67
14
686
8114
89
15
565
7263
Emergency Room Visit
ER [9203]
7.5e-01
1.4e+00
2.8e+00
6.3e+00
2.5e+00
1.4e+00
1.0e+00
cases:46.69%
controls:29.18%
cases:32.85%
controls:10.66%
cases:19.74%
controls:1.49%
cases:28.28%
controls:0.07%
cases:15.83%
controls:1.50%
cases:32.14%
controls:10.53%
cases:56.57%
controls:31.49%
388
2422
443
5878
273
885
558
7415
164
124
667
8176
235
6
596
8294
130
124
691
8163
242
856
511
7272
370
2292
284
4986
Spinal stenosis
M48.0 [45557888]
1.6e+00
2.7e+00
3.4e+00
1.0e+50
3.6e+00
3.0e+00
1.7e+00
cases:5.54%
controls:1.22%
cases:6.02%
controls:0.42%
cases:2.53%
controls:0.08%
cases:3.25%
controls:0.00%
cases:3.78%
controls:0.11%
cases:9.96%
controls:0.57%
cases:8.26%
controls:1.58%
46
101
785
8199
50
35
781
8265
21
7
810
8293
27
0
804
8300
31
9
790
8278
75
46
678
8082
54
115
600
7163
Neurology
13 [38004458]
1.3e+00
2.0e+00
2.8e+00
—
4.1e+00
3.2e+00
2.2e+00
cases:26.59%
controls:8.88%
cases:22.38%
controls:3.94%
cases:9.39%
controls:0.60%
—
—
cases:30.57%
controls:0.75%
cases:51.39%
controls:3.96%
cases:51.22%
controls:10.06%
221
737
610
7563
186
327
645
7973
78
50
753
8250
—
251
62
570
8225
387
322
366
7806
335
732
319
6546
Decubitus ulcer and pressure area
L89 [45601235]
3.0e+00
3.4e+00
—
1.0e+50
1.0e+50
4.1e+00
4.2e+00
cases:2.41%
controls:0.12%
cases:1.81%
controls:0.06%
—
—
cases:1.81%
controls:0.00%
cases:2.07%
controls:0.00%
cases:4.78%
controls:0.09%
cases:7.03%
controls:0.11%
20
10
811
8290
15
5
816
8295
—
15
0
816
8300
17
0
804
8287
36
7
717
8121
46
8
608
7270
Anesthesiology Critical Care Medicine
OMOP4821991 [45756751]
1.8e+00
2.1e+00
2.6e+00
—
2.7e+00
2.4e+00
2.2e+00
cases:3.13%
controls:0.55%
cases:2.53%
controls:0.30%
cases:1.08%
controls:0.08%
—
—
cases:0.85%
controls:0.06%
cases:3.72%
controls:0.33%
cases:6.27%
controls:0.71%
26
46
805
8254
21
25
810
8275
9
7
822
8293
—
7
5
814
8282
28
27
725
8101
41
52
613
7226
General Surgery
2 [38004447]
7.1e-01
1.3e+00
2.4e+00
4.7e+00
2.2e+00
1.5e+00
9.1e-01
cases:32.61%
controls:19.20%
cases:19.86%
controls:6.17%
cases:9.15%
controls:0.89%
cases:7.70%
controls:0.07%
cases:7.67%
controls:0.92%
cases:21.25%
controls:5.81%
cases:34.10%
controls:17.22%
271
1594
560
6706
165
512
666
7788
76
74
755
8226
64
6
767
8294
63
76
758
8211
160
472
593
7656
223
1253
431
6025
Rehabilitation Hospital
283X00000X [38004285]
2.2e+00
3.5e+00
—
1.0e+50
—
3.9e+00
3.7e+00
cases:3.73%
controls:0.45%
cases:4.21%
controls:0.13%
—
—
cases:2.05%
controls:0.00%
—
—
cases:5.44%
controls:0.11%
cases:9.48%
controls:0.25%
31
37
800
8263
35
11
796
8289
—
17
0
814
8300
—
41
9
712
8119
62
18
592
7260
Limited function/disability (L)
L28 [2002000647]
1.2e+00
2.2e+00
2.6e+00
—
3.2e+00
2.5e+00
1.6e+00
cases:4.21%
controls:1.30%
cases:4.09%
controls:0.46%
cases:1.93%
controls:0.14%
—
—
cases:2.56%
controls:0.11%
cases:7.17%
controls:0.63%
cases:11.31%
controls:2.50%
35
108
796
8192
34
38
797
8262
16
12
815
8288
—
21
9
800
8278
54
51
699
8077
74
182
580
7096
methenamine; oral
J01XX05 [21603065]
2.2e+00
2.6e+00
—
—
2.7e+00
3.0e+00
2.8e+00
cases:1.68%
controls:0.19%
cases:1.68%
controls:0.13%
—
—
—
—
cases:0.85%
controls:0.06%
cases:3.32%
controls:0.17%
cases:5.20%
controls:0.33%
14
16
817
8284
14
11
817
8289
—
—
7
5
814
8282
25
14
728
8114
34
24
620
7254
oxycodone; oral, parenteral
N02AA05 [21604260]
1.6e+00
2.3e+00
2.9e+00
—
2.4e+00
2.2e+00
1.7e+00
cases:4.69%
controls:0.98%
cases:5.54%
controls:0.57%
cases:2.89%
controls:0.17%
—
—
cases:2.31%
controls:0.21%
cases:6.37%
controls:0.74%
cases:9.94%
controls:2.01%
39
81
792
8219
46
47
785
8253
24
14
807
8286
—
19
17
802
8270
48
60
705
8068
65
146
589
7132
Physical Medicine And Rehabilitation
25 [38004468]
1.1e+00
1.7e+00
2.6e+00
1.0e+50
3.3e+00
2.6e+00
1.8e+00
cases:14.68%
controls:5.30%
cases:9.51%
controls:1.95%
cases:3.49%
controls:0.27%
cases:5.78%
controls:0.00%
cases:6.21%
controls:0.25%
cases:21.65%
controls:2.07%
cases:29.20%
controls:6.20%
122
440
709
7860
79
162
752
8138
29
22
802
8278
48
0
783
8300
51
21
770
8266
163
168
590
7960
191
451
463
6827
clonazepam; oral, parenteral
N03AE01 [21604415]
1.6e+00
2.1e+00
2.0e+00
—
2.1e+00
2.5e+00
2.5e+00
cases:3.73%
controls:0.76%
cases:3.49%
controls:0.46%
cases:1.20%
controls:0.16%
—
—
cases:1.22%
controls:0.14%
cases:5.71%
controls:0.48%
cases:9.48%
controls:0.82%
31
63
800
8237
29
38
802
8262
10
13
821
8287
—
10
12
811
8275
43
39
710
8089
62
60
592
7218
Office Visit
OMOP4822458 [581477]
8.2e-01
1.5e+00
2.9e+00
—
3.9e+00
2.3e+00
1.4e+00
cases:16.37%
controls:7.93%
cases:9.75%
controls:2.45%
cases:5.29%
controls:0.30%
—
—
cases:11.69%
controls:0.27%
cases:19.79%
controls:2.51%
cases:25.99%
controls:7.68%
136
658
695
7642
81
203
750
8097
44
25
787
8275
—
96
22
725
8265
149
204
604
7924
170
559
484
6719
Lumbar spine X-ray examination without contrast
NA3AA [2001307026]
1.6e+00
2.7e+00
3.5e+00
1.0e+50
1.0e+50
2.7e+00
2.1e+00
cases:3.49%
controls:0.70%
cases:3.13%
controls:0.22%
cases:2.05%
controls:0.06%
cases:1.44%
controls:0.00%
cases:1.10%
controls:0.00%
cases:4.25%
controls:0.30%
cases:5.81%
controls:0.71%
29
58
802
8242
26
18
805
8282
17
5
814
8295
12
0
819
8300
9
0
812
8287
32
24
721
8104
38
52
616
7226
Physiotherapy
R4110 [2001310233]
8.4e-01
1.8e+00
2.3e+00
1.0e+50
4.2e+00
2.2e+00
1.4e+00
cases:7.70%
controls:3.47%
cases:6.38%
controls:1.16%
cases:2.17%
controls:0.23%
cases:5.17%
controls:0.00%
cases:6.70%
controls:0.11%
cases:9.30%
controls:1.08%
cases:11.93%
controls:3.33%
64
288
767
8012
53
96
778
8204
18
19
813
8281
43
0
788
8300
55
9
766
8278
70
88
683
8040
78
242
576
7036
Physiotherapist
Z3226 [2001311560]
1.0e+00
2.0e+00
2.1e+00
1.0e+50
3.8e+00
2.1e+00
1.6e+00
cases:5.42%
controls:1.99%
cases:3.73%
controls:0.53%
cases:0.96%
controls:0.12%
cases:2.17%
controls:0.00%
cases:2.68%
controls:0.06%
cases:3.85%
controls:0.49%
cases:7.34%
controls:1.64%
45
165
786
8135
31
44
800
8256
8
10
823
8290
18
0
813
8300
22
5
799
8282
29
40
724
8088
48
119
606
7159
Outpatient Visit
OP [9202]
6.0e-01
8.7e-01
1.1e+00
4.5e+00
1.7e+00
1.8e+00
1.7e+00
cases:74.97%
controls:62.14%
cases:64.50%
controls:43.29%
cases:25.15%
controls:9.67%
cases:32.37%
controls:0.52%
cases:35.81%
controls:9.63%
cases:82.34%
controls:43.44%
cases:93.58%
controls:73.15%
623
5158
208
3142
536
3593
295
4707
209
803
622
7497
269
43
562
8257
294
798
527
7489
620
3531
133
4597
612
5324
42
1954
Internal Medicine
11 [38004456]
6.9e-01
1.0e+00
2.1e+00
4.5e+00
1.8e+00
1.2e+00
8.8e-01
cases:34.18%
controls:20.73%
cases:21.30%
controls:8.99%
cases:10.95%
controls:1.53%
cases:6.98%
controls:0.08%
cases:9.26%
controls:1.70%
cases:24.70%
controls:8.90%
cases:39.91%
controls:21.68%
284
1721
547
6579
177
746
654
7554
91
127
740
8173
58
7
773
8293
76
141
745
8146
186
723
567
7405
261
1578
393
5700
Fitting and adjustment of other specified devices
Z46.8 [45581035]
2.0e+00
3.2e+00
—
—
1.0e+50
3.8e+00
3.1e+00
cases:1.44%
controls:0.19%
cases:1.44%
controls:0.06%
—
—
—
—
cases:0.73%
controls:0.00%
cases:3.05%
controls:0.07%
cases:5.20%
controls:0.25%
12
16
819
8284
12
5
819
8295
—
—
6
0
815
8287
23
6
730
8122
34
18
620
7260
Prothrombin time (PT) actual/Normal
5894-1 [3033658]
6.6e-01
1.3e+00
3.4e+00
1.0e+50
4.1e+00
1.3e+00
1.1e+00
cases:5.78%
controls:3.06%
cases:5.17%
controls:1.47%
cases:2.89%
controls:0.10%
cases:2.89%
controls:0.00%
cases:4.99%
controls:0.08%
cases:3.98%
controls:1.14%
cases:10.40%
controls:3.64%
48
254
783
8046
43
122
788
8178
24
8
807
8292
24
0
807
8300
41
7
780
8280
30
93
723
8035
68
265
586
7013
pregabalin; oral
N02BF02 [955152]
1.2e+00
1.8e+00
2.2e+00
—
2.1e+00
2.5e+00
1.9e+00
cases:9.51%
controls:3.06%
cases:8.06%
controls:1.47%
cases:4.21%
controls:0.47%
—
—
cases:4.02%
controls:0.53%
cases:14.87%
controls:1.37%
cases:18.50%
controls:3.27%
79
254
752
8046
67
122
764
8178
35
39
796
8261
—
33
44
788
8243
112
111
641
8017
121
238
533
7040
Bacteria identified in Blood by Culture
600-7 [3023368]
9.2e-01
1.7e+00
3.1e+00
1.0e+50
3.2e+00
1.5e+00
1.3e+00
cases:6.62%
controls:2.73%
cases:5.54%
controls:1.07%
cases:3.01%
controls:0.14%
cases:1.32%
controls:0.00%
cases:4.99%
controls:0.21%
cases:5.58%
controls:1.32%
cases:13.61%
controls:4.26%
55
227
776
8073
46
89
785
8211
25
12
806
8288
11
0
820
8300
41
17
780
8270
42
107
711
8021
89
310
565
6968
Retention of urine
R33 [45587507]
1.5e+00
2.2e+00
—
—
2.5e+00
3.1e+00
2.3e+00
cases:3.01%
controls:0.71%
cases:2.77%
controls:0.30%
—
—
—
—
cases:0.73%
controls:0.06%
cases:6.24%
controls:0.31%
cases:9.79%
controls:1.03%
25
59
806
8241
23
25
808
8275
—
—
6
5
815
8282
47
25
706
8103
64
75
590
7203
General Practice
1 [38004446]
8.5e-01
1.6e+00
2.7e+00
—
3.3e+00
2.0e+00
1.2e+00
cases:20.82%
controls:10.14%
cases:16.37%
controls:3.95%
cases:9.39%
controls:0.66%
—
—
cases:16.32%
controls:0.71%
cases:25.23%
controls:4.53%
cases:34.25%
controls:14.00%
173
842
658
7458
136
328
695
7972
78
55
753
8245
—
134
59
687
8228
190
368
563
7760
224
1019
430
6259
Protein [Mass/volume] in Serum or Plasma
2885-2 [3020630]
8.4e-01
2.0e+00
2.9e+00
—
3.8e+00
1.8e+00
1.0e+00
cases:1.68%
controls:0.73%
cases:1.68%
controls:0.24%
cases:1.08%
controls:0.06%
—
—
cases:2.68%
controls:0.06%
cases:1.86%
controls:0.31%
cases:2.75%
controls:1.03%
14
61
817
8239
14
20
817
8280
9
5
822
8295
—
22
5
799
8282
14
25
739
8103
18
75
636
7203
C reactive protein [Mass/volume] in Serum or Plasma
1988-5 [3020460]
2.1e-01
6.8e-01
1.9e+00
5.4e+00
2.3e+00
6.5e-01
4.3e-01
cases:20.58%
controls:17.40%
cases:20.10%
controls:11.33%
cases:14.32%
controls:2.39%
cases:11.79%
controls:0.06%
cases:18.51%
controls:2.16%
cases:21.38%
controls:12.39%
cases:36.85%
controls:27.47%
171
1444
660
6856
167
940
664
7360
119
198
712
8102
98
5
733
8295
152
179
669
8108
161
1007
592
7121
241
1999
413
5279
Magnesium [Moles/volume] in Serum or Plasma
2601-3 [3012095]
1.1e+00
1.7e+00
2.4e+00
—
3.4e+00
1.8e+00
9.6e-01
cases:4.57%
controls:1.60%
cases:3.49%
controls:0.63%
cases:0.96%
controls:0.08%
—
—
cases:3.53%
controls:0.12%
cases:3.59%
controls:0.63%
cases:5.96%
controls:2.36%
38
133
793
8167
29
52
802
8248
8
7
823
8293
—
29
10
792
8277
27
51
726
8077
39
172
615
7106
Home Visit
OMOP4822459 [581476]
9.8e-01
1.3e+00
2.0e+00
1.7e+00
2.1e+00
2.0e+00
1.4e+00
cases:6.98%
controls:2.75%
cases:6.86%
controls:2.05%
cases:4.09%
controls:0.60%
cases:0.96%
controls:0.17%
cases:4.51%
controls:0.57%
cases:14.74%
controls:2.40%
cases:20.18%
controls:6.10%
58
228
773
8072
57
170
774
8130
34
50
797
8250
8
14
823
8286
37
47
784
8240
111
195
642
7933
132
444
522
6834
Exposure to unspecified factor
X59 [45756412]
1.2e+00
1.6e+00
2.4e+00
—
2.7e+00
1.9e+00
1.4e+00
cases:5.17%
controls:1.65%
cases:2.41%
controls:0.48%
cases:0.96%
controls:0.08%
—
—
cases:1.10%
controls:0.07%
cases:3.19%
controls:0.47%
cases:7.34%
controls:1.95%
43
137
788
8163
20
40
811
8260
8
7
823
8293
—
9
6
812
8281
24
38
729
8090
48
142
606
7136
Urgent procedure
ZXD05 [2001311386]
8.6e-01
1.8e+00
2.9e+00
1.0e+50
3.3e+00
1.5e+00
9.3e-01
cases:7.82%
controls:3.46%
cases:6.74%
controls:1.14%
cases:2.05%
controls:0.12%
cases:2.29%
controls:0.00%
cases:2.92%
controls:0.11%
cases:3.72%
controls:0.89%
cases:8.72%
controls:3.61%
65
287
766
8013
56
95
775
8205
17
10
814
8290
19
0
812
8300
24
9
797
8278
28
72
725
8056
57
263
597
7015
Acute tubulo-interstitial nephritis
N10 [45543856]
9.8e-01
2.5e+00
—
1.0e+50
2.8e+00
2.8e+00
2.2e+00
cases:2.89%
controls:1.11%
cases:2.77%
controls:0.23%
—
—
cases:1.32%
controls:0.00%
cases:1.22%
controls:0.07%
cases:4.78%
controls:0.32%
cases:11.47%
controls:1.47%
24
92
807
8208
23
19
808
8281
—
11
0
820
8300
10
6
811
8281
36
26
717
8102
75
107
579
7171
gabapentin; oral
N02BF01 [955005]
1.3e+00
1.7e+00
2.1e+00
—
2.1e+00
2.2e+00
1.8e+00
cases:6.02%
controls:1.71%
cases:5.66%
controls:1.13%
cases:2.17%
controls:0.28%
—
—
cases:3.05%
controls:0.39%
cases:10.89%
controls:1.29%
cases:15.14%
controls:2.78%
50
142
781
8158
47
94
784
8206
18
23
813
8277
—
25
32
796
8255
82
105
671
8023
99
202
555
7076
Limited function/disability NOS
A28 [2002000162]
1.0e+00
1.8e+00
2.2e+00
—
2.3e+00
2.1e+00
1.6e+00
cases:2.89%
controls:1.06%
cases:4.45%
controls:0.73%
cases:2.53%
controls:0.28%
—
—
cases:3.17%
controls:0.31%
cases:7.57%
controls:0.97%
cases:11.16%
controls:2.39%
24
88
807
8212
37
61
794
8239
21
23
810
8277
—
26
26
795
8261
57
79
696
8049
73
174
581
7104
Creatine kinase [Enzymatic activity/volume] in Serum or Plasma
2157-6 [3007220]
7.1e-01
1.5e+00
3.0e+00
1.0e+50
3.5e+00
1.4e+00
9.0e-01
cases:6.02%
controls:3.05%
cases:5.17%
controls:1.20%
cases:3.61%
controls:0.18%
cases:3.01%
controls:0.00%
cases:5.48%
controls:0.17%
cases:4.91%
controls:1.30%
cases:10.70%
controls:4.63%
50
253
781
8047
43
100
788
8200
30
15
801
8285
25
0
806
8300
45
14
776
8273
37
106
716
8022
70
337
584
6941
Supine thorax X-ray examination
GD1QA [2001303648]
1.0e+00
2.7e+00
—
1.0e+50
3.4e+00
2.1e+00
1.7e+00
cases:3.37%
controls:1.22%
cases:4.45%
controls:0.33%
—
—
cases:2.65%
controls:0.00%
cases:2.56%
controls:0.08%
cases:4.38%
controls:0.55%
cases:10.55%
controls:2.02%
28
101
803
8199
37
27
794
8273
—
22
0
809
8300
21
7
800
8280
33
45
720
8083
69
147
585
7131
Lower urinary tract urodynamic studies
252896003 [4099392]
3.0e+00
—
—
—
—
4.3e+00
3.7e+00
cases:2.65%
controls:0.13%
—
—
—
—
—
—
—
—
cases:5.84%
controls:0.09%
cases:6.57%
controls:0.18%
22
11
809
8289
—
—
—
—
44
7
709
8121
43
13
611
7265
Protein electrophoresis panel - Serum or Plasma
24351-9 [3004588]
8.7e-01
1.8e+00
2.5e+00
—
3.6e+00
1.9e+00
1.1e+00
cases:1.56%
controls:0.66%
cases:1.44%
controls:0.24%
cases:0.84%
controls:0.07%
—
—
cases:2.19%
controls:0.06%
cases:1.59%
controls:0.23%
cases:2.60%
controls:0.89%
13
55
818
8245
12
20
819
8280
7
6
824
8294
—
18
5
803
8282
12
19
741
8109
17
65
637
7213
Care involving use of rehabilitation procedure, unspecified
Z50.9 [45595525]
1.8e+00
2.8e+00
—
—
—
3.5e+00
2.6e+00
cases:1.32%
controls:0.22%
cases:0.96%
controls:0.06%
—
—
—
—
—
—
cases:3.59%
controls:0.11%
cases:4.59%
controls:0.34%
11
18
820
8282
8
5
823
8295
—
—
—
27
9
726
8119
30
25
624
7253
Epithelial cells [#/volume] in Urine
30383-4 [3000850]
7.2e-01
1.1e+00
2.9e+00
1.0e+50
3.3e+00
1.5e+00
1.2e+00
cases:4.69%
controls:2.34%
cases:3.85%
controls:1.28%
cases:1.93%
controls:0.11%
cases:1.44%
controls:0.00%
cases:3.65%
controls:0.14%
cases:5.18%
controls:1.18%
cases:9.94%
controls:3.33%
39
194
792
8106
32
106
799
8194
16
9
815
8291
12
0
819
8300
30
12
791
8275
39
96
714
8032
65
242
589
7036
Outpatient Hospital
22 [8756]
7.7e-01
1.6e+00
2.5e+00
—
2.9e+00
1.7e+00
1.1e+00
cases:40.31%
controls:23.89%
cases:27.80%
controls:7.11%
cases:10.35%
controls:0.90%
—
—
cases:14.74%
controls:0.91%
cases:27.49%
controls:6.66%
cases:43.27%
controls:20.68%
335
1983
496
6317
231
590
600
7710
86
75
745
8225
—
121
75
700
8212
207
541
546
7587
283
1505
371
5773
lactulose; oral
A06AD11 [21600571]
1.4e+00
1.7e+00
2.4e+00
—
2.0e+00
1.8e+00
1.4e+00
cases:5.29%
controls:1.42%
cases:3.97%
controls:0.77%
cases:1.93%
controls:0.18%
—
—
cases:0.97%
controls:0.13%
cases:4.52%
controls:0.76%
cases:7.80%
controls:2.13%
44
118
787
8182
33
64
798
8236
16
15
815
8285
—
8
11
813
8276
34
62
719
8066
51
155
603
7123
Thorax X-ray examination outside radiological department
GD1UA [2001303652]
7.3e-01
2.1e+00
2.6e+00
1.0e+50
3.2e+00
1.5e+00
1.1e+00
cases:2.77%
controls:1.35%
cases:3.97%
controls:0.52%
cases:0.84%
controls:0.06%
cases:1.81%
controls:0.00%
cases:1.46%
controls:0.06%
cases:1.86%
controls:0.43%
cases:5.05%
controls:1.69%
23
112
808
8188
33
43
798
8257
7
5
824
8295
15
0
816
8300
12
5
809
8282
14
35
739
8093
33
123
621
7155
Inpatient Visit
IP [9201]
6.2e-01
1.1e+00
2.5e+00
—
3.9e+00
1.6e+00
8.3e-01
cases:7.46%
controls:4.16%
cases:4.45%
controls:1.51%
cases:1.68%
controls:0.14%
—
—
cases:5.48%
controls:0.12%
cases:7.17%
controls:1.59%
cases:11.31%
controls:5.25%
62
345
769
7955
37
125
794
8175
14
12
817
8288
—
45
10
776
8277
54
129
699
7999
74
382
580
6896
trimethoprim; oral, parenteral
J01EA01 [21602931]
1.1e+00
1.7e+00
2.1e+00
—
1.7e+00
2.1e+00
1.7e+00
cases:11.07%
controls:3.95%
cases:7.46%
controls:1.48%
cases:1.32%
controls:0.17%
—
—
cases:1.22%
controls:0.23%
cases:12.62%
controls:1.67%
cases:21.87%
controls:4.84%
92
328
739
7972
62
123
769
8177
11
14
820
8286
—
10
19
811
8268
95
136
658
7992
143
352
511
6926
Urology
34 [38004474]
1.0e+00
1.5e+00
1.7e+00
—
1.9e+00
2.2e+00
1.9e+00
cases:14.32%
controls:5.54%
cases:11.43%
controls:2.70%
cases:2.89%
controls:0.55%
—
—
cases:3.17%
controls:0.51%
cases:21.38%
controls:2.88%
cases:33.18%
controls:6.65%
119
460
712
7840
95
224
736
8076
24
46
807
8254
—
26
42
795
8245
161
234
592
7894
217
484
437
6794
Bacteria identified in Urine by Culture
630-4 [3026008]
5.0e-01
1.2e+00
2.6e+00
1.0e+50
3.2e+00
1.8e+00
1.4e+00
cases:5.17%
controls:3.22%
cases:5.66%
controls:1.71%
cases:2.65%
controls:0.20%
cases:0.72%
controls:0.00%
cases:5.12%
controls:0.22%
cases:9.69%
controls:1.66%
cases:17.74%
controls:5.25%
43
267
788
8033
47
142
784
8158
22
17
809
8283
6
0
825
8300
42
18
779
8269
73
135
680
7993
116
382
538
6896
Emergency Room and Inpatient Visit
ERIP [262]
7.1e-01
1.3e+00
2.9e+00
—
3.5e+00
1.1e+00
7.2e-01
cases:5.78%
controls:2.92%
cases:5.54%
controls:1.57%
cases:3.73%
controls:0.20%
—
—
cases:5.85%
controls:0.19%
cases:4.91%
controls:1.77%
cases:10.86%
controls:5.59%
48
242
783
8058
46
130
785
8170
31
17
800
8283
—
48
16
773
8271
37
144
716
7984
71
407
583
6871
ABO and Rh group [Type] in Blood by Confirmatory method
77397-8 [46236098]
5.6e-01
1.2e+00
3.1e+00
1.0e+50
3.4e+00
1.5e+00
9.6e-01
cases:4.69%
controls:2.73%
cases:3.61%
controls:1.13%
cases:2.17%
controls:0.10%
cases:1.32%
controls:0.00%
cases:3.41%
controls:0.12%
cases:4.38%
controls:1.00%
cases:7.95%
controls:3.19%
39
227
792
8073
30
94
801
8206
18
8
813
8292
11
0
820
8300
28
10
793
8277
33
81
720
8047
52
232
602
7046
nortriptyline; oral, parenteral
N06AA10 [21604697]
1.1e+00
1.7e+00
—
—
3.1e+00
2.6e+00
1.7e+00
cases:1.56%
controls:0.54%
cases:1.56%
controls:0.29%
—
—
—
—
cases:1.34%
controls:0.06%
cases:2.66%
controls:0.20%
cases:3.21%
controls:0.63%
13
45
818
8255
13
24
818
8276
—
—
11
5
810
8282
20
16
733
8112
21
46
633
7232
Nuclear Ab [Titer] in Serum
29953-7 [3037522]
1.0e+00
1.9e+00
2.6e+00
—
3.2e+00
1.4e+00
6.5e-01
cases:4.09%
controls:1.54%
cases:2.53%
controls:0.40%
cases:0.84%
controls:0.06%
—
—
cases:1.46%
controls:0.06%
cases:1.99%
controls:0.48%
cases:3.36%
controls:1.79%
34
128
797
8172
21
33
810
8267
7
5
824
8295
—
12
5
809
8282
15
39
738
8089
22
130
632
7148
Blood type and Crossmatch panel - Blood
34531-4 [3044640]
6.0e-01
1.2e+00
2.6e+00
1.0e+50
3.4e+00
1.4e+00
9.3e-01
cases:6.50%
controls:3.66%
cases:4.81%
controls:1.57%
cases:2.77%
controls:0.20%
cases:1.93%
controls:0.00%
cases:4.63%
controls:0.17%
cases:5.58%
controls:1.41%
cases:10.86%
controls:4.59%
54
304
777
7996
40
130
791
8170
23
17
808
8283
16
0
815
8300
38
14
783
8273
42
115
711
8013
71
334
583
6944
Clinic/Center
261Q00000X [38004207]
1.3e+00
1.7e+00
—
—
2.5e+00
2.9e+00
1.8e+00
cases:1.56%
controls:0.45%
cases:0.96%
controls:0.18%
—
—
—
—
cases:0.97%
controls:0.08%
cases:1.33%
controls:0.07%
cases:2.14%
controls:0.37%
13
37
818
8263
8
15
823
8285
—
—
8
7
813
8280
10
6
743
8122
14
27
640
7251
General anesthesia, balanced
WX408 [2001310808]
9.1e-01
2.1e+00
3.5e+00
—
—
2.2e+00
1.4e+00
cases:7.22%
controls:3.02%
cases:6.26%
controls:0.82%
cases:1.93%
controls:0.06%
—
—
—
—
cases:4.38%
controls:0.53%
cases:8.26%
controls:2.21%
60
251
771
8049
52
68
779
8232
16
5
815
8295
—
—
33
43
720
8085
54
161
600
7117
Car occupant [any] injured in unspecified traffic accident
V49.9 [45566025]
1.9e+00
2.9e+00
—
—
—
3.0e+00
2.2e+00
cases:1.44%
controls:0.22%
cases:1.44%
controls:0.08%
—
—
—
—
—
—
cases:1.20%
controls:0.06%
cases:2.91%
controls:0.32%
12
18
819
8282
12
7
819
8293
—
—
—
9
5
744
8123
19
23
635
7255
ciprofloxacin; oral, parenteral
J01MA02 [21603009]
8.4e-01
1.5e+00
1.8e+00
—
2.5e+00
1.8e+00
1.5e+00
cases:11.79%
controls:5.46%
cases:6.62%
controls:1.59%
cases:1.44%
controls:0.24%
—
—
cases:1.58%
controls:0.13%
cases:8.76%
controls:1.51%
cases:21.87%
controls:5.91%
98
453
733
7847
55
132
776
8168
12
20
819
8280
—
13
11
808
8276
66
123
687
8005
143
430
511
6848
Sodium [Moles/volume] in Serum or Plasma
2951-2 [3019550]
1.8e-01
4.8e-01
1.7e+00
5.2e+00
2.1e+00
4.3e-01
2.8e-01
cases:22.38%
controls:19.45%
cases:22.98%
controls:15.61%
cases:14.68%
controls:3.08%
cases:11.91%
controls:0.07%
cases:19.61%
controls:2.87%
cases:23.90%
controls:16.90%
cases:38.38%
controls:32.10%
186
1614
645
6686
191
1296
640
7004
122
256
709
8044
99
6
732
8294
161
238
660
8049
180
1374
573
6754
251
2336
403
4942
Aid fitting and borrowing and monitoring of use
SPAT1230 [2001700331]
7.8e-01
1.8e+00
—
—
3.2e+00
2.4e+00
1.8e+00
cases:3.01%
controls:1.40%
cases:2.65%
controls:0.47%
—
—
—
—
cases:1.83%
controls:0.07%
cases:5.31%
controls:0.52%
cases:11.62%
controls:2.23%
25
116
806
8184
22
39
809
8261
—
—
15
6
806
8281
40
42
713
8086
76
162
578
7116
Potassium [Moles/volume] in Serum or Plasma
2823-3 [3023103]
1.7e-01
4.8e-01
1.6e+00
5.2e+00
2.1e+00
4.3e-01
2.6e-01
cases:22.38%
controls:19.54%
cases:23.35%
controls:15.83%
cases:14.68%
controls:3.20%
cases:11.79%
controls:0.07%
cases:19.85%
controls:3.00%
cases:24.04%
controls:17.02%
cases:38.38%
controls:32.36%
186
1622
645
6678
194
1314
637
6986
122
266
709
8034
98
6
733
8294
163
249
658
8038
181
1383
572
6745
251
2355
403
4923
Implementation of physical therapy rehabilitation plan
SPAT1223 [2001700324]
6.1e-01
1.3e+00
2.0e+00
—
2.7e+00
2.1e+00
1.1e+00
cases:5.54%
controls:3.10%
cases:3.85%
controls:1.13%
cases:1.68%
controls:0.23%
—
—
cases:3.05%
controls:0.21%
cases:8.37%
controls:1.07%
cases:9.79%
controls:3.64%
46
257
785
8043
32
94
799
8206
14
19
817
8281
—
25
17
796
8270
63
87
690
8041
64
265
590
7013
INR in Blood by Coagulation assay
34714-6 [3032080]
4.4e-01
9.6e-01
1.3e+00
3.7e+00
1.8e+00
9.1e-01
7.6e-01
cases:9.39%
controls:6.28%
cases:8.54%
controls:3.45%
cases:4.21%
controls:1.23%
cases:5.05%
controls:0.13%
cases:6.46%
controls:1.18%
cases:8.50%
controls:3.62%
cases:17.28%
controls:8.93%
78
521
753
7779
71
286
760
8014
35
102
796
8198
42
11
789
8289
53
98
768
8189
64
294
689
7834
113
650
541
6628
Depressive episode, unspecified
F32.9 [45571760]
1.0e+00
1.4e+00
2.1e+00
—
2.2e+00
1.7e+00
1.4e+00
cases:3.25%
controls:1.18%
cases:1.68%
controls:0.43%
cases:0.84%
controls:0.11%
—
—
cases:0.73%
controls:0.08%
cases:2.26%
controls:0.42%
cases:4.59%
controls:1.14%
27
98
804
8202
14
36
817
8264
7
9
824
8291
—
6
7
815
8280
17
34
736
8094
30
83
624
7195
Osmolality of Urine
2695-5 [3026782]
4.1e-01
9.1e-01
2.6e+00
1.0e+50
3.3e+00
1.8e+00
1.1e+00
cases:3.73%
controls:2.51%
cases:3.25%
controls:1.34%
cases:1.56%
controls:0.12%
cases:1.08%
controls:0.00%
cases:3.29%
controls:0.12%
cases:5.31%
controls:0.96%
cases:8.26%
controls:3.04%
31
208
800
8092
27
111
804
8189
13
10
818
8290
9
0
822
8300
27
10
794
8277
40
78
713
8050
54
221
600
7057
Essential (primary) hypertension
I10 [45591453]
3.1e-01
5.6e-01
1.6e+00
4.6e+00
2.0e+00
8.3e-01
2.4e-01
cases:17.69%
controls:13.59%
cases:11.19%
controls:6.71%
cases:4.93%
controls:1.00%
cases:6.74%
controls:0.07%
cases:7.67%
controls:1.16%
cases:14.87%
controls:7.11%
cases:22.48%
controls:18.54%
147
1128
684
7172
93
557
738
7743
41
83
790
8217
56
6
775
8294
63
96
758
8191
112
578
641
7550
147
1349
507
5929
General psychiatric examination, not elsewhere classified
Z00.4 [45605094]
1.1e+00
1.7e+00
—
—
3.0e+00
2.3e+00
1.4e+00
cases:2.17%
controls:0.73%
cases:1.20%
controls:0.23%
—
—
—
—
cases:1.46%
controls:0.07%
cases:2.39%
controls:0.23%
cases:3.52%
controls:0.87%
18
61
813
8239
10
19
821
8281
—
—
12
6
809
8281
18
19
735
8109
23
63
631
7215
Fall on same level from slipping, tripping and stumbling
W01 [45756243]
7.8e-01
1.4e+00
2.2e+00
1.0e+50
2.5e+00
1.5e+00
1.0e+00
cases:6.38%
controls:3.04%
cases:4.57%
controls:1.14%
cases:1.68%
controls:0.18%
cases:1.32%
controls:0.00%
cases:2.07%
controls:0.17%
cases:4.78%
controls:1.06%
cases:11.01%
controls:4.30%
53
252
778
8048
38
95
793
8205
14
15
817
8285
11
0
820
8300
17
14
804
8273
36
86
717
8042
72
313
582
6965
Bacteria [Presence] in Urine
87829-8 [36304419]
4.2e-01
9.3e-01
2.8e+00
1.0e+50
3.4e+00
1.4e+00
1.0e+00
cases:4.57%
controls:3.05%
cases:4.33%
controls:1.75%
cases:2.89%
controls:0.18%
cases:1.32%
controls:0.00%
cases:4.63%
controls:0.17%
cases:6.24%
controls:1.61%
cases:11.62%
controls:4.55%
38
253
793
8047
36
145
795
8155
24
15
807
8285
11
0
820
8300
38
14
783
8273
47
131
706
7997
76
331
578
6947
IgG [Mass/volume] in Serum or Plasma
2465-3 [3005719]
1.1e+00
2.0e+00
—
—
3.7e+00
1.4e+00
1.3e+00
cases:2.17%
controls:0.72%
cases:1.93%
controls:0.28%
—
—
—
—
cases:2.92%
controls:0.07%
cases:1.59%
controls:0.41%
cases:3.98%
controls:1.13%
18
60
813
8240
16
23
815
8277
—
—
24
6
797
8281
12
33
741
8095
26
82
628
7196
Leukocytes [#/volume] in Urine
30405-5 [3018095]
5.3e-01
9.7e-01
2.6e+00
1.0e+50
3.1e+00
1.3e+00
9.9e-01
cases:6.62%
controls:4.01%
cases:6.02%
controls:2.37%
cases:3.49%
controls:0.27%
cases:2.17%
controls:0.00%
cases:5.72%
controls:0.28%
cases:8.10%
controls:2.40%
cases:16.97%
controls:7.03%
55
333
776
7967
50
197
781
8103
29
22
802
8278
18
0
813
8300
47
23
774
8264
61
195
692
7933
111
512
543
6766
Other and unspecified symptoms and signs involving the nervous and musculoskeletal systems
R29.8 [45587505]
1.7e+00
2.5e+00
1.0e+50
1.0e+50
—
3.4e+00
1.9e+00
cases:3.49%
controls:0.69%
cases:2.53%
controls:0.20%
cases:1.44%
controls:0.00%
cases:2.65%
controls:0.00%
—
—
cases:5.18%
controls:0.18%
cases:5.66%
controls:0.92%
29
57
802
8243
21
17
810
8283
12
0
819
8300
22
0
809
8300
—
39
15
714
8113
37
67
617
7211
oxycodone and naloxone; oral
N02AA55 [21604265]
1.3e+00
1.2e+00
2.2e+00
—
2.0e+00
1.7e+00
1.1e+00
cases:3.61%
controls:1.04%
cases:1.81%
controls:0.53%
cases:0.72%
controls:0.08%
—
—
cases:0.97%
controls:0.13%
cases:3.05%
controls:0.58%
cases:5.66%
controls:2.01%
30
86
801
8214
15
44
816
8256
6
7
825
8293
—
8
11
813
8276
23
47
730
8081
37
146
617
7132
tramadol; oral, parenteral, rectal
N02AX02 [21604298]
1.0e+00
1.6e+00
2.3e+00
—
1.8e+00
1.7e+00
1.1e+00
cases:15.76%
controls:6.33%
cases:10.47%
controls:2.39%
cases:4.33%
controls:0.47%
—
—
cases:2.92%
controls:0.51%
cases:11.55%
controls:2.44%
cases:17.28%
controls:6.22%
131
525
700
7775
87
198
744
8102
36
39
795
8261
—
24
42
797
8245
87
198
666
7930
113
453
541
6825
Creatinine [Moles/volume] in Serum or Plasma
14682-9 [3020564]
1.1e-01
4.1e-01
1.6e+00
5.2e+00
1.8e+00
4.1e-01
2.5e-01
cases:23.35%
controls:21.36%
cases:25.27%
controls:18.30%
cases:15.76%
controls:3.81%
cases:11.91%
controls:0.07%
cases:19.61%
controls:3.86%
cases:26.83%
controls:19.51%
cases:41.13%
controls:35.17%
194
1773
637
6527
210
1519
621
6781
131
316
700
7984
99
6
732
8294
161
320
660
7967
202
1586
551
6542
269
2560
385
4718
Casts [#/volume] in Urine by Automated count
51483-6 [3030467]
3.2e-01
9.0e-01
2.7e+00
1.0e+50
3.4e+00
1.3e+00
1.0e+00
cases:4.33%
controls:3.18%
cases:4.45%
controls:1.86%
cases:3.01%
controls:0.20%
cases:1.32%
controls:0.00%
cases:4.63%
controls:0.16%
cases:6.51%
controls:1.80%
cases:12.54%
controls:4.97%
36
264
795
8036
37
154
794
8146
25
17
806
8283
11
0
820
8300
38
13
783
8274
49
146
704
7982
82
362
572
6916
Blood group antibody screen [Presence] in Serum or Plasma
890-4 [3001079]
4.7e-01
1.0e+00
2.5e+00
1.0e+50
3.3e+00
1.3e+00
7.9e-01
cases:8.18%
controls:5.28%
cases:5.90%
controls:2.16%
cases:3.01%
controls:0.25%
cases:2.17%
controls:0.00%
cases:5.60%
controls:0.23%
cases:6.51%
controls:1.91%
cases:13.76%
controls:6.75%
68
438
763
7862
49
179
782
8121
25
21
806
8279
18
0
813
8300
46
19
775
8268
49
155
704
7973
90
491
564
6787
Urinalysis microscopic panel [#/volume] - Urine by Automated count
50554-5 [3029287]
5.5e-01
1.0e+00
2.5e+00
1.0e+50
2.9e+00
1.3e+00
9.7e-01
cases:7.46%
controls:4.43%
cases:6.02%
controls:2.25%
cases:3.37%
controls:0.28%
cases:2.17%
controls:0.00%
cases:5.60%
controls:0.31%
cases:7.84%
controls:2.37%
cases:15.44%
controls:6.46%
62
368
769
7932
50
187
781
8113
28
23
803
8277
18
0
813
8300
46
26
775
8261
59
193
694
7935
101
470
553
6808
Erythrocytes [#/volume] in Urine
30391-7 [3002582]
5.2e-01
1.0e+00
2.5e+00
1.0e+50
3.3e+00
1.4e+00
1.0e+00
cases:5.90%
controls:3.60%
cases:5.66%
controls:2.10%
cases:3.13%
controls:0.25%
cases:2.05%
controls:0.00%
cases:5.60%
controls:0.22%
cases:7.57%
controls:2.03%
cases:14.53%
controls:5.89%
49
299
782
8001
47
174
784
8126
26
21
805
8279
17
0
814
8300
46
18
775
8269
57
165
696
7963
95
429
559
6849
duloxetine; oral
N06AX21 [21604749]
1.4e+00
1.9e+00
2.1e+00
—
1.6e+00
2.1e+00
1.7e+00
cases:3.97%
controls:0.96%
cases:2.53%
controls:0.39%
cases:1.44%
controls:0.18%
—
—
cases:0.73%
controls:0.14%
cases:3.85%
controls:0.47%
cases:6.88%
controls:1.39%
33
80
798
8220
21
32
810
8268
12
15
819
8285
—
6
12
815
8275
29
38
724
8090
45
101
609
7177
Lumbar and other intervertebral disc disorders with radiculopathy
M51.1 [45562747]
1.0e+00
2.0e+00
—
1.0e+50
2.8e+00
2.0e+00
1.4e+00
cases:4.09%
controls:1.53%
cases:3.85%
controls:0.53%
—
—
cases:1.81%
controls:0.00%
cases:1.71%
controls:0.11%
cases:3.32%
controls:0.46%
cases:6.57%
controls:1.69%
34
127
797
8173
32
44
799
8256
—
15
0
816
8300
14
9
807
8278
25
37
728
8091
43
123
611
7155
Erythrocyte [DistWidth] in Red Blood Cells
30385-9 [3002385]
1.0e-01
4.1e-01
1.5e+00
5.1e+00
1.8e+00
3.7e-01
1.8e-01
cases:15.52%
controls:14.24%
cases:17.09%
controls:12.00%
cases:10.95%
controls:2.69%
cases:9.15%
controls:0.06%
cases:14.25%
controls:2.62%
cases:17.26%
controls:12.56%
cases:27.37%
controls:24.02%
129
1182
702
7118
142
996
689
7304
91
223
740
8077
76
5
755
8295
117
217
704
8070
130
1021
623
7107
179
1748
475
5530
Catheterisation of bladder
TKC20 [2001306020]
1.4e+00
2.7e+00
—
1.0e+50
—
3.0e+00
2.1e+00
cases:2.65%
controls:0.66%
cases:2.65%
controls:0.18%
—
—
cases:0.84%
controls:0.00%
—
—
cases:3.19%
controls:0.16%
cases:5.05%
controls:0.66%
22
55
809
8245
22
15
809
8285
—
7
0
824
8300
—
24
13
729
8115
33
48
621
7230
fentanyl; nasal, sublingual, transdermal
N02AB03 [21604272]
1.9e+00
2.2e+00
2.6e+00
—
2.1e+00
2.5e+00
1.9e+00
cases:0.72%
controls:0.11%
cases:1.08%
controls:0.12%
cases:0.84%
controls:0.06%
—
—
cases:0.61%
controls:0.07%
cases:2.12%
controls:0.18%
cases:2.60%
controls:0.40%
6
9
825
8291
9
10
822
8290
7
5
824
8295
—
5
6
816
8281
16
15
737
8113
17
29
637
7249
oxybutynin; oral, transdermal
G04BD04 [21602637]
2.5e+00
2.5e+00
—
—
—
2.3e+00
1.9e+00
cases:3.01%
controls:0.25%
cases:1.44%
controls:0.12%
—
—
—
—
—
—
cases:1.86%
controls:0.20%
cases:2.91%
controls:0.43%
25
21
806
8279
12
10
819
8290
—
—
—
14
16
739
8112
19
31
635
7247
Orthopedic Surgery
20 [38004465]
8.0e-01
1.5e+00
2.1e+00
—
2.4e+00
1.5e+00
7.9e-01
cases:21.54%
controls:10.95%
cases:15.88%
controls:4.14%
cases:5.66%
controls:0.70%
—
—
cases:6.58%
controls:0.62%
cases:16.60%
controls:4.28%
cases:27.22%
controls:14.54%
179
909
652
7391
132
344
699
7956
47
58
784
8242
—
54
51
767
8236
125
348
628
7780
178
1058
476
6220
Lumbar spine MRI examination with high intensity magnet
NA3BG [2001307034]
1.6e+00
3.3e+00
—
1.0e+50
1.0e+50
2.3e+00
1.9e+00
cases:3.01%
controls:0.65%
cases:2.89%
controls:0.11%
—
—
cases:3.13%
controls:0.00%
cases:1.34%
controls:0.00%
cases:1.86%
controls:0.20%
cases:5.96%
controls:0.91%
25
54
806
8246
24
9
807
8291
—
26
0
805
8300
11
0
810
8287
14
16
739
8112
39
66
615
7212
Plastic And Reconstructive Surgery
24 [38004467]
1.0e+00
1.7e+00
—
—
2.7e+00
2.2e+00
1.4e+00
cases:5.17%
controls:1.95%
cases:3.61%
controls:0.70%
—
—
—
—
cases:1.46%
controls:0.10%
cases:5.71%
controls:0.68%
cases:8.56%
controls:2.17%
43
162
788
8138
30
58
801
8242
—
—
12
8
809
8279
43
55
710
8073
56
158
598
7120
Type 2 diabetes mellitus, without complications
E11.9 [45561952]
4.7e-01
6.8e-01
1.6e+00
3.7e+00
2.1e+00
9.7e-01
3.0e-01
cases:6.14%
controls:3.94%
cases:4.21%
controls:2.17%
cases:1.81%
controls:0.39%
cases:2.41%
controls:0.06%
cases:2.80%
controls:0.35%
cases:5.71%
controls:2.24%
cases:7.80%
controls:5.89%
51
327
780
7973
35
180
796
8120
15
32
816
8268
20
5
811
8295
23
29
798
8258
43
182
710
7946
51
429
603
6849
More than one and less than three hours
ZXE10 [2001311401]
8.1e-01
1.5e+00
2.0e+00
1.0e+50
2.2e+00
1.5e+00
9.4e-01
cases:9.39%
controls:4.40%
cases:5.05%
controls:1.13%
cases:0.96%
controls:0.13%
cases:0.96%
controls:0.00%
cases:0.97%
controls:0.11%
cases:4.65%
controls:1.05%
cases:11.01%
controls:4.63%
78
365
753
7935
42
94
789
8206
8
11
823
8289
8
0
823
8300
8
9
813
8278
35
85
718
8043
72
337
582
6941
Epithelial cells.non-squamous [#/volume] in Urine by Automated count
51485-1 [3030306]
1.5e-02
9.9e-01
2.5e+00
1.0e+50
3.6e+00
1.0e+00
8.9e-01
cases:1.56%
controls:1.54%
cases:2.17%
controls:0.82%
cases:1.56%
controls:0.13%
cases:0.60%
controls:0.00%
cases:2.19%
controls:0.06%
cases:2.92%
controls:1.07%
cases:7.19%
controls:3.09%
13
128
818
8172
18
68
813
8232
13
11
818
8289
5
0
826
8300
18
5
803
8282
22
87
731
8041
47
225
607
7053
Assessment of need for aid
SPAT1229 [2001700330]
1.2e+00
2.5e+00
—
—
—
3.0e+00
2.3e+00
cases:1.56%
controls:0.49%
cases:1.81%
controls:0.16%
—
—
—
—
—
—
cases:3.45%
controls:0.17%
cases:7.34%
controls:0.78%
13
41
818
8259
15
13
816
8287
—
—
—
26
14
727
8114
48
57
606
7221
Cervical spine MRI examination with high intensity magnet
NA1BG [2001306990]
1.7e+00
2.5e+00
1.0e+50
1.0e+50
—
2.2e+00
2.6e+00
cases:1.81%
controls:0.33%
cases:1.56%
controls:0.13%
cases:0.60%
controls:0.00%
cases:2.17%
controls:0.00%
—
—
cases:1.06%
controls:0.12%
cases:4.28%
controls:0.34%
15
27
816
8273
13
11
818
8289
5
0
826
8300
18
0
813
8300
—
8
10
745
8118
28
25
626
7253
Low back symptom/complaint
L03 [2002000628]
7.1e-01
1.5e+00
2.2e+00
—
2.4e+00
1.4e+00
6.9e-01
cases:4.21%
controls:2.12%
cases:2.77%
controls:0.64%
cases:1.68%
controls:0.19%
—
—
cases:1.22%
controls:0.11%
cases:3.59%
controls:0.92%
cases:6.42%
controls:3.34%
35
176
796
8124
23
53
808
8247
14
16
817
8284
—
10
9
811
8278
27
75
726
8053
42
243
612
7035
Low back pain
M54.5 [45553207]
8.5e-01
1.4e+00
2.6e+00
—
1.9e+00
1.4e+00
6.9e-01
cases:7.94%
controls:3.54%
cases:5.05%
controls:1.28%
cases:2.65%
controls:0.20%
—
—
cases:1.58%
controls:0.23%
cases:4.65%
controls:1.22%
cases:9.94%
controls:5.26%
66
294
765
8006
42
106
789
8194
22
17
809
8283
—
13
19
808
8268
35
99
718
8029
65
383
589
6895
Functional capacity evaluation
443351003 [40481051]
9.1e-01
1.7e+00
—
—
2.5e+00
2.3e+00
1.5e+00
cases:3.01%
controls:1.23%
cases:2.65%
controls:0.52%
—
—
—
—
cases:1.46%
controls:0.12%
cases:5.71%
controls:0.62%
cases:8.87%
controls:2.14%
25
102
806
8198
22
43
809
8257
—
—
12
10
809
8277
43
50
710
8078
58
156
596
7122
Reticulocytes/Erythrocytes in Blood
4679-7 [3027945]
1.1e+00
1.4e+00
2.4e+00
—
2.7e+00
1.1e+00
5.9e-01
cases:3.37%
controls:1.16%
cases:2.41%
controls:0.58%
cases:1.08%
controls:0.10%
—
—
cases:1.10%
controls:0.07%
cases:1.86%
controls:0.60%
cases:3.67%
controls:2.06%
28
96
803
8204
20
48
811
8252
9
8
822
8292
—
9
6
812
8281
14
49
739
8079
24
150
630
7128
Psychiatry
26 [38004469]
1.2e+00
1.3e+00
1.4e+00
—
1.8e+00
1.7e+00
1.4e+00
cases:12.76%
controls:4.16%
cases:7.34%
controls:2.04%
cases:2.77%
controls:0.72%
—
—
cases:4.63%
controls:0.83%
cases:10.62%
controls:2.10%
cases:15.60%
controls:4.33%
106
345
725
7955
61
169
770
8131
23
60
808
8240
—
38
69
783
8218
80
171
673
7957
102
315
552
6963
Bacteria [#/volume] in Urine by Automated count
51480-2 [3031040]
5.0e-01
1.1e+00
2.4e+00
1.0e+50
2.6e+00
1.3e+00
9.1e-01
cases:13.96%
controls:8.95%
cases:12.52%
controls:4.76%
cases:6.38%
controls:0.64%
cases:2.77%
controls:0.00%
cases:9.26%
controls:0.74%
cases:15.80%
controls:4.72%
cases:28.75%
controls:14.00%
116
743
715
7557
104
395
727
7905
53
53
778
8247
23
0
808
8300
76
61
745
8226
119
384
634
7744
188
1019
466
6259
tolterodine; oral
G04BD07 [21602640]
1.8e+00
2.2e+00
—
—
—
2.3e+00
2.4e+00
cases:2.41%
controls:0.42%
cases:1.20%
controls:0.13%
—
—
—
—
—
—
cases:1.33%
controls:0.14%
cases:3.06%
controls:0.27%
20
35
811
8265
10
11
821
8289
—
—
—
10
11
743
8117
20
20
634
7258
Infectious Disease
44 [38004484]
9.9e-01
1.3e+00
2.8e+00
1.0e+50
—
1.8e+00
1.8e+00
cases:2.77%
controls:1.05%
cases:2.05%
controls:0.54%
cases:1.68%
controls:0.11%
cases:0.60%
controls:0.00%
—
—
cases:3.19%
controls:0.53%
cases:8.10%
controls:1.47%
23
87
808
8213
17
45
814
8255
14
9
817
8291
5
0
826
8300
—
24
43
729
8085
53
107
601
7171
tizanidine; oral
M03BX02 [21604116]
6.0e-01
1.3e+00
2.2e+00
—
1.9e+00
1.5e+00
1.1e+00
cases:19.74%
controls:11.84%
cases:11.31%
controls:3.52%
cases:3.85%
controls:0.46%
—
—
cases:2.56%
controls:0.39%
cases:14.74%
controls:3.57%
cases:26.45%
controls:11.13%
164
983
667
7317
94
292
737
8008
32
38
799
8262
—
21
32
800
8255
111
290
642
7838
173
810
481
6468
Epilepsy, unspecified
G40.9 [45562083]
2.1e+00
2.6e+00
2.1e+00
1.0e+50
—
2.4e+00
1.4e+00
cases:2.17%
controls:0.27%
cases:1.81%
controls:0.13%
cases:0.60%
controls:0.07%
cases:0.84%
controls:0.00%
—
—
cases:1.86%
controls:0.17%
cases:1.99%
controls:0.51%
18
22
813
8278
15
11
816
8289
5
6
826
8294
7
0
824
8300
—
14
14
739
8114
13
37
641
7241
MCH [Entitic mass]
28539-5 [3035941]
5.3e-02
3.6e-01
1.4e+00
4.7e+00
1.7e+00
3.3e-01
1.7e-01
cases:24.19%
controls:23.23%
cases:26.59%
controls:20.13%
cases:16.49%
controls:4.64%
cases:12.76%
controls:0.13%
cases:20.46%
controls:4.56%
cases:27.36%
controls:21.26%
cases:41.74%
controls:37.62%
201
1928
630
6372
221
1671
610
6629
137
385
694
7915
106
11
725
8289
168
378
653
7909
206
1728
547
6400
273
2738
381
4540
MCV [Entitic mean volume] in Red Blood Cells
30428-7 [3024731]
5.2e-02
3.6e-01
1.4e+00
4.7e+00
1.7e+00
3.3e-01
1.7e-01
cases:24.19%
controls:23.25%
cases:26.59%
controls:20.16%
cases:16.49%
controls:4.64%
cases:12.76%
controls:0.13%
cases:20.46%
controls:4.56%
cases:27.36%
controls:21.27%
cases:41.74%
controls:37.63%
201
1930
630
6370
221
1673
610
6627
137
385
694
7915
106
11
725
8289
168
378
653
7909
206
1729
547
6399
273
2739
381
4539
Platelets [#/volume] in Blood
26515-7 [3007461]
5.6e-02
3.6e-01
1.4e+00
4.7e+00
1.7e+00
3.3e-01
1.8e-01
cases:24.19%
controls:23.18%
cases:26.59%
controls:20.14%
cases:16.37%
controls:4.63%
cases:12.76%
controls:0.13%
cases:20.46%
controls:4.55%
cases:27.36%
controls:21.24%
cases:41.74%
controls:37.51%
201
1924
630
6376
221
1672
610
6628
136
384
695
7916
106
11
725
8289
168
377
653
7910
206
1726
547
6402
273
2730
381
4548
Hemoglobin [Mass/volume] in Blood
718-7 [3000963]
4.7e-02
3.6e-01
1.4e+00
4.7e+00
1.7e+00
3.3e-01
1.7e-01
cases:24.19%
controls:23.34%
cases:26.59%
controls:20.20%
cases:16.49%
controls:4.66%
cases:12.76%
controls:0.13%
cases:20.46%
controls:4.57%
cases:27.49%
controls:21.35%
cases:41.74%
controls:37.69%
201
1937
630
6363
221
1677
610
6623
137
387
694
7913
106
11
725
8289
168
379
653
7908
207
1735
546
6393
273
2743
381
4535
Hematocrit [Volume Fraction] of Blood by calculation
20570-8 [3009542]
5.2e-02
3.6e-01
1.4e+00
4.7e+00
1.7e+00
3.3e-01
1.7e-01
cases:24.19%
controls:23.24%
cases:26.59%
controls:20.14%
cases:16.49%
controls:4.67%
cases:12.76%
controls:0.13%
cases:20.46%
controls:4.57%
cases:27.36%
controls:21.28%
cases:41.74%
controls:37.62%
201
1929
630
6371
221
1672
610
6628
137
388
694
7912
106
11
725
8289
168
379
653
7908
206
1730
547
6398
273
2738
381
4540
MCHC [Entitic Mass/volume] in Red Blood Cells
28540-3 [3003338]
6.9e-02
3.4e-01
1.4e+00
4.6e+00
1.7e+00
3.5e-01
4.0e-02
cases:18.17%
controls:17.17%
cases:18.53%
controls:13.96%
cases:11.67%
controls:3.04%
cases:8.90%
controls:0.10%
cases:13.89%
controls:2.99%
cases:19.52%
controls:14.60%
cases:29.36%
controls:28.54%
151
1425
680
6875
154
1159
677
7141
97
252
734
8048
74
8
757
8292
114
248
707
8039
147
1187
606
6941
192
2077
462
5201
Erythrocytes [#/volume] in Blood
26453-1 [3026361]
5.2e-02
3.6e-01
1.4e+00
4.6e+00
1.7e+00
3.3e-01
1.7e-01
cases:24.19%
controls:23.25%
cases:26.59%
controls:20.16%
cases:16.49%
controls:4.65%
cases:12.76%
controls:0.14%
cases:20.46%
controls:4.57%
cases:27.36%
controls:21.28%
cases:41.74%
controls:37.65%
201
1930
630
6370
221
1673
610
6627
137
386
694
7914
106
12
725
8288
168
379
653
7908
206
1730
547
6398
273
2740
381
4538
Leukocytes [#/volume] in Blood
26464-8 [3010813]
5.2e-02
3.6e-01
1.4e+00
4.6e+00
1.7e+00
3.4e-01
1.8e-01
cases:24.19%
controls:23.25%
cases:26.59%
controls:20.17%
cases:16.49%
controls:4.66%
cases:12.76%
controls:0.14%
cases:20.46%
controls:4.60%
cases:27.49%
controls:21.30%
cases:41.90%
controls:37.65%
201
1930
630
6370
221
1674
610
6626
137
387
694
7913
106
12
725
8288
168
381
653
7906
207
1731
546
6397
274
2740
380
4538
Pulmonary Disease
29 [38004472]
5.5e-01
7.1e-01
1.3e+00
2.9e+00
1.4e+00
7.7e-01
7.5e-01
cases:12.52%
controls:7.61%
cases:7.46%
controls:3.81%
cases:2.89%
controls:0.83%
cases:1.08%
controls:0.06%
cases:3.53%
controls:0.88%
cases:8.50%
controls:4.13%
cases:17.13%
controls:8.90%
104
632
727
7668
62
316
769
7984
24
69
807
8231
9
5
822
8295
29
73
792
8214
64
336
689
7792
112
648
542
6630
Other and unspecified abnormalities of gait and mobility
R26.8 [45597174]
2.4e+00
3.4e+00
—
1.0e+50
—
—
2.5e+00
cases:1.44%
controls:0.13%
cases:1.81%
controls:0.06%
—
—
cases:0.60%
controls:0.00%
—
—
—
—
cases:2.14%
controls:0.18%
12
11
819
8289
15
5
816
8295
—
5
0
826
8300
—
—
14
13
640
7265
Calcium.ionized [Moles/volume] in Serum or Plasma
1995-0 [3021347]
5.5e-01
1.2e+00
2.0e+00
1.0e+50
2.9e+00
9.4e-01
7.7e-01
cases:9.03%
controls:5.42%
cases:8.78%
controls:2.93%
cases:4.09%
controls:0.58%
cases:2.29%
controls:0.00%
cases:7.06%
controls:0.42%
cases:7.97%
controls:3.28%
cases:16.21%
controls:8.20%
75
450
756
7850
73
243
758
8057
34
48
797
8252
19
0
812
8300
58
35
763
8252
60
267
693
7861
106
597
548
6681
CBC panel - Blood by Automated count
58410-2 [40761511]
1.1e-01
3.8e-01
1.5e+00
4.7e+00
1.7e+00
3.1e-01
2.1e-01
cases:20.94%
controls:19.13%
cases:19.13%
controls:13.89%
cases:10.47%
controls:2.59%
cases:7.58%
controls:0.07%
cases:12.91%
controls:2.68%
cases:18.59%
controls:14.35%
cases:33.79%
controls:29.33%
174
1588
657
6712
159
1153
672
7147
87
215
744
8085
63
6
768
8294
106
222
715
8065
140
1166
613
6962
221
2135
433
5143
Albumin [Mass/volume] in Serum or Plasma
1751-7 [3024561]
6.0e-01
9.6e-01
2.3e+00
—
2.7e+00
9.9e-01
7.1e-01
cases:9.39%
controls:5.37%
cases:6.86%
controls:2.75%
cases:4.21%
controls:0.46%
—
—
cases:7.19%
controls:0.54%
cases:7.44%
controls:2.90%
cases:14.83%
controls:7.87%
78
446
753
7854
57
228
774
8072
35
38
796
8262
—
59
45
762
8242
56
236
697
7892
97
573
557
6705
oxcarbazepine; oral
N03AF02 [21604418]
2.1e+00
2.0e+00
—
—
—
2.3e+00
1.7e+00
cases:2.05%
controls:0.25%
cases:1.56%
controls:0.20%
—
—
—
—
—
—
cases:1.59%
controls:0.16%
cases:2.29%
controls:0.43%
17
21
814
8279
13
17
818
8283
—
—
—
12
13
741
8115
15
31
639
7247
Voluntary or Charitable Agency
251V00000X [38004202]
1.6e+00
2.7e+00
—
—
—
3.1e+00
2.3e+00
cases:0.72%
controls:0.14%
cases:1.08%
controls:0.07%
—
—
—
—
—
—
cases:2.39%
controls:0.11%
cases:4.13%
controls:0.41%
6
12
825
8288
9
6
822
8294
—
—
—
18
9
735
8119
27
30
627
7248
Other specified intervertebral disc degeneration
M51.3 [45591865]
1.3e+00
2.3e+00
—
—
—
2.9e+00
1.6e+00
cases:2.05%
controls:0.57%
cases:1.56%
controls:0.16%
—
—
—
—
—
—
cases:2.52%
controls:0.14%
cases:2.91%
controls:0.62%
17
47
814
8253
13
13
818
8287
—
—
—
19
11
734
8117
19
45
635
7233
Cystitis, unspecified
N30.9 [45606488]
1.8e+00
2.0e+00
—
—
—
2.6e+00
1.8e+00
cases:1.20%
controls:0.20%
cases:0.84%
controls:0.12%
—
—
—
—
—
—
cases:1.73%
controls:0.14%
cases:2.91%
controls:0.48%
10
17
821
8283
7
10
824
8290
—
—
—
13
11
740
8117
19
35
635
7243
Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
34487-9 [3044938]
1.0e+00
1.2e+00
—
1.0e+50
2.8e+00
1.9e+00
1.2e+00
cases:3.25%
controls:1.19%
cases:2.05%
controls:0.65%
—
—
cases:0.72%
controls:0.00%
cases:0.97%
controls:0.06%
cases:3.72%
controls:0.59%
cases:7.65%
controls:2.42%
27
99
804
8201
17
54
814
8246
—
6
0
825
8300
8
5
813
8282
28
48
725
8080
50
176
604
7102
Phosphate [Moles/volume] in Serum or Plasma
14879-1 [3003458]
7.5e-01
1.2e+00
2.0e+00
—
2.7e+00
9.9e-01
1.0e+00
cases:3.01%
controls:1.45%
cases:3.01%
controls:0.89%
cases:0.96%
controls:0.13%
—
—
cases:2.56%
controls:0.17%
cases:2.39%
controls:0.90%
cases:5.81%
controls:2.13%
25
120
806
8180
25
74
806
8226
8
11
823
8289
—
21
14
800
8273
18
73
735
8055
38
155
616
7123
macrogol; oral
A06AD15 [21600575]
8.5e-01
1.7e+00
—
—
2.1e+00
2.5e+00
1.6e+00
cases:1.93%
controls:0.83%
cases:2.17%
controls:0.39%
—
—
—
—
cases:1.10%
controls:0.13%
cases:4.38%
controls:0.39%
cases:6.57%
controls:1.35%
16
69
815
8231
18
32
813
8268
—
—
9
11
812
8276
33
32
720
8096
43
98
611
7180
pH of Serum or Plasma
2753-2 [3018418]
6.1e-01
1.1e+00
1.9e+00
—
2.8e+00
8.5e-01
5.7e-01
cases:6.02%
controls:3.35%
cases:5.54%
controls:1.89%
cases:2.77%
controls:0.41%
—
—
cases:4.14%
controls:0.25%
cases:4.91%
controls:2.17%
cases:9.63%
controls:5.70%
50
278
781
8022
46
157
785
8143
23
34
808
8266
—
34
21
787
8266
37
176
716
7952
63
415
591
6863
Cathetrisation of vein
TPH04 [2001309597]
2.8e-01
7.8e-01
2.2e+00
1.0e+50
2.7e+00
1.7e+00
1.3e+00
cases:2.77%
controls:2.10%
cases:1.56%
controls:0.72%
cases:0.72%
controls:0.08%
cases:1.81%
controls:0.00%
cases:1.10%
controls:0.07%
cases:3.32%
controls:0.64%
cases:8.72%
controls:2.43%
23
174
808
8126
13
60
818
8240
6
7
825
8293
15
0
816
8300
9
6
812
8281
25
52
728
8076
57
177
597
7101
Urinary tract ultrasound examination
KH1AE [2001306329]
1.9e+00
1.5e+00
—
—
1.0e+50
3.2e+00
2.7e+00
cases:1.93%
controls:0.29%
cases:0.72%
controls:0.17%
—
—
—
—
cases:0.73%
controls:0.00%
cases:3.19%
controls:0.14%
cases:7.65%
controls:0.54%
16
24
815
8276
6
14
825
8286
—
—
6
0
815
8287
24
11
729
8117
50
39
604
7239
amitriptyline; oral, parenteral
N06AA09 [21604696]
1.0e+00
7.7e-01
1.7e+00
—
1.7e+00
1.4e+00
1.2e+00
cases:7.34%
controls:2.76%
cases:3.13%
controls:1.47%
cases:1.20%
controls:0.22%
—
—
cases:1.34%
controls:0.25%
cases:5.31%
controls:1.38%
cases:9.63%
controls:3.01%
61
229
770
8071
26
122
805
8178
10
18
821
8282
—
11
21
810
8266
40
112
713
8016
63
219
591
7059
solifenacin; oral
G04BD08 [21602641]
1.6e+00
1.7e+00
—
—
—
2.3e+00
2.2e+00
cases:2.77%
controls:0.57%
cases:1.32%
controls:0.24%
—
—
—
—
—
—
cases:2.39%
controls:0.25%
cases:5.05%
controls:0.59%
23
47
808
8253
11
20
820
8280
—
—
—
18
20
735
8108
33
43
621
7235
Extensive MRI examination of brain with high intensity magnet
AA1CG [2001300116]
1.2e+00
2.6e+00
—
1.0e+50
—
2.2e+00
1.8e+00
cases:2.17%
controls:0.67%
cases:1.93%
controls:0.14%
—
—
cases:1.56%
controls:0.00%
—
—
cases:1.33%
controls:0.15%
cases:2.60%
controls:0.44%
18
56
813
8244
16
12
815
8288
—
13
0
818
8300
—
10
12
743
8116
17
32
637
7246
Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction
14804-9 [3022250]
9.5e-01
1.4e+00
1.5e+00
—
3.4e+00
1.1e+00
8.9e-01
cases:2.77%
controls:1.08%
cases:2.89%
controls:0.72%
cases:0.84%
controls:0.18%
—
—
cases:2.07%
controls:0.07%
cases:1.99%
controls:0.66%
cases:4.13%
controls:1.73%
23
90
808
8210
24
60
807
8240
7
15
824
8285
—
17
6
804
8281
15
54
738
8074
27
126
627
7152
Glucose [Moles/volume] in Serum or Plasma
14749-6 [3013826]
3.3e-01
1.0e+00
2.3e+00
1.0e+50
2.9e+00
9.0e-01
6.4e-01
cases:10.11%
controls:7.46%
cases:9.15%
controls:3.51%
cases:4.69%
controls:0.49%
cases:6.38%
controls:0.00%
cases:6.82%
controls:0.41%
cases:8.90%
controls:3.81%
cases:19.88%
controls:11.61%
84
619
747
7681
76
291
755
8009
39
41
792
8259
53
0
778
8300
56
34
765
8253
67
310
686
7818
130
845
524
6433
Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma
19072-8 [3016431]
4.3e-01
1.1e+00
1.9e+00
1.0e+50
2.7e+00
9.2e-01
6.6e-01
cases:9.15%
controls:6.13%
cases:9.27%
controls:3.45%
cases:4.33%
controls:0.65%
cases:2.05%
controls:0.00%
cases:7.55%
controls:0.53%
cases:8.63%
controls:3.63%
cases:17.13%
controls:9.66%
76
509
755
7791
77
286
754
8014
36
54
795
8246
17
0
814
8300
62
44
759
8243
65
295
688
7833
112
703
542
6575
buprenorphine; parenteral, sublingual, transdermal
N02AE01 [21604287]
1.2e+00
1.5e+00
1.8e+00
—
8.8e-01
1.8e+00
1.4e+00
cases:3.85%
controls:1.18%
cases:2.65%
controls:0.63%
cases:1.32%
controls:0.23%
—
—
cases:0.61%
controls:0.25%
cases:3.98%
controls:0.65%
cases:7.03%
controls:1.76%
32
98
799
8202
22
52
809
8248
11
19
820
8281
—
5
21
816
8266
30
53
723
8075
46
128
608
7150
pH of Specimen
17433-4 [3019225]
4.5e-01
1.0e+00
2.2e+00
—
2.4e+00
1.1e+00
1.1e+00
cases:2.05%
controls:1.31%
cases:1.81%
controls:0.67%
cases:0.84%
controls:0.10%
—
—
cases:1.34%
controls:0.12%
cases:1.86%
controls:0.65%
cases:4.28%
controls:1.53%
17
109
814
8191
15
56
816
8244
7
8
824
8292
—
11
10
810
8277
14
53
739
8075
28
111
626
7167
Pelvis X-ray examination
NE1AA [2001307792]
1.4e+00
2.9e+00
—
—
—
1.9e+00
1.4e+00
cases:1.32%
controls:0.33%
cases:1.56%
controls:0.08%
—
—
—
—
—
—
cases:1.06%
controls:0.16%
cases:2.60%
controls:0.63%
11
27
820
8273
13
7
818
8293
—
—
—
8
13
745
8115
17
46
637
7232
Epithelial cells.squamous [#/volume] in Urine by Automated count
51486-9 [3029879]
1.1e-01
9.0e-01
2.2e+00
1.0e+50
3.4e+00
1.1e+00
8.7e-01
cases:1.81%
controls:1.61%
cases:2.05%
controls:0.84%
cases:1.32%
controls:0.14%
cases:0.60%
controls:0.00%
cases:2.07%
controls:0.07%
cases:2.92%
controls:1.00%
cases:6.57%
controls:2.86%
15
134
816
8166
17
70
814
8230
11
12
820
8288
5
0
826
8300
17
6
804
8281
22
81
731
8047
43
208
611
7070
Oncology Clinic/Center
261QX0200X [38004268]
4.9e-01
1.3e+00
2.7e+00
—
3.1e+00
9.8e-02
2.0e-01
cases:6.98%
controls:4.39%
cases:4.81%
controls:1.33%
cases:1.68%
controls:0.12%
—
—
cases:2.80%
controls:0.13%
cases:1.33%
controls:1.21%
cases:5.50%
controls:4.56%
58
364
773
7936
40
110
791
8190
14
10
817
8290
—
23
11
798
8276
10
98
743
8030
36
332
618
6946
Urinalysis macro (dipstick) panel - Urine
24357-6 [3037467]
4.3e-01
8.2e-01
1.9e+00
1.0e+50
2.4e+00
1.1e+00
8.1e-01
cases:14.44%
controls:9.88%
cases:11.07%
controls:5.19%
cases:5.05%
controls:0.76%
cases:2.05%
controls:0.00%
cases:7.80%
controls:0.76%
cases:14.74%
controls:5.23%
cases:27.98%
controls:14.74%
120
820
711
7480
92
431
739
7869
42
63
789
8237
17
0
814
8300
64
63
757
8224
111
425
642
7703
183
1073
471
6205
diazepam; oral, parenteral, rectal
N05BA01 [21604566]
1.3e+00
1.7e+00
1.2e+00
—
1.4e+00
1.7e+00
1.4e+00
cases:7.70%
controls:2.25%
cases:5.42%
controls:1.02%
cases:0.96%
controls:0.30%
—
—
cases:1.34%
controls:0.35%
cases:5.71%
controls:1.07%
cases:7.80%
controls:1.96%
64
187
767
8113
45
85
786
8215
8
25
823
8275
—
11
29
810
8258
43
87
710
8041
51
143
603
7135
Lumbar spine extensive MRI examination with high intensity magnet
NA3CG [2001307039]
2.0e+00
2.9e+00
—
1.0e+50
—
—
2.7e+00
cases:1.93%
controls:0.27%
cases:1.44%
controls:0.08%
—
—
cases:0.84%
controls:0.00%
—
—
—
—
cases:2.29%
controls:0.16%
16
22
815
8278
12
7
819
8293
—
7
0
824
8300
—
—
15
12
639
7266
Urinary tract infection, site not specified
N39.0 [45548665]
1.1e+00
1.8e+00
2.3e+00
—
2.1e+00
2.4e+00
2.2e+00
cases:3.37%
controls:1.20%
cases:2.29%
controls:0.39%
cases:0.60%
controls:0.06%
—
—
cases:0.61%
controls:0.07%
cases:4.12%
controls:0.38%
cases:11.62%
controls:1.40%
28
100
803
8200
19
32
812
8268
5
5
826
8295
—
5
6
816
8281
31
31
722
8097
76
102
578
7176
Medical doctor
Z2221 [2001311556]
5.8e-01
1.2e+00
1.7e+00
—
1.7e+00
1.2e+00
1.1e+00
cases:6.26%
controls:3.59%
cases:4.21%
controls:1.36%
cases:1.08%
controls:0.19%
—
—
cases:1.22%
controls:0.22%
cases:3.05%
controls:0.98%
cases:8.72%
controls:3.05%
52
298
779
8002
35
113
796
8187
9
16
822
8284
—
10
18
811
8269
23
80
730
8048
57
222
597
7056
Thorax X-ray examination
GD1AA [2001303617]
7.6e-01
1.1e+00
2.0e+00
—
1.7e+00
9.2e-01
9.3e-01
cases:11.43%
controls:5.71%
cases:6.98%
controls:2.33%
cases:1.93%
controls:0.28%
—
—
cases:1.46%
controls:0.27%
cases:5.44%
controls:2.24%
cases:15.44%
controls:6.75%
95
474
736
7826
58
193
773
8107
16
23
815
8277
—
12
22
809
8265
41
182
712
7946
101
491
553
6787
Extensive body CT
JN4BD [2001310899]
7.9e-01
2.0e+00
2.4e+00
1.0e+50
—
1.7e+00
1.3e+00
cases:2.29%
controls:1.05%
cases:3.01%
controls:0.42%
cases:1.08%
controls:0.10%
cases:1.20%
controls:0.00%
—
—
cases:1.86%
controls:0.34%
cases:2.45%
controls:0.70%
19
87
812
8213
25
35
806
8265
9
8
822
8292
10
0
821
8300
—
14
28
739
8100
16
51
638
7227
Care involving use of other rehabilitation procedures
Z50.8 [45556842]
1.0e+00
2.1e+00
—
1.0e+50
—
2.2e+00
2.0e+00
cases:1.68%
controls:0.60%
cases:1.56%
controls:0.19%
—
—
cases:0.72%
controls:0.00%
—
—
cases:2.66%
controls:0.30%
cases:5.81%
controls:0.82%
14
50
817
8250
13
16
818
8284
—
6
0
825
8300
—
20
24
733
8104
38
60
616
7218
Flaccid neuropathic bladder, not elsewhere classified
N31.2 [45543864]
3.3e+00
—
—
—
—
1.0e+50
4.0e+00
cases:1.68%
controls:0.06%
—
—
—
—
—
—
—
—
cases:2.12%
controls:0.00%
cases:5.05%
controls:0.10%
14
5
817
8295
—
—
—
—
16
0
737
8128
33
7
621
7271
Occupational therapy
R4120 [2001310234]
1.1e+00
2.3e+00
—
1.0e+50
—
3.2e+00
1.9e+00
cases:1.32%
controls:0.45%
cases:1.08%
controls:0.11%
—
—
cases:1.44%
controls:0.00%
—
—
cases:2.26%
controls:0.10%
cases:3.36%
controls:0.52%
11
37
820
8263
9
9
822
8291
—
12
0
819
8300
—
17
8
736
8120
22
38
632
7240
metoclopramide; oral, parenteral, rectal
A03FA01 [21600484]
1.1e+00
1.2e+00
2.0e+00
—
2.0e+00
1.1e+00
4.9e-01
cases:6.50%
controls:2.34%
cases:3.13%
controls:0.98%
cases:1.08%
controls:0.14%
—
—
cases:0.85%
controls:0.12%
cases:3.19%
controls:1.07%
cases:4.43%
controls:2.76%
54
194
777
8106
26
81
805
8219
9
12
822
8288
—
7
10
814
8277
24
87
729
8041
29
201
625
7077
Polyneuropathy, unspecified
G62.9 [45566898]
9.2e-01
1.8e+00
—
—
—
3.6e+00
2.0e+00
cases:1.08%
controls:0.43%
cases:0.84%
controls:0.14%
—
—
—
—
—
—
cases:2.52%
controls:0.07%
cases:2.45%
controls:0.33%
9
36
822
8264
7
12
824
8288
—
—
—
19
6
734
8122
16
24
638
7254
Abdominal X-ray examination without contrast
JN3AA [2001305553]
1.4e+00
2.8e+00
—
—
—
2.4e+00
2.1e+00
cases:1.20%
controls:0.31%
cases:1.32%
controls:0.08%
—
—
—
—
—
—
cases:1.33%
controls:0.12%
cases:2.60%
controls:0.32%
10
26
821
8274
11
7
820
8293
—
—
—
10
10
743
8118
17
23
637
7255
Cystoscopy
UKC02 [2001306005]
1.2e+00
1.9e+00
—
—
—
2.2e+00
2.0e+00
cases:5.90%
controls:1.89%
cases:3.97%
controls:0.63%
—
—
—
—
—
—
cases:6.11%
controls:0.70%
cases:13.91%
controls:2.14%
49
157
782
8143
33
52
798
8248
—
—
—
46
57
707
8071
91
156
563
7122
Other specified urinary incontinence
N39.4 [45577525]
1.5e+00
1.8e+00
—
1.0e+50
—
2.1e+00
1.7e+00
cases:2.05%
controls:0.47%
cases:1.32%
controls:0.22%
—
—
cases:0.60%
controls:0.00%
—
—
cases:1.86%
controls:0.22%
cases:4.74%
controls:0.89%
17
39
814
8261
11
18
820
8282
—
5
0
826
8300
—
14
18
739
8110
31
65
623
7213
Surgical procedure, unspecified as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure
Y83.9 [45547252]
—
2.6e+00
—
—
—
2.4e+00
2.1e+00
—
—
cases:0.84%
controls:0.06%
—
—
—
—
—
—
cases:0.66%
controls:0.06%
cases:0.92%
controls:0.11%
—
7
5
824
8295
—
—
—
5
5
748
8123
6
8
648
7270
Bilirubin.total [Moles/volume] in Serum or Plasma
14631-6 [3006140]
4.3e-01
1.1e+00
1.7e+00
—
2.3e+00
8.0e-01
7.6e-01
cases:9.39%
controls:6.29%
cases:9.27%
controls:3.33%
cases:3.73%
controls:0.67%
—
—
cases:6.09%
controls:0.64%
cases:7.70%
controls:3.63%
cases:18.35%
controls:9.49%
78
522
753
7778
77
276
754
8024
31
56
800
8244
—
50
53
771
8234
58
295
695
7833
120
691
534
6587
Differential panel, method unspecified - Blood
69738-3 [42870588]
6.0e-01
8.7e-01
1.9e+00
—
2.2e+00
6.7e-01
8.6e-01
cases:7.34%
controls:4.18%
cases:5.42%
controls:2.35%
cases:3.61%
controls:0.54%
—
—
cases:4.99%
controls:0.58%
cases:5.44%
controls:2.87%
cases:13.00%
controls:5.94%
61
347
770
7953
45
195
786
8105
30
45
801
8255
—
41
48
780
8239
41
233
712
7895
85
432
569
6846
Other fall from one level to another
W17 [45756255]
1.9e+00
—
1.0e+50
—
1.0e+50
2.9e+00
2.3e+00
cases:2.05%
controls:0.30%
—
—
cases:0.60%
controls:0.00%
—
—
cases:0.61%
controls:0.00%
cases:2.12%
controls:0.12%
cases:3.98%
controls:0.41%
17
25
814
8275
—
5
0
826
8300
—
5
0
816
8287
16
10
737
8118
26
30
628
7248
Observation for suspected nervous system disorder
Z03.3 [45609903]
1.5e+00
2.0e+00
—
—
—
2.2e+00
1.3e+00
cases:1.56%
controls:0.34%
cases:1.08%
controls:0.14%
—
—
—
—
—
—
cases:1.33%
controls:0.15%
cases:2.14%
controls:0.58%
13
28
818
8272
9
12
822
8288
—
—
—
10
12
743
8116
14
42
640
7236
Amylase [Enzymatic activity/volume] in Serum or Plasma
1798-8 [3016771]
2.9e-01
1.1e+00
2.4e+00
1.0e+50
2.0e+00
1.0e+00
5.6e-01
cases:4.57%
controls:3.46%
cases:4.09%
controls:1.47%
cases:1.32%
controls:0.12%
cases:1.20%
controls:0.00%
cases:1.10%
controls:0.14%
cases:4.38%
controls:1.64%
cases:9.63%
controls:5.73%
38
287
793
8013
34
122
797
8178
11
10
820
8290
10
0
821
8300
9
12
812
8275
33
133
720
7995
63
417
591
6861
Counselling/guidance promoting independent living
SPAT1222 [2001700323]
6.9e-01
1.0e+00
1.8e+00
—
2.0e+00
2.0e+00
1.2e+00
cases:2.29%
controls:1.16%
cases:1.68%
controls:0.63%
cases:1.08%
controls:0.18%
—
—
cases:1.34%
controls:0.18%
cases:4.38%
controls:0.62%
cases:6.42%
controls:1.99%
19
96
812
8204
14
52
817
8248
9
15
822
8285
—
11
15
810
8272
33
50
720
8078
42
145
612
7133
Bacteria identified in Skin by Aerobe culture
620-5 [3007853]
7.7e-01
1.4e+00
2.5e+00
—
—
1.7e+00
1.4e+00
cases:2.53%
controls:1.18%
cases:1.81%
controls:0.45%
cases:0.72%
controls:0.06%
—
—
—
—
cases:2.39%
controls:0.46%
cases:6.88%
controls:1.70%
21
98
810
8202
15
37
816
8263
6
5
825
8295
—
—
18
37
735
8091
45
124
609
7154
One hour or less
ZXE00 [2001311394]
8.2e-01
1.6e+00
1.7e+00
1.0e+50
2.1e+00
1.4e+00
1.0e+00
cases:10.71%
controls:5.02%
cases:6.50%
controls:1.39%
cases:0.60%
controls:0.11%
cases:0.96%
controls:0.00%
cases:1.22%
controls:0.14%
cases:5.05%
controls:1.25%
cases:11.01%
controls:4.29%
89
417
742
7883
54
115
777
8185
5
9
826
8291
8
0
823
8300
10
12
811
8275
38
102
715
8026
72
312
582
6966
venlafaxine; oral
N06AX16 [21604745]
1.2e+00
1.4e+00
1.7e+00
—
1.1e+00
1.4e+00
1.3e+00
cases:5.29%
controls:1.70%
cases:4.09%
controls:1.07%
cases:1.68%
controls:0.31%
—
—
cases:1.10%
controls:0.36%
cases:4.38%
controls:1.14%
cases:7.19%
controls:2.01%
44
141
787
8159
34
89
797
8211
14
26
817
8274
—
9
30
812
8257
33
93
720
8035
47
146
607
7132
pH of Urine
2756-5 [3015736]
4.7e-01
7.5e-01
1.9e+00
1.0e+50
2.3e+00
1.0e+00
5.4e-01
cases:7.58%
controls:4.87%
cases:4.81%
controls:2.34%
cases:2.41%
controls:0.39%
cases:1.93%
controls:0.00%
cases:3.53%
controls:0.37%
cases:6.91%
controls:2.63%
cases:14.98%
controls:9.27%
63
404
768
7896
40
194
791
8106
20
32
811
8268
16
0
815
8300
29
31
792
8256
52
214
701
7914
98
675
556
6603
Emergency Medicine
93 [38004510]
3.6e-01
1.0e+00
2.4e+00
—
2.0e+00
8.1e-01
6.5e-01
cases:11.19%
controls:8.11%
cases:11.79%
controls:4.64%
cases:6.98%
controls:0.66%
—
—
cases:3.90%
controls:0.54%
cases:10.49%
controls:4.96%
cases:24.16%
controls:14.23%
93
673
738
7627
98
385
733
7915
58
55
773
8245
—
32
45
789
8242
79
403
674
7725
158
1036
496
6242
Hyaline casts [#/volume] in Urine by Automated count
51484-4 [3030981]
8.4e-01
1.6e+00
—
1.0e+50
2.9e+00
1.3e+00
1.1e+00
cases:1.44%
controls:0.63%
cases:1.32%
controls:0.27%
—
—
cases:0.72%
controls:0.00%
cases:1.10%
controls:0.06%
cases:1.46%
controls:0.41%
cases:3.98%
controls:1.39%
12
52
819
8248
11
22
820
8278
—
6
0
825
8300
9
5
812
8282
11
33
742
8095
26
101
628
7177
Urine symptom/complaint other
U07 [2002001142]
1.2e+00
1.9e+00
—
—
—
2.8e+00
2.2e+00
cases:0.84%
controls:0.25%
cases:1.08%
controls:0.17%
—
—
—
—
—
—
cases:2.12%
controls:0.14%
cases:6.73%
controls:0.76%
7
21
824
8279
9
14
822
8286
—
—
—
16
11
737
8117
44
55
610
7223
Paraesthesia of skin
R20.2 [45568120]
1.9e+00
2.5e+00
—
—
1.0e+50
2.5e+00
1.0e+00
cases:2.17%
controls:0.34%
cases:1.44%
controls:0.12%
—
—
—
—
cases:0.61%
controls:0.00%
cases:1.46%
controls:0.12%
cases:1.53%
controls:0.56%
18
28
813
8272
12
10
819
8290
—
—
5
0
816
8287
11
10
742
8118
10
41
644
7237
Social worker
Z2446 [2001311559]
1.2e+00
2.1e+00
—
1.0e+50
—
2.1e+00
1.4e+00
cases:2.17%
controls:0.64%
cases:1.68%
controls:0.20%
—
—
cases:0.60%
controls:0.00%
—
—
cases:1.20%
controls:0.15%
cases:1.53%
controls:0.38%
18
53
813
8247
14
17
817
8283
—
5
0
826
8300
—
9
12
744
8116
10
28
644
7250
Scheduled procedure
ZXD10 [2001311387]
8.4e-01
1.5e+00
1.3e+00
—
2.1e+00
1.5e+00
9.1e-01
cases:11.31%
controls:5.22%
cases:6.50%
controls:1.53%
cases:0.72%
controls:0.20%
—
—
cases:1.10%
controls:0.13%
cases:5.31%
controls:1.27%
cases:10.70%
controls:4.60%
94
433
737
7867
54
127
777
8173
6
17
825
8283
—
9
11
812
8276
40
103
713
8025
70
335
584
6943
Thoracal spine MRI examination with high intensity magnet
NA2BG [2001307013]
3.2e+00
—
—
1.0e+50
1.0e+50
1.0e+50
3.6e+00
cases:1.44%
controls:0.06%
—
—
—
—
cases:2.41%
controls:0.00%
cases:1.10%
controls:0.00%
cases:1.46%
controls:0.00%
cases:3.52%
controls:0.10%
12
5
819
8295
—
—
20
0
811
8300
9
0
812
8287
11
0
742
8128
23
7
631
7271
nitrofurantoin; oral
J01XE01 [21603058]
1.1e+00
1.7e+00
—
—
—
2.0e+00
2.0e+00
cases:4.45%
controls:1.53%
cases:3.25%
controls:0.59%
—
—
—
—
—
—
cases:5.31%
controls:0.76%
cases:12.08%
controls:1.84%
37
127
794
8173
27
49
804
8251
—
—
—
40
62
713
8066
79
134
575
7144
Bacterial infection, unspecified
A49.9 [45590816]
1.3e+00
1.7e+00
—
—
—
2.3e+00
1.5e+00
cases:2.05%
controls:0.54%
cases:1.56%
controls:0.30%
—
—
—
—
—
—
cases:2.92%
controls:0.31%
cases:5.20%
controls:1.21%
17
45
814
8255
13
25
818
8275
—
—
—
22
25
731
8103
34
88
620
7190
Paralysis/weakness
N18 [2002000729]
3.1e+00
—
1.0e+50
—
—
—
3.7e+00
cases:1.56%
controls:0.07%
—
—
cases:0.60%
controls:0.00%
—
—
—
—
—
—
cases:6.12%
controls:0.16%
13
6
818
8294
—
5
0
826
8300
—
—
—
40
12
614
7266
Insertion of central venous catheter through external or internal jugular vein
TPH15 [2001309600]
1.2e+00
2.4e+00
—
1.0e+50
—
2.8e+00
1.5e+00
cases:1.32%
controls:0.40%
cases:1.32%
controls:0.12%
—
—
cases:0.60%
controls:0.00%
—
—
cases:1.46%
controls:0.09%
cases:1.99%
controls:0.45%
11
33
820
8267
11
10
820
8290
—
5
0
826
8300
—
11
7
742
8121
13
33
641
7245
sulfamethoxazole and trimethoprim
J01EE01 [21602961]
1.3e+00
1.5e+00
—
—
—
2.1e+00
1.8e+00
cases:1.68%
controls:0.45%
cases:1.20%
controls:0.27%
—
—
—
—
—
—
cases:1.73%
controls:0.22%
cases:2.29%
controls:0.38%
14
37
817
8263
10
22
821
8278
—
—
—
13
18
740
8110
15
28
639
7250
Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure
Y83 [45552036]
1.1e+00
2.0e+00
—
—
—
2.0e+00
1.6e+00
cases:1.68%
controls:0.54%
cases:1.44%
controls:0.20%
—
—
—
—
—
—
cases:1.59%
controls:0.22%
cases:2.60%
controls:0.55%
14
45
817
8255
12
17
819
8283
—
—
—
12
18
741
8110
17
40
637
7238
Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture
13317-3 [3019902]
7.4e-01
1.2e+00
—
1.0e+50
3.2e+00
1.4e+00
8.3e-01
cases:2.05%
controls:0.99%
cases:1.56%
controls:0.46%
—
—
cases:0.96%
controls:0.00%
cases:1.95%
controls:0.08%
cases:2.26%
controls:0.54%
cases:3.36%
controls:1.50%
17
82
814
8218
13
38
818
8262
—
8
0
823
8300
16
7
805
8280
17
44
736
8084
22
109
632
7169
Diffuse lymphoma with large B cells
C83.31 [2000501224]
1.7e+00
2.0e+00
—
1.0e+50
—
2.5e+00
2.2e+00
cases:0.72%
controls:0.13%
cases:0.84%
controls:0.12%
—
—
cases:0.60%
controls:0.00%
—
—
cases:1.46%
controls:0.12%
cases:1.38%
controls:0.15%
6
11
825
8289
7
10
824
8290
—
5
0
826
8300
—
11
10
742
8118
9
11
645
7267
Treatment plan or consultation
WZC00 [2001310885]
2.7e-01
1.2e+00
1.7e+00
—
2.5e+00
1.2e+00
4.8e-01
cases:4.45%
controls:3.43%
cases:4.21%
controls:1.30%
cases:1.32%
controls:0.24%
—
—
cases:2.07%
controls:0.17%
cases:3.19%
controls:1.02%
cases:7.80%
controls:4.97%
37
285
794
8015
35
108
796
8192
11
20
820
8280
—
17
14
804
8273
24
83
729
8045
51
362
603
6916
buprenorphine; implant, parenteral, sublingual
N07BC01 [21604826]
1.8e+00
2.5e+00
—
—
—
—
2.3e+00
cases:0.96%
controls:0.16%
cases:0.84%
controls:0.07%
—
—
—
—
—
—
—
—
cases:1.38%
controls:0.14%
8
13
823
8287
7
6
824
8294
—
—
—
—
9
10
645
7268
Upper gastrointestinal surgery
106 [44777669]
5.9e-01
7.9e-01
1.6e+00
1.0e+50
1.3e+00
1.3e+00
9.7e-01
cases:11.07%
controls:6.48%
cases:6.50%
controls:3.05%
cases:1.68%
controls:0.35%
cases:0.60%
controls:0.00%
cases:1.46%
controls:0.40%
cases:9.96%
controls:2.88%
cases:19.42%
controls:8.34%
92
538
739
7762
54
253
777
8047
14
29
817
8271
5
0
826
8300
12
33
809
8254
75
234
678
7894
127
607
527
6671
Lumbar puncture
TAB00 [2001300538]
1.5e+00
—
—
1.0e+50
1.0e+50
3.1e+00
2.0e+00
cases:1.32%
controls:0.30%
—
—
—
—
cases:1.68%
controls:0.00%
cases:1.58%
controls:0.00%
cases:2.12%
controls:0.10%
cases:1.38%
controls:0.19%
11
25
820
8275
—
—
14
0
817
8300
13
0
808
8287
16
8
737
8120
9
14
645
7264
Infection following a procedure, not elsewhere classified
T81.4 [45575538]
1.1e+00
2.1e+00
—
—
—
1.8e+00
1.6e+00
cases:2.17%
controls:0.76%
cases:2.17%
controls:0.28%
—
—
—
—
—
—
cases:2.26%
controls:0.37%
cases:3.82%
controls:0.82%
18
63
813
8237
18
23
813
8277
—
—
—
17
30
736
8098
25
60
629
7218
Dorsalgia, unspecified
M54.9 [45538791]
1.3e+00
2.0e+00
—
—
—
1.5e+00
1.7e+00
cases:2.53%
controls:0.73%
cases:2.05%
controls:0.28%
—
—
—
—
—
—
cases:1.20%
controls:0.26%
cases:4.13%
controls:0.77%
21
61
810
8239
17
23
814
8277
—
—
—
9
21
744
8107
27
56
627
7222
Reticulocytes [#/volume] in Blood
14196-0 [3023520]
1.1e+00
1.6e+00
2.5e+00
—
—
1.3e+00
5.2e-01
cases:2.17%
controls:0.70%
cases:1.81%
controls:0.37%
cases:0.72%
controls:0.06%
—
—
—
—
cases:1.59%
controls:0.44%
cases:2.60%
controls:1.57%
18
58
813
8242
15
31
816
8269
6
5
825
8295
—
—
12
36
741
8092
17
114
637
7164
ABO and Rh group [Type] in Blood
882-1 [3003694]
1.1e-01
8.8e-01
2.2e+00
1.0e+50
3.4e+00
5.6e-01
4.9e-01
cases:3.13%
controls:2.82%
cases:2.53%
controls:1.06%
cases:0.84%
controls:0.10%
cases:0.72%
controls:0.00%
cases:1.83%
controls:0.06%
cases:1.46%
controls:0.84%
cases:5.81%
controls:3.65%
26
234
805
8066
21
88
810
8212
7
8
824
8292
6
0
825
8300
15
5
806
8282
11
68
742
8060
38
266
616
7012
Extensive abdominal CT
JN3BD [2001305556]
1.0e+00
1.9e+00
—
—
—
2.2e+00
1.5e+00
cases:1.81%
controls:0.66%
cases:1.68%
controls:0.27%
—
—
—
—
—
—
cases:1.46%
controls:0.17%
cases:2.60%
controls:0.62%
15
55
816
8245
14
22
817
8278
—
—
—
11
14
742
8114
17
45
637
7233
Other and unspecified abdominal pain
R10.4 [45568113]
6.7e-01
1.3e+00
2.3e+00
—
—
1.2e+00
9.4e-01
cases:7.34%
controls:3.90%
cases:4.45%
controls:1.22%
cases:1.20%
controls:0.12%
—
—
—
—
cases:4.25%
controls:1.28%
cases:11.47%
controls:4.82%
61
324
770
7976
37
101
794
8199
10
10
821
8290
—
—
32
104
721
8024
75
351
579
6927
Metamyelocytes/Leukocytes in Blood
28541-1 [3002179]
8.4e-01
1.3e+00
2.2e+00
—
3.0e+00
1.1e+00
6.7e-01
cases:1.32%
controls:0.58%
cases:1.44%
controls:0.41%
cases:0.96%
controls:0.11%
—
—
cases:1.22%
controls:0.06%
cases:1.46%
controls:0.47%
cases:2.75%
controls:1.43%
11
48
820
8252
12
34
819
8266
8
9
823
8291
—
10
5
811
8282
11
38
742
8090
18
104
636
7174
Nitrite [Presence] in Urine by Test strip
5802-4 [3021601]
4.1e-01
7.4e-01
1.8e+00
—
2.5e+00
9.9e-01
4.5e-01
cases:8.66%
controls:5.93%
cases:6.38%
controls:3.16%
cases:3.37%
controls:0.59%
—
—
cases:5.60%
controls:0.47%
cases:9.03%
controls:3.57%
cases:17.13%
controls:11.65%
72
492
759
7808
53
262
778
8038
28
49
803
8251
—
46
39
775
8248
68
290
685
7838
112
848
542
6430
Other spondylosis with radiculopathy
M47.2 [45591850]
1.4e+00
1.6e+00
—
1.0e+50
2.1e+00
2.2e+00
1.4e+00
cases:2.05%
controls:0.53%
cases:1.08%
controls:0.23%
—
—
cases:0.60%
controls:0.00%
cases:0.61%
controls:0.07%
cases:2.26%
controls:0.26%
cases:2.91%
controls:0.77%
17
44
814
8256
9
19
822
8281
—
5
0
826
8300
5
6
816
8281
17
21
736
8107
19
56
635
7222
Laboratory Visit
OMOP4822461 [32036]
2.2e-02
2.3e-01
1.1e+00
3.8e+00
1.3e+00
3.1e-01
1.4e-01
cases:26.23%
controls:25.82%
cases:29.84%
controls:25.35%
cases:20.34%
controls:7.94%
cases:15.04%
controls:0.40%
cases:24.00%
controls:8.10%
cases:32.93%
controls:26.49%
cases:45.11%
controls:41.70%
218
2143
613
6157
248
2104
583
6196
169
659
662
7641
125
33
706
8267
197
671
624
7616
248
2153
505
5975
295
3035
359
4243
Medical Oncology
90 [38004507]
7.0e-01
1.1e+00
1.3e+00
—
2.3e+00
1.1e+00
4.3e-01
cases:5.17%
controls:2.64%
cases:5.66%
controls:2.02%
cases:2.89%
controls:0.77%
—
—
cases:6.33%
controls:0.70%
cases:5.71%
controls:1.99%
cases:5.35%
controls:3.56%
43
219
788
8081
47
168
784
8132
24
64
807
8236
—
52
58
769
8229
43
162
710
7966
35
259
619
7019
Constipation, unspecified
K59.09 [2000502926]
1.1e+00
2.7e+00
—
—
—
2.2e+00
1.6e+00
cases:1.32%
controls:0.45%
cases:1.08%
controls:0.07%
—
—
—
—
—
—
cases:1.46%
controls:0.17%
cases:2.45%
controls:0.51%
11
37
820
8263
9
6
822
8294
—
—
—
11
14
742
8114
16
37
638
7241
Myoglobin [Mass/volume] in Serum or Plasma
2639-3 [3005895]
1.3e+00
2.2e+00
—
1.0e+50
1.0e+50
2.6e+00
1.6e+00
cases:0.96%
controls:0.28%
cases:0.84%
controls:0.10%
—
—
cases:0.60%
controls:0.00%
cases:1.34%
controls:0.00%
cases:1.33%
controls:0.10%
cases:2.75%
controls:0.55%
8
23
823
8277
7
8
824
8292
—
5
0
826
8300
11
0
810
8287
10
8
743
8120
18
40
636
7238
alprostadil; parenteral
C01EA01 [21600362]
1.5e+00
—
—
—
—
2.5e+00
2.4e+00
cases:1.44%
controls:0.34%
—
—
—
—
—
—
—
—
cases:1.33%
controls:0.11%
cases:2.14%
controls:0.19%
12
28
819
8272
—
—
—
—
10
9
743
8119
14
14
640
7264
Sepsis, unspecified
A41.9 [45585911]
2.0e+00
2.5e+00
—
—
—
1.9e+00
1.9e+00
cases:1.08%
controls:0.14%
cases:0.84%
controls:0.07%
—
—
—
—
—
—
cases:0.66%
controls:0.10%
cases:1.99%
controls:0.32%
9
12
822
8288
7
6
824
8294
—
—
—
5
8
748
8120
13
23
641
7255
Ketones [Presence] in Urine by Test strip
2514-8 [3035350]
3.8e-01
7.1e-01
1.7e+00
—
2.5e+00
9.2e-01
4.9e-01
cases:8.66%
controls:6.10%
cases:6.38%
controls:3.25%
cases:3.37%
controls:0.63%
—
—
cases:5.60%
controls:0.48%
cases:8.76%
controls:3.68%
cases:17.89%
controls:11.82%
72
506
759
7794
53
270
778
8030
28
52
803
8248
—
46
40
775
8247
66
299
687
7829
117
860
537
6418
Glucose [Presence] in Urine by Test strip
25428-4 [3009261]
4.3e-01
7.2e-01
1.7e+00
—
2.5e+00
9.5e-01
4.6e-01
cases:9.15%
controls:6.16%
cases:6.62%
controls:3.35%
cases:3.37%
controls:0.65%
—
—
cases:5.72%
controls:0.49%
cases:9.16%
controls:3.74%
cases:17.58%
controls:11.87%
76
511
755
7789
55
278
776
8022
28
54
803
8246
—
47
41
774
8246
69
304
684
7824
115
864
539
6414
Eosinophils/Leukocytes in Blood
26450-7 [3006504]
4.0e-01
7.7e-01
1.9e+00
1.0e+50
2.3e+00
6.5e-01
7.0e-01
cases:9.27%
controls:6.40%
cases:7.82%
controls:3.78%
cases:4.81%
controls:0.78%
cases:0.84%
controls:0.00%
cases:7.55%
controls:0.80%
cases:7.30%
controls:3.96%
cases:16.51%
controls:8.96%
77
531
754
7769
65
314
766
7986
40
65
791
8235
7
0
824
8300
62
66
759
8221
55
322
698
7806
108
652
546
6626
Monocytes/Leukocytes in Blood
26485-3 [3019069]
4.2e-01
7.7e-01
1.9e+00
1.0e+50
2.3e+00
6.5e-01
7.0e-01
cases:9.39%
controls:6.39%
cases:7.82%
controls:3.80%
cases:4.81%
controls:0.78%
cases:1.08%
controls:0.00%
cases:7.43%
controls:0.80%
cases:7.30%
controls:3.95%
cases:16.51%
controls:8.92%
78
530
753
7770
65
315
766
7985
40
65
791
8235
9
0
822
8300
61
66
760
8221
55
321
698
7807
108
649
546
6629
Insertion of urinary catheter
SPAT1167 [2001700268]
—
—
—
—
—
3.4e+00
2.8e+00
—
—
—
—
—
—
—
—
—
—
cases:1.86%
controls:0.06%
cases:4.59%
controls:0.29%
—
—
—
—
—
14
5
739
8123
30
21
624
7257
Basophils/Leukocytes in Blood
30180-4 [3022096]
4.1e-01
7.6e-01
1.9e+00
1.0e+50
2.3e+00
6.5e-01
6.8e-01
cases:9.27%
controls:6.33%
cases:7.70%
controls:3.77%
cases:4.81%
controls:0.77%
cases:0.96%
controls:0.00%
cases:7.19%
controls:0.78%
cases:7.30%
controls:3.96%
cases:16.21%
controls:8.96%
77
525
754
7775
64
313
767
7987
40
64
791
8236
8
0
823
8300
59
65
762
8222
55
322
698
7806
106
652
548
6626
Chronic ulcer skin
S97 [2002001061]
1.2e+00
1.6e+00
—
—
—
1.6e+00
1.7e+00
cases:1.44%
controls:0.42%
cases:0.96%
controls:0.19%
—
—
—
—
—
—
cases:1.33%
controls:0.26%
cases:3.82%
controls:0.70%
12
35
819
8265
8
16
823
8284
—
—
—
10
21
743
8107
25
51
629
7227
Hip X-ray examination
NF1AA [2001307894]
1.1e+00
1.8e+00
—
—
—
2.2e+00
1.0e+00
cases:2.17%
controls:0.70%
cases:1.81%
controls:0.29%
—
—
—
—
—
—
cases:1.86%
controls:0.21%
cases:2.29%
controls:0.82%
18
58
813
8242
15
24
816
8276
—
—
—
14
17
739
8111
15
60
639
7218
Physiologic investigation of micturition
XKD06 [2001306098]
2.8e+00
—
—
—
—
—
3.5e+00
cases:3.13%
controls:0.20%
—
—
—
—
—
—
—
—
—
—
cases:7.03%
controls:0.23%
26
17
805
8283
—
—
—
—
—
46
17
608
7261
Major dressing of wound of skin of trunk
QBB10 [2001309842]
1.6e+00
1.4e+00
—
—
—
2.1e+00
2.5e+00
cases:1.08%
controls:0.23%
cases:0.60%
controls:0.14%
—
—
—
—
—
—
cases:0.93%
controls:0.11%
cases:1.99%
controls:0.16%
9
19
822
8281
5
12
826
8288
—
—
—
7
9
746
8119
13
12
641
7266
Erythrocytes [Presence] in Urine by Automated
53292-9 [3041096]
3.7e-01
8.4e-01
1.8e+00
1.0e+50
2.6e+00
9.6e-01
4.7e-01
cases:4.69%
controls:3.29%
cases:3.73%
controls:1.65%
cases:1.56%
controls:0.25%
cases:1.08%
controls:0.00%
cases:2.44%
controls:0.19%
cases:4.52%
controls:1.78%
cases:9.02%
controls:5.83%
39
273
792
8027
31
137
800
8163
13
21
818
8279
9
0
822
8300
20
16
801
8271
34
145
719
7983
59
424
595
6854
alprostadil; implant, parenteral
G04BE01 [21602646]
1.4e+00
—
—
—
—
2.5e+00
2.3e+00
cases:1.44%
controls:0.36%
—
—
—
—
—
—
—
—
cases:1.59%
controls:0.14%
cases:2.29%
controls:0.23%
12
30
819
8270
—
—
—
—
12
11
741
8117
15
17
639
7261
Lymphocytes/Leukocytes in Blood
26478-8 [3002030]
3.9e-01
7.6e-01
1.9e+00
1.0e+50
2.3e+00
6.2e-01
6.4e-01
cases:9.51%
controls:6.63%
cases:7.94%
controls:3.89%
cases:4.81%
controls:0.77%
cases:0.96%
controls:0.00%
cases:7.31%
controls:0.80%
cases:7.30%
controls:4.06%
cases:16.36%
controls:9.38%
79
550
752
7750
66
323
765
7977
40
64
791
8236
8
0
823
8300
60
66
761
8221
55
330
698
7798
107
683
547
6595
Respiratory and circulatory monitoring
WX700 [2001310817]
9.9e-01
1.9e+00
—
—
—
2.2e+00
1.0e+00
cases:3.85%
controls:1.47%
cases:3.13%
controls:0.46%
—
—
—
—
—
—
cases:3.45%
controls:0.39%
cases:4.89%
controls:1.83%
32
122
799
8178
26
38
805
8262
—
—
—
26
32
727
8096
32
133
622
7145
Holo-transcobalamin II [Moles/volume] in Serum
72160-5 [43054903]
3.6e-01
7.5e-01
2.2e+00
—
2.5e+00
7.4e-01
3.1e-01
cases:6.86%
controls:4.87%
cases:5.42%
controls:2.63%
cases:2.05%
controls:0.24%
—
—
cases:3.41%
controls:0.29%
cases:5.18%
controls:2.53%
cases:11.47%
controls:8.67%
57
404
774
7896
45
218
786
8082
17
20
814
8280
—
28
24
793
8263
39
206
714
7922
75
631
579
6647
Urethral pressure profilometry
XKD03 [2001306097]
3.0e+00
—
—
—
—
—
3.1e+00
cases:2.17%
controls:0.11%
—
—
—
—
—
—
—
—
—
—
cases:2.14%
controls:0.10%
18
9
813
8291
—
—
—
—
—
14
7
640
7271
Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma
1920-8 [3013721]
3.4e-01
8.8e-01
1.4e+00
—
2.4e+00
8.0e-01
5.7e-01
cases:5.90%
controls:4.27%
cases:4.33%
controls:1.84%
cases:1.20%
controls:0.29%
—
—
cases:2.56%
controls:0.23%
cases:4.12%
controls:1.89%
cases:11.01%
controls:6.51%
49
354
782
7946
36
153
795
8147
10
24
821
8276
—
21
19
800
8268
31
154
722
7974
72
474
582
6804
pH of Capillary blood
2745-8 [3009343]
7.4e-01
1.2e+00
—
—
3.4e+00
1.5e+00
1.3e+00
cases:1.20%
controls:0.58%
cases:1.08%
controls:0.31%
—
—
—
—
cases:1.71%
controls:0.06%
cases:1.59%
controls:0.36%
cases:3.52%
controls:1.03%
10
48
821
8252
9
26
822
8274
—
—
14
5
807
8282
12
29
741
8099
23
75
631
7203
Carbon dioxide [Partial pressure] in Capillary blood
2020-6 [3023024]
7.4e-01
1.1e+00
—
—
3.4e+00
1.5e+00
1.3e+00
cases:1.20%
controls:0.58%
cases:1.08%
controls:0.35%
—
—
—
—
cases:1.71%
controls:0.06%
cases:1.59%
controls:0.37%
cases:3.67%
controls:1.07%
10
48
821
8252
9
29
822
8271
—
—
14
5
807
8282
12
30
741
8098
24
78
630
7200
Cervical spine CT examination
NA1AD [2001306982]
1.6e+00
2.6e+00
1.0e+50
1.0e+50
—
—
1.8e+00
cases:1.32%
controls:0.27%
cases:0.84%
controls:0.06%
cases:0.72%
controls:0.00%
cases:1.08%
controls:0.00%
—
—
—
—
cases:1.68%
controls:0.27%
11
22
820
8278
7
5
824
8295
6
0
825
8300
9
0
822
8300
—
—
11
20
643
7258
Troponin T.cardiac [Mass/volume] in Serum or Plasma
6598-7 [3019800]
3.5e-01
9.4e-01
2.5e+00
1.0e+50
2.2e+00
6.0e-01
4.8e-01
cases:6.14%
controls:4.41%
cases:4.81%
controls:1.93%
cases:2.53%
controls:0.22%
cases:2.65%
controls:0.00%
cases:2.44%
controls:0.29%
cases:4.12%
controls:2.30%
cases:11.16%
controls:7.19%
51
366
780
7934
40
160
791
8140
21
18
810
8282
22
0
809
8300
20
24
801
8263
31
187
722
7941
73
523
581
6755
Multiple sclerosis
G35 [45571794]
1.1e+00
1.3e+00
—
—
—
3.0e+00
3.0e+00
cases:0.60%
controls:0.20%
cases:0.72%
controls:0.19%
—
—
—
—
—
—
cases:3.85%
controls:0.20%
cases:5.20%
controls:0.26%
5
17
826
8283
6
16
825
8284
—
—
—
29
16
724
8112
34
19
620
7259
Neutrophils/Leukocytes in Blood
26511-6 [3018010]
3.7e-01
7.4e-01
1.8e+00
1.0e+50
2.2e+00
6.3e-01
6.6e-01
cases:9.03%
controls:6.43%
cases:7.82%
controls:3.89%
cases:4.69%
controls:0.78%
cases:0.96%
controls:0.00%
cases:6.70%
controls:0.81%
cases:7.17%
controls:3.96%
cases:16.21%
controls:9.05%
75
534
756
7766
65
323
766
7977
39
65
792
8235
8
0
823
8300
55
67
766
8220
54
322
699
7806
106
659
548
6619
Chloride [Moles/volume] in Serum or Plasma
2075-0 [3014576]
3.0e-01
1.1e+00
2.1e+00
1.0e+50
2.9e+00
1.3e+00
7.9e-01
cases:1.81%
controls:1.35%
cases:1.56%
controls:0.54%
cases:0.60%
controls:0.07%
cases:1.08%
controls:0.00%
cases:1.10%
controls:0.06%
cases:2.12%
controls:0.62%
cases:4.13%
controls:1.91%
15
112
816
8188
13
45
818
8255
5
6
826
8294
9
0
822
8300
9
5
812
8282
16
50
737
8078
27
139
627
7139
Folate [Moles/volume] in Serum or Plasma
14732-2 [3021960]
5.6e-01
8.9e-01
2.1e+00
—
3.0e+00
6.5e-01
4.6e-01
cases:2.89%
controls:1.67%
cases:2.89%
controls:1.20%
cases:1.20%
controls:0.14%
—
—
cases:2.80%
controls:0.14%
cases:2.66%
controls:1.40%
cases:7.19%
controls:4.64%
24
139
807
8161
24
100
807
8200
10
12
821
8288
—
23
12
798
8275
20
114
733
8014
47
338
607
6940
Uroflowmetry
44856007 [4261340]
7.0e-01
1.3e+00
—
—
—
2.2e+00
1.8e+00
cases:3.97%
controls:2.01%
cases:2.17%
controls:0.58%
—
—
—
—
—
—
cases:3.98%
controls:0.46%
cases:9.79%
controls:1.83%
33
167
798
8133
18
48
813
8252
—
—
—
30
37
723
8091
64
133
590
7145
Taking care of patient’s/customer’s hygiene
SPAT1137 [2001700238]
9.6e-01
1.7e+00
1.8e+00
—
—
2.4e+00
1.8e+00
cases:0.72%
controls:0.28%
cases:1.32%
controls:0.24%
cases:0.72%
controls:0.12%
—
—
—
—
cases:2.66%
controls:0.25%
cases:4.59%
controls:0.77%
6
23
825
8277
11
20
820
8280
6
10
825
8290
—
—
20
20
733
8108
30
56
624
7222
Musculoskeletal sympt/complt other
L29 [2002000648]
1.1e+00
1.7e+00
—
—
—
2.0e+00
1.1e+00
cases:1.68%
controls:0.57%
cases:1.08%
controls:0.19%
—
—
—
—
—
—
cases:1.06%
controls:0.15%
cases:2.45%
controls:0.81%
14
47
817
8253
9
16
822
8284
—
—
—
8
12
745
8116
16
59
638
7219
Measurement of bone density from two or more locations with X-ray
NK6QA [2001308500]
4.5e-01
2.0e+00
—
—
—
1.9e+00
2.0e+00
cases:0.60%
controls:0.39%
cases:0.72%
controls:0.10%
—
—
—
—
—
—
cases:1.20%
controls:0.17%
cases:2.29%
controls:0.33%
5
32
826
8268
6
8
825
8292
—
—
—
9
14
744
8114
15
24
639
7254
Myelocytes/Leukocytes in Blood
26498-6 [3017181]
9.1e-01
1.2e+00
2.1e+00
—
2.6e+00
1.0e+00
5.9e-01
cases:1.68%
controls:0.69%
cases:1.81%
controls:0.53%
cases:1.08%
controls:0.13%
—
—
cases:1.10%
controls:0.08%
cases:1.46%
controls:0.53%
cases:2.75%
controls:1.54%
14
57
817
8243
15
44
816
8256
9
11
822
8289
—
9
7
812
8280
11
43
742
8085
18
112
636
7166
Constipation
K59.0 [45557663]
1.2e+00
2.1e+00
—
—
—
2.5e+00
1.3e+00
cases:1.08%
controls:0.33%
cases:1.08%
controls:0.13%
—
—
—
—
—
—
cases:1.33%
controls:0.11%
cases:2.45%
controls:0.67%
9
27
822
8273
9
11
822
8289
—
—
—
10
9
743
8119
16
49
638
7229
Neutrophils [#/volume] in Blood by Automated count
751-8 [3013650]
4.3e-01
6.9e-01
1.5e+00
1.0e+50
2.0e+00
6.1e-01
7.4e-01
cases:11.91%
controls:8.11%
cases:9.75%
controls:5.16%
cases:5.78%
controls:1.36%
cases:1.32%
controls:0.00%
cases:8.16%
controls:1.24%
cases:8.90%
controls:5.04%
cases:20.49%
controls:10.99%
99
673
732
7627
81
428
750
7872
48
113
783
8187
11
0
820
8300
67
103
754
8184
67
410
686
7718
134
800
520
6478
Treatment of a patient needing special arrangements
WYA30 [2001310874]
7.2e-01
2.0e+00
—
—
—
2.0e+00
1.9e+00
cases:1.32%
controls:0.65%
cases:1.08%
controls:0.14%
—
—
—
—
—
—
cases:1.33%
controls:0.18%
cases:4.59%
controls:0.73%
11
54
820
8246
9
12
822
8288
—
—
—
10
15
743
8113
30
53
624
7225
Pneumonia, unspecified
J18.9 [45601123]
5.6e-01
1.4e+00
1.7e+00
1.0e+50
2.2e+00
1.3e+00
1.0e+00
cases:3.85%
controls:2.23%
cases:3.37%
controls:0.89%
cases:0.72%
controls:0.13%
cases:0.96%
controls:0.00%
cases:1.10%
controls:0.12%
cases:3.45%
controls:0.98%
cases:10.24%
controls:4.03%
32
185
799
8115
28
74
803
8226
6
11
825
8289
8
0
823
8300
9
10
812
8277
26
80
727
8048
67
293
587
6985
Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma
6768-6 [3035995]
2.7e-01
7.7e-01
1.7e+00
—
2.2e+00
6.8e-01
5.7e-01
cases:14.44%
controls:11.46%
cases:13.84%
controls:6.93%
cases:6.62%
controls:1.33%
—
—
cases:9.50%
controls:1.21%
cases:13.81%
controls:7.48%
cases:27.22%
controls:17.46%
120
951
711
7349
115
575
716
7725
55
110
776
8190
—
78
100
743
8187
104
608
649
7520
178
1271
476
6007
Handing over of treatment supplies
SPAT1262 [2001700363]
6.7e-01
8.3e-01
1.6e+00
—
1.1e+00
1.6e+00
1.1e+00
cases:5.42%
controls:2.86%
cases:3.61%
controls:1.60%
cases:1.08%
controls:0.23%
—
—
cases:1.10%
controls:0.36%
cases:7.17%
controls:1.53%
cases:11.93%
controls:4.14%
45
237
786
8063
30
133
801
8167
9
19
822
8281
—
9
30
812
8257
54
124
699
8004
78
301
576
6977
Monocytes [#/volume] in Blood
26484-6 [3001604]
3.6e-01
6.7e-01
1.8e+00
1.0e+50
2.1e+00
5.8e-01
6.1e-01
cases:9.27%
controls:6.67%
cases:7.46%
controls:3.95%
cases:4.81%
controls:0.82%
cases:0.60%
controls:0.00%
cases:6.82%
controls:0.86%
cases:7.17%
controls:4.16%
cases:16.51%
controls:9.71%
77
554
754
7746
62
328
769
7972
40
68
791
8232
5
0
826
8300
56
71
765
8216
54
338
699
7790
108
707
546
6571
Assessment of need for medical rehabilitation
SPAT1215 [2001700316]
1.1e+00
2.3e+00
—
—
—
3.0e+00
2.8e+00
cases:0.84%
controls:0.29%
cases:0.60%
controls:0.06%
—
—
—
—
—
—
cases:1.46%
controls:0.07%
cases:3.52%
controls:0.22%
7
24
824
8276
5
5
826
8295
—
—
—
11
6
742
8122
23
16
631
7262
Acute cystitis
N30.0 [45601724]
1.1e+00
1.4e+00
2.3e+00
—
—
1.9e+00
1.4e+00
cases:3.01%
controls:0.99%
cases:1.68%
controls:0.43%
cases:0.60%
controls:0.06%
—
—
—
—
cases:3.59%
controls:0.57%
cases:7.19%
controls:1.84%
25
82
806
8218
14
36
817
8264
5
5
826
8295
—
—
27
46
726
8082
47
134
607
7144
Basophils [#/volume] in Blood
26444-0 [3006315]
3.4e-01
6.7e-01
1.8e+00
1.0e+50
2.1e+00
5.8e-01
6.1e-01
cases:9.27%
controls:6.75%
cases:7.46%
controls:3.96%
cases:4.81%
controls:0.82%
cases:0.60%
controls:0.00%
cases:6.82%
controls:0.87%
cases:7.17%
controls:4.15%
cases:16.67%
controls:9.77%
77
560
754
7740
62
329
769
7971
40
68
791
8232
5
0
826
8300
56
72
765
8215
54
337
699
7791
109
711
545
6567
Intravenous general anesthesia
WX404 [2001310807]
6.5e-01
2.0e+00
1.8e+00
1.0e+50
—
1.9e+00
1.3e+00
cases:3.97%
controls:2.11%
cases:2.77%
controls:0.39%
cases:0.60%
controls:0.10%
cases:0.84%
controls:0.00%
—
—
cases:2.39%
controls:0.38%
cases:4.74%
controls:1.35%
33
175
798
8125
23
32
808
8268
5
8
826
8292
7
0
824
8300
—
18
31
735
8097
31
98
623
7180
Erythrocyte sedimentation rate [Velocity] in Red Blood Cells by Westergren method
4537-7 [3013707]
2.7e-01
8.0e-01
2.0e+00
—
1.9e+00
6.5e-01
3.8e-01
cases:14.44%
controls:11.39%
cases:11.79%
controls:5.67%
cases:5.42%
controls:0.76%
—
—
cases:6.09%
controls:0.93%
cases:11.16%
controls:6.13%
cases:22.32%
controls:16.36%
120
945
711
7355
98
471
733
7829
45
63
786
8237
—
50
77
771
8210
84
498
669
7630
146
1191
508
6087
Borrelia burgdorferi IgM Ab [Units/volume] in Serum
7818-8 [3008230]
9.4e-01
2.6e+00
1.0e+50
1.0e+50
—
2.2e+00
1.0e+00
cases:1.81%
controls:0.71%
cases:1.81%
controls:0.13%
cases:0.96%
controls:0.00%
cases:0.60%
controls:0.00%
—
—
cases:1.46%
controls:0.17%
cases:2.29%
controls:0.85%
15
59
816
8241
15
11
816
8289
8
0
823
8300
5
0
826
8300
—
11
14
742
8114
15
62
639
7216
levofloxacin; inhalant, oral, parenteral
J01MA12 [21603019]
7.7e-01
1.5e+00
—
—
—
1.7e+00
1.8e+00
cases:4.33%
controls:2.05%
cases:3.13%
controls:0.70%
—
—
—
—
—
—
cases:3.72%
controls:0.69%
cases:12.69%
controls:2.42%
36
170
795
8130
26
58
805
8242
—
—
—
28
56
725
8072
83
176
571
7102
Exposure to other specified factors
X58 [45756411]
1.5e+00
1.7e+00
—
1.0e+50
—
1.7e+00
8.6e-01
cases:3.37%
controls:0.73%
cases:1.20%
controls:0.23%
—
—
cases:0.72%
controls:0.00%
—
—
cases:1.73%
controls:0.33%
cases:3.52%
controls:1.53%
28
61
803
8239
10
19
821
8281
—
6
0
825
8300
—
13
27
740
8101
23
111
631
7167
Constipation caused by slow bowel passage (SCT)
K59.00 [2000502924]
1.7e+00
—
—
—
—
2.7e+00
3.0e+00
cases:0.60%
controls:0.11%
—
—
—
—
—
—
—
—
cases:0.93%
controls:0.06%
cases:2.45%
controls:0.12%
5
9
826
8291
—
—
—
—
7
5
746
8123
16
9
638
7269
alendronic acid and colecalciferol; oral
M05BB03 [21604160]
1.2e+00
1.8e+00
—
—
—
2.2e+00
1.8e+00
cases:0.84%
controls:0.25%
cases:0.84%
controls:0.14%
—
—
—
—
—
—
cases:1.06%
controls:0.12%
cases:1.38%
controls:0.23%
7
21
824
8279
7
12
824
8288
—
—
—
8
10
745
8118
9
17
645
7261
enoxaparin; parenteral
B01AB05 [21600976]
5.0e-01
1.3e+00
1.2e+00
—
1.8e+00
1.8e+00
8.3e-01
cases:6.14%
controls:3.82%
cases:3.73%
controls:1.07%
cases:0.72%
controls:0.23%
—
—
cases:1.34%
controls:0.22%
cases:5.98%
controls:1.07%
cases:8.56%
controls:3.93%
51
317
780
7983
31
89
800
8211
6
19
825
8281
—
11
18
810
8269
45
87
708
8041
56
286
598
6992
Calcium [Moles/volume] corrected for albumin in Serum or Plasma
29265-6 [3020059]
4.8e-01
1.4e+00
2.4e+00
—
1.9e+00
5.8e-01
2.7e-01
cases:3.01%
controls:1.89%
cases:3.49%
controls:0.92%
cases:0.96%
controls:0.08%
—
—
cases:1.10%
controls:0.17%
cases:1.86%
controls:1.05%
cases:3.98%
controls:3.05%
25
157
806
8143
29
76
802
8224
8
7
823
8293
—
9
14
812
8273
14
85
739
8043
26
222
628
7056
Ankle X-ray examination without contrast
NH1AA [2001308235]
1.1e+00
1.8e+00
—
—
—
2.0e+00
1.9e+00
cases:1.20%
controls:0.42%
cases:1.08%
controls:0.18%
—
—
—
—
—
—
cases:0.93%
controls:0.12%
cases:2.75%
controls:0.44%
10
35
821
8265
9
15
822
8285
—
—
—
7
10
746
8118
18
32
636
7246
Short blood count panel - Blood
55429-5 [40758558]
2.7e-01
8.5e-01
1.4e+00
—
2.0e+00
7.5e-01
6.3e-01
cases:4.81%
controls:3.71%
cases:4.33%
controls:1.89%
cases:1.68%
controls:0.41%
—
—
cases:2.92%
controls:0.41%
cases:3.72%
controls:1.78%
cases:7.95%
controls:4.38%
40
308
791
7992
36
157
795
8143
14
34
817
8266
—
24
34
797
8253
28
145
725
7983
52
319
602
6959
Eosinophils [#/volume] in Blood
26449-9 [3013115]
3.4e-01
6.7e-01
1.8e+00
1.0e+50
2.1e+00
5.7e-01
6.0e-01
cases:9.63%
controls:7.07%
cases:7.94%
controls:4.22%
cases:4.93%
controls:0.89%
cases:0.72%
controls:0.00%
cases:6.82%
controls:0.93%
cases:7.44%
controls:4.34%
cases:16.97%
controls:10.09%
80
587
751
7713
66
350
765
7950
41
74
790
8226
6
0
825
8300
56
77
765
8210
56
353
697
7775
111
734
543
6544
Protein [Presence] in Urine by Test strip
20454-5 [3014051]
3.9e-01
6.3e-01
2.0e+00
1.0e+50
2.1e+00
1.0e+00
5.2e-01
cases:3.61%
controls:2.47%
cases:2.53%
controls:1.36%
cases:1.81%
controls:0.24%
cases:0.84%
controls:0.00%
cases:1.58%
controls:0.21%
cases:4.12%
controls:1.49%
cases:8.87%
controls:5.47%
30
205
801
8095
21
113
810
8187
15
20
816
8280
7
0
824
8300
13
17
808
8270
31
121
722
8007
58
398
596
6880
Leukocyte esterase [Presence] in Urine by Automated test strip
60026-2 [40763086]
3.4e-01
8.3e-01
1.7e+00
1.0e+50
2.3e+00
8.1e-01
4.0e-01
cases:7.10%
controls:5.14%
cases:5.54%
controls:2.48%
cases:2.17%
controls:0.42%
cases:1.68%
controls:0.00%
cases:3.53%
controls:0.35%
cases:6.11%
controls:2.81%
cases:13.30%
controls:9.29%
59
427
772
7873
46
206
785
8094
18
35
813
8265
14
0
817
8300
29
29
792
8258
46
228
707
7900
87
676
567
6602
Albumin [Presence] in Urine by Test strip
50949-7 [3029937]
4.3e-01
7.4e-01
1.4e+00
—
2.7e+00
7.8e-01
4.3e-01
cases:5.42%
controls:3.58%
cases:4.09%
controls:1.99%
cases:1.56%
controls:0.39%
—
—
cases:3.90%
controls:0.28%
cases:4.65%
controls:2.18%
cases:9.79%
controls:6.60%
45
297
786
8003
34
165
797
8135
13
32
818
8268
—
32
23
789
8264
35
177
718
7951
64
480
590
6798
More than three and less than five hours
ZXE20 [2001311408]
8.4e-01
1.7e+00
—
—
—
1.9e+00
1.2e+00
cases:3.01%
controls:1.33%
cases:1.93%
controls:0.35%
—
—
—
—
—
—
cases:1.99%
controls:0.31%
cases:3.67%
controls:1.17%
25
110
806
8190
16
29
815
8271
—
—
—
15
25
738
8103
24
85
630
7193
Lymphocytes [#/volume] in Blood
26474-7 [3019198]
3.2e-01
6.6e-01
1.8e+00
1.0e+50
2.1e+00
5.1e-01
5.8e-01
cases:9.51%
controls:7.08%
cases:7.70%
controls:4.13%
cases:4.81%
controls:0.86%
cases:0.72%
controls:0.00%
cases:6.70%
controls:0.89%
cases:7.17%
controls:4.42%
cases:16.82%
controls:10.14%
79
588
752
7712
64
343
767
7957
40
71
791
8229
6
0
825
8300
55
74
766
8213
54
359
699
7769
110
738
544
6540
lamotrigine; oral
N03AX09 [21604431]
1.9e+00
1.4e+00
—
—
—
1.9e+00
1.8e+00
cases:2.17%
controls:0.33%
cases:0.96%
controls:0.23%
—
—
—
—
—
—
cases:1.33%
controls:0.21%
cases:2.75%
controls:0.45%
18
27
813
8273
8
19
823
8281
—
—
—
10
17
743
8111
18
33
636
7245
Instability of the detrusor vesicae muscle
N32.82 [2000503170]
2.1e+00
—
—
—
—
—
3.5e+00
cases:1.08%
controls:0.13%
—
—
—
—
—
—
—
—
—
—
cases:2.60%
controls:0.08%
9
11
822
8289
—
—
—
—
—
17
6
637
7272
Blasts/Leukocytes in Blood
26446-5 [3025159]
6.8e-01
1.1e+00
1.9e+00
—
2.5e+00
7.3e-01
5.3e-01
cases:1.20%
controls:0.61%
cases:1.56%
controls:0.52%
cases:0.96%
controls:0.14%
—
—
cases:1.22%
controls:0.10%
cases:1.06%
controls:0.52%
cases:2.60%
controls:1.55%
10
51
821
8249
13
43
818
8257
8
12
823
8288
—
10
8
811
8279
8
42
745
8086
17
113
637
7165
Pain in limb
M79.6 [45587063]
6.3e-01
9.8e-01
2.4e+00
—
1.2e+00
1.0e+00
4.9e-01
cases:6.38%
controls:3.49%
cases:3.97%
controls:1.53%
cases:2.17%
controls:0.19%
—
—
cases:0.61%
controls:0.19%
cases:4.52%
controls:1.67%
cases:9.17%
controls:5.84%
53
290
778
8010
33
127
798
8173
18
16
813
8284
—
5
16
816
8271
34
136
719
7992
60
425
594
6853
Emotionally unstable personality disorder, borderline condition
F60.31 [2000502023]
2.5e+00
—
—
—
—
—
3.0e+00
cases:0.72%
controls:0.06%
—
—
—
—
—
—
—
—
—
—
cases:1.68%
controls:0.08%
6
5
825
8295
—
—
—
—
—
11
6
643
7272
Unspecified haematuria
R31 [45553726]
1.1e+00
1.8e+00
—
—
—
1.5e+00
1.1e+00
cases:2.53%
controls:0.84%
cases:2.05%
controls:0.35%
—
—
—
—
—
—
cases:1.33%
controls:0.31%
cases:3.36%
controls:1.11%
21
70
810
8230
17
29
814
8271
—
—
—
10
25
743
8103
22
81
632
7197
Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection
54067-4 [3051552]
6.8e-01
—
—
—
2.7e+00
1.7e+00
1.1e+00
cases:1.08%
controls:0.55%
—
—
—
—
—
—
cases:0.85%
controls:0.06%
cases:1.46%
controls:0.26%
cases:2.75%
controls:0.95%
9
46
822
8254
—
—
—
7
5
814
8282
11
21
742
8107
18
69
636
7209
Limited function/disability (N)
N28 [2002000733]
—
2.6e+00
—
—
—
—
2.8e+00
—
—
cases:0.84%
controls:0.06%
—
—
—
—
—
—
—
—
cases:2.29%
controls:0.14%
—
7
5
824
8295
—
—
—
—
15
10
639
7268
Calcium [Moles/volume] in Serum or Plasma
2000-8 [3015377]
5.0e-01
9.8e-01
1.9e+00
—
2.1e+00
5.2e-01
5.2e-01
cases:5.54%
controls:3.45%
cases:5.17%
controls:2.00%
cases:1.68%
controls:0.27%
—
—
cases:2.56%
controls:0.33%
cases:3.05%
controls:1.83%
cases:8.87%
controls:5.47%
46
286
785
8014
43
166
788
8134
14
22
817
8278
—
21
27
800
8260
23
149
730
7979
58
398
596
6880
Polyuria
R35 [45539331]
1.0e+00
2.0e+00
—
—
—
1.8e+00
1.7e+00
cases:1.32%
controls:0.47%
cases:0.84%
controls:0.12%
—
—
—
—
—
—
cases:1.06%
controls:0.17%
cases:3.52%
controls:0.69%
11
39
820
8261
7
10
824
8290
—
—
—
8
14
745
8114
23
50
631
7228
Kidney ultrasound examination
KA1AE [2001305627]
2.5e+00
—
—
—
—
—
2.9e+00
cases:1.32%
controls:0.11%
—
—
—
—
—
—
—
—
—
—
cases:3.21%
controls:0.18%
11
9
820
8291
—
—
—
—
—
21
13
633
7265
Erysipelas
A46 [45561706]
1.0e+00
1.6e+00
—
—
—
1.2e+00
1.6e+00
cases:3.61%
controls:1.33%
cases:2.05%
controls:0.43%
—
—
—
—
—
—
cases:1.59%
controls:0.48%
cases:7.80%
controls:1.64%
30
110
801
8190
17
36
814
8264
—
—
—
12
39
741
8089
51
119
603
7159
Clinical Cytogenetics and Genomics
OMOP4822000 [32411]
1.0e+00
1.1e+00
—
—
—
3.4e+00
2.0e+00
cases:1.08%
controls:0.39%
cases:0.72%
controls:0.24%
—
—
—
—
—
—
cases:2.12%
controls:0.07%
cases:3.52%
controls:0.47%
9
32
822
8268
6
20
825
8280
—
—
—
16
6
737
8122
23
34
631
7244
Transferrin receptor.soluble [Mass/volume] in Serum or Plasma
30248-9 [3015399]
5.0e-01
7.6e-01
1.9e+00
—
2.1e+00
6.9e-01
5.6e-01
cases:3.97%
controls:2.45%
cases:3.37%
controls:1.60%
cases:1.32%
controls:0.19%
—
—
cases:1.22%
controls:0.14%
cases:2.92%
controls:1.49%
cases:7.95%
controls:4.69%
33
203
798
8097
28
133
803
8167
11
16
820
8284
—
10
12
811
8275
22
121
731
8007
52
341
602
6937
Hemoglobin [Presence] in Urine by Test strip
5794-3 [3011397]
4.4e-01
6.7e-01
1.7e+00
1.0e+50
2.2e+00
9.5e-01
5.7e-01
cases:3.97%
controls:2.59%
cases:2.65%
controls:1.37%
cases:1.44%
controls:0.28%
cases:1.08%
controls:0.00%
cases:2.19%
controls:0.24%
cases:3.98%
controls:1.59%
cases:9.02%
controls:5.32%
33
215
798
8085
22
114
809
8186
12
23
819
8277
9
0
822
8300
18
20
803
8267
30
129
723
7999
59
387
595
6891
Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma
2324-2 [3026910]
1.6e-01
6.6e-01
1.9e+00
—
2.3e+00
3.0e-01
5.1e-01
cases:10.71%
controls:9.30%
cases:7.94%
controls:4.27%
cases:2.65%
controls:0.41%
—
—
cases:5.12%
controls:0.52%
cases:5.98%
controls:4.49%
cases:20.34%
controls:13.31%
89
772
742
7528
66
354
765
7946
22
34
809
8266
—
42
43
779
8244
45
365
708
7763
133
969
521
6309
Cathetrisation of artery
TPH07 [2001309747]
5.8e-01
1.8e+00
—
—
1.0e+50
2.3e+00
1.3e+00
cases:1.32%
controls:0.75%
cases:1.32%
controls:0.23%
—
—
—
—
cases:0.97%
controls:0.00%
cases:1.86%
controls:0.18%
cases:2.75%
controls:0.77%
11
62
820
8238
11
19
820
8281
—
—
8
0
813
8287
14
15
739
8113
18
56
636
7222
Fever, unspecified
R50.9 [45582716]
9.5e-01
1.4e+00
—
—
—
1.6e+00
1.4e+00
cases:2.77%
controls:1.08%
cases:1.81%
controls:0.45%
—
—
—
—
—
—
cases:1.46%
controls:0.31%
cases:5.66%
controls:1.40%
23
90
808
8210
15
37
816
8263
—
—
—
11
25
742
8103
37
102
617
7176
calcium (different salts in combination); oral
A12AA20 [21600872]
8.1e-01
1.0e+00
8.8e-01
-1.0e+50
5.4e-01
1.4e+00
1.2e+00
cases:11.91%
controls:5.66%
cases:11.91%
controls:4.65%
cases:2.65%
controls:1.12%
cases:0.00%
controls:0.06%
cases:2.31%
controls:1.36%
cases:16.73%
controls:4.61%
cases:22.17%
controls:7.68%
99
470
732
7830
99
386
732
7914
22
93
809
8207
0
5
831
8295
19
113
802
8174
126
375
627
7753
145
559
509
6719
General anaesthesia
WX402 [2001310806]
4.2e-01
8.6e-01
—
—
3.1e+00
1.4e+00
8.3e-01
cases:2.05%
controls:1.35%
cases:1.44%
controls:0.61%
—
—
—
—
cases:1.34%
controls:0.06%
cases:2.12%
controls:0.53%
cases:4.28%
controls:1.91%
17
112
814
8188
12
51
819
8249
—
—
11
5
810
8282
16
43
737
8085
28
139
626
7139
Spine and spinal cord very extensive MRI examination with high intensity magnet
NA7DG [2001307084]
2.4e+00
2.9e+00
1.0e+50
1.0e+50
1.0e+50
—
—
cases:0.96%
controls:0.08%
cases:1.08%
controls:0.06%
cases:0.96%
controls:0.00%
cases:3.61%
controls:0.00%
cases:1.10%
controls:0.00%
—
—
—
—
8
7
823
8293
9
5
822
8295
8
0
823
8300
30
0
801
8300
9
0
812
8287
—
—
Faecal incontinence
R15 [45573014]
2.4e+00
—
—
—
—
—
2.9e+00
cases:1.08%
controls:0.10%
—
—
—
—
—
—
—
—
—
—
cases:1.68%
controls:0.10%
9
8
822
8292
—
—
—
—
—
11
7
643
7271
Malaise and fatigue
R53 [45553741]
6.0e-01
1.2e+00
3.2e+00
—
—
8.2e-01
8.3e-01
cases:3.13%
controls:1.73%
cases:2.77%
controls:0.82%
cases:2.41%
controls:0.10%
—
—
—
—
cases:1.86%
controls:0.82%
cases:7.03%
controls:3.20%
26
144
805
8156
23
68
808
8232
20
8
811
8292
—
—
14
67
739
8061
46
233
608
7045
ondansetron; oral, parenteral, rectal
A04AA01 [21600493]
1.7e+00
2.4e+00
—
—
—
—
1.3e+00
cases:1.68%
controls:0.33%
cases:1.68%
controls:0.16%
—
—
—
—
—
—
—
—
cases:1.99%
controls:0.58%
14
27
817
8273
14
13
817
8287
—
—
—
—
13
42
641
7236
Promyelocytes/Leukocytes in Blood
26524-9 [3021440]
8.1e-01
1.1e+00
2.0e+00
—
2.2e+00
9.5e-01
4.3e-01
cases:1.44%
controls:0.65%
cases:1.56%
controls:0.51%
cases:0.96%
controls:0.13%
—
—
cases:0.73%
controls:0.08%
cases:1.33%
controls:0.52%
cases:2.29%
controls:1.50%
12
54
819
8246
13
42
818
8258
8
11
823
8289
—
6
7
815
8280
10
42
743
8086
15
109
639
7169
temazepam; oral
N05CD07 [21604642]
7.6e-01
7.4e-01
1.6e+00
—
1.2e+00
1.3e+00
9.5e-01
cases:6.02%
controls:2.92%
cases:3.73%
controls:1.82%
cases:2.17%
controls:0.45%
—
—
cases:1.10%
controls:0.33%
cases:5.98%
controls:1.78%
cases:7.34%
controls:2.98%
50
242
781
8058
31
151
800
8149
18
37
813
8263
—
9
27
812
8260
45
145
708
7983
48
217
606
7061
Hematology
82 [38004501]
9.0e-01
1.2e+00
1.2e+00
—
1.8e+00
1.4e+00
9.2e-01
cases:2.05%
controls:0.84%
cases:1.81%
controls:0.55%
cases:0.84%
controls:0.25%
—
—
cases:0.85%
controls:0.14%
cases:2.39%
controls:0.60%
cases:2.91%
controls:1.18%
17
70
814
8230
15
46
816
8254
7
21
824
8279
—
7
12
814
8275
18
49
735
8079
19
86
635
7192
Prealbumin [Mass/volume] in Serum or Plasma
14338-8 [3013742]
1.0e+00
1.5e+00
—
—
—
1.8e+00
1.1e+00
cases:2.65%
controls:0.99%
cases:1.32%
controls:0.31%
—
—
—
—
—
—
cases:1.86%
controls:0.32%
cases:2.91%
controls:1.03%
22
82
809
8218
11
26
820
8274
—
—
—
14
26
739
8102
19
75
635
7203
Monitored bed care
WX892 [2001310850]
2.6e-01
1.7e+00
—
—
—
1.8e+00
1.8e+00
cases:0.84%
controls:0.65%
cases:1.08%
controls:0.20%
—
—
—
—
—
—
cases:1.20%
controls:0.21%
cases:2.91%
controls:0.48%
7
54
824
8246
9
17
822
8283
—
—
—
9
17
744
8111
19
35
635
7243
Bacteria identified in Isolate by Culture
43409-2 [3042936]
8.0e-01
1.4e+00
—
—
—
1.6e+00
1.4e+00
cases:2.65%
controls:1.20%
cases:2.41%
controls:0.58%
—
—
—
—
—
—
cases:3.05%
controls:0.62%
cases:7.19%
controls:1.94%
22
100
809
8200
20
48
811
8252
—
—
—
23
50
730
8078
47
141
607
7137
ECG with 12 standard connections
XF400 [2001303368]
9.0e-01
1.5e+00
—
1.0e+50
2.1e+00
1.7e+00
1.2e+00
cases:4.21%
controls:1.76%
cases:1.93%
controls:0.46%
—
—
cases:2.77%
controls:0.00%
cases:0.61%
controls:0.07%
cases:2.26%
controls:0.43%
cases:4.89%
controls:1.58%
35
146
796
8154
16
38
815
8262
—
23
0
808
8300
5
6
816
8281
17
35
736
8093
32
115
622
7163
aPTT in Platelet poor plasma by Coagulation assay
14979-9 [3018677]
1.1e+00
1.6e+00
—
1.0e+50
—
1.5e+00
1.0e+00
cases:4.21%
controls:1.41%
cases:2.77%
controls:0.58%
—
—
cases:2.41%
controls:0.00%
—
—
cases:2.52%
controls:0.59%
cases:5.66%
controls:2.16%
35
117
796
8183
23
48
808
8252
—
20
0
811
8300
—
19
48
734
8080
37
157
617
7121
Cell count panel - Cerebral spinal fluid
34563-7 [3044290]
1.4e+00
—
1.0e+50
—
1.0e+50
3.2e+00
2.0e+00
cases:0.84%
controls:0.22%
—
—
cases:0.96%
controls:0.00%
—
—
cases:3.78%
controls:0.00%
cases:1.46%
controls:0.06%
cases:2.14%
controls:0.30%
7
18
824
8282
—
8
0
823
8300
—
31
0
790
8287
11
5
742
8123
14
22
640
7256
Fracture of thoracic vertebra
S22.0 [45592654]
2.6e+00
—
1.0e+50
1.0e+50
1.0e+50
—
2.5e+00
cases:0.96%
controls:0.07%
—
—
cases:1.20%
controls:0.00%
cases:1.08%
controls:0.00%
cases:1.34%
controls:0.00%
—
—
cases:2.91%
controls:0.23%
8
6
823
8294
—
10
0
821
8300
9
0
822
8300
11
0
810
8287
—
19
17
635
7261
Case Management Agency
251B00000X [38004193]
1.8e-01
3.5e-01
7.9e-01
3.0e+00
6.3e-01
3.2e-01
2.3e-01
cases:51.26%
controls:46.78%
cases:48.50%
controls:39.83%
cases:29.60%
controls:16.05%
cases:17.45%
controls:1.01%
cases:27.16%
controls:16.62%
cases:51.13%
controls:43.10%
cases:68.20%
controls:62.97%
426
3883
405
4417
403
3306
428
4994
246
1332
585
6968
145
84
686
8216
223
1377
598
6910
385
3503
368
4625
446
4583
208
2695
Examination of eyes and vision
Z01.0 [45566391]
1.6e-01
3.7e-01
2.3e+00
—
2.8e+00
7.8e-01
3.9e-01
cases:2.29%
controls:1.95%
cases:1.08%
controls:0.75%
cases:0.72%
controls:0.07%
—
—
cases:0.97%
controls:0.06%
cases:2.12%
controls:0.98%
cases:4.28%
controls:2.93%
19
162
812
8138
9
62
822
8238
6
6
825
8294
—
8
5
813
8282
16
80
737
8048
28
213
626
7065
Intravenous administration of medicine
SPAT1255 [2001700356]
1.3e+00
—
—
—
—
2.1e+00
1.7e+00
cases:1.44%
controls:0.40%
—
—
—
—
—
—
—
—
cases:1.33%
controls:0.17%
cases:3.21%
controls:0.60%
12
33
819
8267
—
—
—
—
10
14
743
8114
21
44
633
7234
paracetamol; oral, parenteral, rectal
N02BE01 [21604344]
4.6e-01
8.8e-01
1.1e+00
1.4e+00
8.8e-01
1.1e+00
6.3e-01
cases:33.69%
controls:24.20%
cases:26.59%
controls:13.11%
cases:6.98%
controls:2.40%
cases:0.60%
controls:0.14%
cases:5.72%
controls:2.45%
cases:31.61%
controls:13.68%
cases:47.40%
controls:32.40%
280
2009
551
6291
221
1088
610
7212
58
199
773
8101
5
12
826
8288
47
203
774
8084
238
1112
515
7016
310
2358
344
4920
HIV 1 and 2 tests - Meaningful Use set
75622-1 [46235355]
1.2e-01
9.8e-01
—
—
3.4e+00
7.9e-01
6.9e-01
cases:2.17%
controls:1.93%
cases:2.41%
controls:0.92%
—
—
—
—
cases:1.71%
controls:0.06%
cases:1.73%
controls:0.79%
cases:5.35%
controls:2.75%
18
160
813
8140
20
76
811
8224
—
—
14
5
807
8282
13
64
740
8064
35
200
619
7078
pantoprazole; oral, parenteral
A02BC02 [21600097]
4.7e-01
9.7e-01
9.4e-01
-1.0e+50
8.4e-01
1.1e+00
7.0e-01
cases:18.29%
controls:12.24%
cases:16.97%
controls:7.16%
cases:3.97%
controls:1.59%
cases:0.00%
controls:0.08%
cases:3.65%
controls:1.62%
cases:18.99%
controls:7.32%
cases:27.37%
controls:15.76%
152
1016
679
7284
141
594
690
7706
33
132
798
8168
0
7
831
8293
30
134
791
8153
143
595
610
7533
179
1147
475
6131
Sedation and analgesia
WX002 [2001310758]
1.0e+00
1.5e+00
—
—
—
1.5e+00
9.5e-01
cases:4.09%
controls:1.53%
cases:1.93%
controls:0.42%
—
—
—
—
—
—
cases:1.73%
controls:0.39%
cases:4.59%
controls:1.83%
34
127
797
8173
16
35
815
8265
—
—
—
13
32
740
8096
30
133
624
7145
Lumbar spine and sacrum CT examination
NA3AD [2001307027]
2.5e+00
1.0e+50
—
1.0e+50
—
—
2.4e+00
cases:1.20%
controls:0.10%
cases:1.56%
controls:0.00%
—
—
cases:0.96%
controls:0.00%
—
—
—
—
cases:1.68%
controls:0.15%
10
8
821
8292
13
0
818
8300
—
8
0
823
8300
—
—
11
11
643
7267
Standard MRI examination of brain with high intensity magnet
AA1BG [2001300112]
9.6e-01
1.5e+00
—
1.0e+50
—
1.9e+00
1.4e+00
cases:1.56%
controls:0.60%
cases:1.44%
controls:0.31%
—
—
cases:0.84%
controls:0.00%
—
—
cases:1.20%
controls:0.17%
cases:2.91%
controls:0.70%
13
50
818
8250
12
26
819
8274
—
7
0
824
8300
—
9
14
744
8114
19
51
635
7227
norfloxacin; oral
J01MA06 [21603013]
1.4e+00
1.3e+00
—
—
—
2.0e+00
1.6e+00
cases:3.85%
controls:1.01%
cases:1.32%
controls:0.37%
—
—
—
—
—
—
cases:1.73%
controls:0.25%
cases:5.50%
controls:1.17%
32
84
799
8216
11
31
820
8269
—
—
—
13
20
740
8108
36
85
618
7193
Catheterisation instruction
TKC22 [2001306021]
—
—
—
—
—
2.6e+00
2.4e+00
—
—
—
—
—
—
—
—
—
—
cases:0.80%
controls:0.06%
cases:1.99%
controls:0.19%
—
—
—
—
—
6
5
747
8123
13
14
641
7264
Urination problems other
U05 [2002001140]
—
1.8e+00
—
—
—
2.7e+00
2.2e+00
—
—
cases:0.60%
controls:0.10%
—
—
—
—
—
—
cases:1.06%
controls:0.07%
cases:4.43%
controls:0.49%
—
5
8
826
8292
—
—
—
8
6
745
8122
29
36
625
7242

LabWAS

↥
OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
cases
controls
unit
-log10(p)
N cases
N controls
103
153
7.52
67.57
1.8
1.5
—
—
—
0
0
110
189
6.53
62.83
1.7
1.5
962.96
483.64
mg/l
2.74
99
179
70
73
10.35
60.88
2.0
1.6
—
—
—
0
0
98
166
6.54
56.62
1.7
1.5
3.70
3.71
mmol/l
0.02
90
156
429
2168
2.96
53.01
8.1
4.4
—
—
—
0
0
90
167
5.90
47.24
1.9
1.6
961.58
1206.83
e6/l
0.10
64
129
89
164
5.94
47.05
1.9
1.5
31.38
15.11
e6/l
0.43
64
121
49
49
10.55
43.71
1.2
1.1
104.57
40.89
mg/l
0.88
44
40
55
76
7.67
38.11
2.1
1.7
—
—
—
0
0
220
908
2.92
37.41
3.7
1.7
—
—
—
0
0
410
2338
2.45
35.63
2.9
2.2
244.10
280.12
u/l
0.26
393
2220
273
1291
2.64
35.41
4.3
3.6
0.81
0.82
mmol/l
0.34
255
1216
99
277
3.91
31.28
2.1
2.5
309.72
446.19
ug/l
0.33
93
264
506
3299
2.31
30.68
6.8
5.2
33.37
35.57
g/l
10.96
476
3098
237
1123
2.54
29.93
3.4
2.1
—
—
—
0
0
508
3363
2.26
29.06
10.6
7.0
1.20
1.21
mmol/l
3.00
485
3098
145
551
2.96
28.04
7.3
3.9
5.56
5.13
kpa
3.85
139
536
543
3735
2.24
27.70
11.2
7.6
1.20
1.21
mmol/l
1.57
489
3208
216
1044
2.43
25.66
6.5
6.3
1.07
1.04
mmol/l
0.51
197
967
637
4768
2.31
25.16
11.7
4.6
4332.95
974.89
e6/l
0.82
20
76
299
1680
2.20
24.76
5.5
2.7
4.46
5.31
e6/l
0.63
283
1529
137
540
2.83
24.61
7.5
3.9
7.41
7.42
ph
0.61
116
448
392
2451
2.11
24.55
7.6
3.4
38.00
84.20
e6/l
0.87
319
1878
32
39
8.48
24.51
1.3
1.1
0.53
0.51
ratio
0.22
19
22
507
3498
2.10
24.27
10.3
6.6
8.76
8.97
%
0.98
481
3287
505
3489
2.09
23.96
10.2
6.5
2.77
2.89
%
0.65
479
3276
505
3497
2.08
23.71
19.2
14.8
1.31
1.27
inr
0.87
432
2901
266
1447
2.22
23.70
5.7
3.0
511.53
541.34
mosm/kgh2o
1.83
247
1266
503
3485
2.08
23.50
10.4
6.5
0.65
0.67
%
0.25
477
3270
347
2110
2.08
23.04
7.1
3.3
0.36
0.40
e6/l
0.13
280
1549
189
902
2.41
22.83
10.1
8.6
1.60
0.86
mmol/l
1.52
154
743
501
3493
2.05
22.67
10.0
6.5
59.89
57.57
%
3.95
484
3346
384
2434
2.05
22.67
4.1
2.5
—
—
—
0
0
229
1202
2.24
22.06
2.7
2.4
30.38
29.56
s
0.99
222
1166
506
3561
2.03
22.06
10.2
6.6
25.31
27.30
%
3.67
489
3384
104
375
3.02
21.87
5.6
4.3
—
—
—
0
0
421
2798
1.99
21.36
9.2
4.0
166.14
120.13
e6/l
0.31
327
1974
188
921
2.33
21.27
10.2
8.5
5.28
5.11
kpa
1.25
173
889
188
922
2.33
21.21
10.2
8.5
12.60
12.12
kpa
0.52
173
893
526
3795
2.00
20.87
9.5
6.4
0.04
0.04
e9/l
0.27
467
3254
186
914
2.32
20.85
10.5
8.6
7.42
7.41
ph
0.05
107
523
163
757
2.42
20.77
2.8
2.4
0.19
0.21
g/l
1.44
150
705
95
337
3.05
20.52
2.8
2.0
10.83
2.45
ug/l
0.65
82
302
523
3787
1.98
20.28
9.4
6.3
0.60
0.59
e9/l
0.20
464
3242
536
3917
1.99
20.19
9.7
6.6
0.19
0.20
e9/l
0.31
478
3417
49
113
4.54
19.90
9.9
5.8
11.93
11.34
mg/l
0.34
44
106
527
3849
1.96
19.64
9.7
6.4
1.76
1.90
e9/l
1.40
468
3387
140
621
2.50
19.64
2.2
2.7
65.10
66.59
g/l
1.26
131
576
307
1875
1.99
19.39
7.4
4.3
86.44
89.02
%
1.05
299
1842
120
503
2.61
18.91
2.0
2.5
—
—
—
0
0
136
606
2.48
18.86
2.8
2.6
9.84
10.85
g/l
1.79
128
560
149
694
2.39
18.74
2.8
2.1
0.00
0.02
estimate
0.50
23
138
532
3951
1.92
18.24
8.2
6.8
10.33
11.58
umol/l
0.89
522
3786
575
4386
1.95
18.12
9.1
5.4
6.69
6.70
mmol/l
0.01
554
4171
151
726
2.31
17.59
10.3
8.8
1.35
1.37
mmol/l
0.11
146
713
165
826
2.24
17.45
10.9
9.0
95.25
95.32
%
0.04
154
802
443
3145
1.85
17.05
5.8
3.5
6.26
6.20
ph
0.62
249
1791
555
4232
1.89
16.93
13.2
9.8
4.42
4.15
e9/l
1.90
496
3681
518
3867
1.86
16.88
7.2
3.8
0.00
0.00
estimate
0.50
114
802
313
2001
1.89
16.74
3.0
2.3
3.08
2.89
mg/l
0.55
270
1718
521
3908
1.85
16.59
7.2
3.8
23.32
6.44
estimate
0.50
130
816
522
3929
1.84
16.32
7.3
3.8
0.02
0.41
estimate
0.49
124
758
170
892
2.13
15.86
2.9
2.7
1.82
1.81
%
0.08
152
809
450
3258
1.80
15.79
3.3
2.5
77.14
76.33
nmol/l
0.24
418
2934
150
760
2.18
15.26
11.5
9.5
120.97
121.14
g/l
0.03
143
745
467
3441
1.79
15.23
4.3
2.8
—
—
estimate
—
0
0
47
132
3.71
14.68
1.6
1.2
55.21
60.99
mmol/l
0.49
34
114
209
1221
1.94
14.35
6.6
3.2
2.30
2.25
e6/l
0.03
122
615
155
814
2.10
14.33
5.4
4.5
7.37
7.38
ph
1.14
92
477
215
1273
1.92
14.16
1.9
1.7
1030.84
1182.90
nmol/l
1.72
165
968
53
169
3.28
13.65
5.5
2.4
89.99
89.40
%
0.21
53
162
218
1314
1.88
13.52
6.1
3.0
1.26
0.96
e6/l
0.46
132
710
23
38
6.19
13.45
1.3
1.2
142.57
146.47
nmol/l
0.08
23
38
326
2232
1.74
13.17
5.5
4.3
7.40
7.40
ph
1.36
256
1591
146
783
2.04
12.66
5.6
4.5
2.06
1.73
mmol/l
0.37
132
667
440
3319
1.67
12.08
2.6
2.1
91.67
95.60
pmol/l
1.03
267
1783
132
699
2.05
11.81
2.8
2.8
70.09
68.29
e9/l
0.25
96
522
130
685
2.06
11.79
13.1
10.1
—
—
—
0
0
354
2536
1.68
11.76
3.2
3.4
2.33
2.35
mmol/l
2.38
322
2305
17
9
19.24
11.62
1.2
1.0
14.04
7.00
mg/g
—
17
9
332
2353
1.67
11.41
3.2
2.7
54.35
93.93
u/l
0.62
313
2202
660
5590
1.79
11.37
12.2
8.4
84.51
79.86
u/l
1.72
640
5303
198
1217
1.82
11.31
3.0
2.6
2.22
2.28
g/l
0.75
184
1140
17
10
17.32
11.22
1.2
1.0
—
—
—
0
0
27
62
4.46
11.04
3.6
1.9
1043.18
1164.88
e6/l
0.27
22
52
130
701
2.01
11.04
6.9
8.5
9.67
10.12
mmol/l
0.25
125
677
38
113
3.47
10.93
3.7
3.7
1.78
1.21
%
0.36
29
104
172
1031
1.84
10.60
1.5
1.4
400.00
471.54
titre
0.35
33
227
185
1138
1.80
10.46
3.0
2.6
18.51
23.05
%
4.62
171
1070
132
729
1.96
10.44
2.2
2.1
320.98
386.19
nmol/l
3.47
123
680
22
47
4.78
9.81
3.8
2.0
329.71
546.81
e6/l
1.21
17
36
108
571
2.02
9.65
3.9
4.1
75.75
88.21
ng/l
0.76
99
504
97
494
2.09
9.59
2.1
1.7
1.05
1.46
g/l
1.65
92
459
22
48
4.68
9.57
4.0
2.2
212.88
191.77
e6/l
0.21
17
39
291
2065
1.62
9.57
5.0
3.0
0.17
0.04
—
6
49
202
1305
1.72
9.54
3.1
2.6
10.23
13.12
umol/l
4.78
188
1224
25
62
4.12
9.29
3.0
1.8
44.78
40.41
%
0.60
25
62
95
486
2.07
9.28
11.3
6.7
25.61
24.32
mmol/l
2.32
86
465
221
1475
1.67
9.21
2.7
2.9
2.46
2.45
mmol/l
0.72
190
1328
191
2792
0.59
9.08
3.3
3.1
—
—
—
0
0
58
244
2.48
9.01
4.2
4.4
1.62
1.56
mg/l
0.19
52
220
27
73
3.79
8.94
3.7
4.2
61.13
54.87
%
0.65
20
67
298
2156
1.59
8.91
7.4
3.9
0.00
0.01
estimate
1.34
113
737
43
157
2.83
8.83
3.9
2.3
15.19
16.25
%
1.26
43
152
77
370
2.19
8.83
2.8
2.1
0.00
2.19
estimate
0.51
19
116
105
567
1.97
8.82
3.6
2.4
6.11
6.11
ph
0.00
76
385
44
164
2.77
8.70
1.4
1.7
—
—
—
0
0
45
171
2.72
8.58
5.2
3.4
—
—
—
0
0
88
452
2.06
8.50
12.8
11.6
16.34
15.75
%
1.00
80
436
29
90
3.30
7.86
1.4
1.4
275.91
278.09
mosm/kgh2o
0.16
22
68
310
2322
1.53
7.69
3.7
3.4
990.08
1402.38
ng/l
1.88
277
1996
26
77
3.45
7.57
1.7
1.5
34.80
26.40
ng/l
0.24
26
77
296
2203
1.53
7.54
2.0
1.7
20.01
20.21
nmol/l
0.08
263
1861
53
235
2.34
7.37
2.6
3.9
585.20
77.16
mg/l
0.45
46
206
57
261
2.27
7.36
2.1
2.5
10.06
10.78
g/l
0.52
51
237
372
2915
1.49
7.34
5.7
3.9
171.86
94.22
ng/l
0.24
311
2098
114
673
1.80
7.26
6.0
4.1
7.35
7.34
ph
0.14
97
487
65
316
2.14
7.26
3.2
1.9
—
—
—
0
0
112
659
1.80
7.21
5.2
4.7
1.27
0.88
%
0.72
56
229
13
13
10.13
7.05
1.1
1.0
—
—
—
0
0
61
293
2.16
7.02
3.4
2.6
20.43
21.26
s
0.57
54
270
52
234
2.30
7.00
2.7
3.9
40.14
63.51
mg/l
0.73
45
206
424
3434
1.47
6.95
3.8
3.1
178.41
138.79
ug/l
1.02
389
3203
216
1527
1.55
6.85
1.8
1.5
2.30
2.51
g/l
0.89
142
955
149
964
1.66
6.83
1.8
1.4
—
—
—
0
0
10
6
16.84
6.75
1.9
5.8
—
—
—
0
0
19
49
3.94
6.74
1.3
1.3
5.23
6.45
u/l
0.52
13
39
48
213
2.33
6.68
2.5
3.6
266.69
2.50
ratio
0.48
25
125
326
2527
1.47
6.61
4.4
3.4
33.41
33.42
u/l
0.00
308
2395
18
34
5.38
6.49
1.6
3.6
604.17
702.53
u/ml
0.26
18
34
105
632
1.75
6.25
5.2
5.1
0.08
0.12
%
0.21
39
180
104
625
1.76
6.23
4.9
4.6
1.03
0.54
%
0.83
51
208
68
359
1.97
6.11
1.8
1.9
1.76
1.49
g/l
1.25
57
322
103
625
1.74
5.96
5.1
4.8
0.17
0.13
%
0.20
47
195
103
628
1.73
5.86
1.4
1.4
—
—
—
0
0
231
1706
1.48
5.85
2.5
1.9
1.43
1.34
mg/l
0.23
188
1323
67
358
1.95
5.82
3.9
3.7
1.02
1.02
ratio
1.88
58
339
288
2222
1.45
5.82
11.0
6.2
—
—
—
0
0
25
87
2.93
5.66
1.2
1.1
—
—
—
0
0
13
20
6.58
5.57
3.0
1.7
0.11
0.30
e9/l
—
5
7
42
191
2.26
5.56
3.9
2.0
123.18
129.85
g/l
0.96
34
149
234
1750
1.46
5.52
7.6
3.9
1.02
1.02
kg/l
1.68
174
1166
54
273
2.04
5.49
1.1
1.2
—
—
—
0
0
59
312
1.96
5.30
2.2
1.9
6.69
8.01
iu/ml
—
9
75
134
903
1.57
5.15
3.0
2.7
9.95
7.38
umol/l
0.40
114
810
641
6953
0.69
5.03
5.1
5.0
1.37
1.44
mmol/l
3.32
584
6440
208
1552
1.45
4.90
1.7
1.8
55747561.41
22050113.03
pmol/l
0.38
174
1288
134
915
1.55
4.86
4.8
3.2
4.82
5.47
e9/l
0.40
110
799
357
2932
1.37
4.81
7.7
3.7
0.07
0.03
estimate
0.34
90
662
99
632
1.64
4.75
3.6
2.4
6.77
8.05
ug/l
0.36
82
562
22
80
2.80
4.64
1.9
2.5
1.38
1.24
g/24h
0.11
16
51
391
3272
1.36
4.63
18.7
11.4
0.00
0.00
e9/l
0.10
317
2664
268
2111
1.39
4.62
7.0
3.3
0.02
0.06
estimate
0.34
97
616
92
582
1.65
4.58
2.9
3.1
194.04
208.58
ng/l
0.12
81
542
64
366
1.81
4.56
6.7
5.3
2.14
1.54
%
2.78
57
347
45
229
2.02
4.53
7.7
6.9
1.65
1.30
mmol/l
0.77
33
200
14
33
4.30
4.33
1.3
1.2
—
—
—
0
0
59
336
1.81
4.27
7.2
5.6
0.79
0.86
%
0.50
52
316
661
7083
0.71
4.17
5.7
5.8
2.60
2.68
mmol/l
1.15
607
6577
16
52
3.12
4.10
3.1
2.9
16.37
16.46
%
0.04
16
52
25
104
2.45
4.09
1.9
2.3
31.96
33.24
pg
0.63
25
104
32
149
2.19
4.07
3.3
4.0
3.15
2.36
mmol/l
0.58
26
96
26
111
2.38
4.03
2.0
2.5
1.13
0.85
%
0.69
20
81
652
6979
0.72
3.79
5.2
5.1
4.46
4.58
mmol/l
2.16
597
6506
87
574
1.57
3.68
1.2
1.2
—
—
—
0
0
20
79
2.57
3.65
1.0
1.1
—
—
—
0
0
33
164
2.05
3.59
9.2
7.8
12.23
11.52
mmol/l
0.38
26
150
33
164
2.05
3.59
9.2
7.8
104.27
105.42
mmol/l
0.70
26
150
27
541
0.48
3.55
1.3
1.7
3.48
3.46
mmol/l
0.03
18
393
28
131
2.18
3.55
1.6
1.5
—
—
—
0
0
105
730
1.50
3.51
3.3
2.5
28.29
33.66
u/l
1.06
87
622
620
6657
0.75
3.35
4.5
4.3
1.33
1.29
mmol/l
0.79
559
6122
13
38
3.46
3.32
5.3
2.4
—
—
—
0
0
30
150
2.04
3.23
1.3
1.4
171.25
158.72
au/ml
—
8
42
19
78
2.47
3.23
1.3
1.2
0.16
0.18
nmol/l
0.65
14
56
32
164
1.99
3.23
1.3
1.4
—
—
—
0
0
121
880
1.44
3.22
1.9
1.7
—
—
—
0
0
12
34
3.56
3.20
3.1
1.9
85.89
72.64
ug/l
0.17
12
34
173
1340
1.36
3.19
2.1
1.9
—
—
—
0
0
19
79
2.44
3.15
1.2
1.3
—
—
—
0
0
27
131
2.10
3.15
1.4
1.8
0.58
0.85
g/l
0.84
22
106
86
587
1.52
3.15
7.4
3.8
—
—
—
0
0
211
1694
1.33
3.06
1.4
1.3
1.21
2.02
u/ml
0.86
54
466
66
428
1.59
3.03
6.8
3.4
0.56
0.62
%
0.95
66
428
135
1013
1.39
3.02
1.3
1.2
—
—
—
0
0
9
21
4.32
3.00
5.0
2.7
—
—
—
0
0
8
17
4.74
2.92
1.5
1.3
60.13
56.35
nmol/24h
—
8
17
9
22
4.12
2.88
3.6
1.6
31.56
29.55
%
—
9
22
9
22
4.12
2.88
1.8
1.1
—
—
—
0
0
185
1480
1.32
2.73
4.9
4.0
404.14
407.73
ng/l
0.01
143
1172
145
1120
1.35
2.71
1.8
1.7
—
—
—
0
0
14
54
2.62
2.71
2.4
2.7
37.23
39.37
%
—
7
29
6
10
6.03
2.70
1.2
1.3
—
—
—
0
0
19
86
2.24
2.65
1.3
1.3
—
—
—
0
0
37
215
1.75
2.60
1.5
1.5
10.36
8.84
u/l
0.31
31
171
235
1954
1.28
2.59
3.2
2.8
331.37
349.02
umol/l
1.62
208
1715
8
20
4.03
2.57
3.3
1.5
—
—
—
0
0
5
7
7.18
2.55
1.4
1.1
—
—
—
0
0
81
574
1.45
2.50
4.7
3.7
1.21
1.22
mmol/l
1.12
74
493
23
116
2.01
2.47
2.3
3.0
—
—
—
0
0
10
251
0.39
2.41
1.2
1.1
1.65
1.54
g/l
—
10
251
19
90
2.14
2.40
1.3
1.3
0.58
0.60
nmol/l
0.05
19
82
83
597
1.43
2.38
1.6
1.5
—
—
—
0
0
14
58
2.44
2.38
1.6
1.6
15.16
12.32
umol/l
0.51
14
52
538
4943
1.24
2.36
4.4
3.4
60.86
50.57
u/l
1.42
514
4668
7
17
4.14
2.36
1.3
1.5
—
—
—
0
0
16
71
2.28
2.35
1.0
1.2
—
—
—
0
0
34
199
1.74
2.35
6.6
3.1
4.29
2.58
index
0.31
21
102
42
261
1.64
2.34
2.7
3.5
419.78
347.38
mg/l
0.26
18
121
63
432
1.49
2.31
3.1
3.7
4.67
4.56
pmol/l
0.28
56
382
25
134
1.89
2.28
11.4
2.5
—
—
—
0
0
17
79
2.18
2.26
1.3
1.3
—
—
nmol/l
—
0
0
319
2790
1.23
2.20
2.3
2.2
—
—
—
0
0
10
238
0.41
2.15
1.2
1.1
—
0.66
—
0
24
27
152
1.80
2.14
3.7
1.9
—
—
—
0
0
13
55
2.38
2.13
2.1
2.7
9.34
8.78
mmol/l
0.15
13
55
166
1353
1.28
2.12
1.5
1.3
25.93
30.32
iu/ml
0.22
54
422
25
138
1.84
2.11
1.2
1.1
—
—
—
0
0
9
31
2.92
2.07
1.2
1.4
153.89
170.05
mmol/24h
—
9
31
5
10
5.02
2.07
1.0
1.1
0.01
0.41
u/ml
—
5
10
13
56
2.34
2.05
1.2
1.1
—
—
—
0
0
39
247
1.61
2.04
1.5
1.3
—
—
—
0
0
31
187
1.68
1.96
1.8
1.6
7938.83
11398.11
e6/l
0.43
23
133
28
165
1.72
1.93
1.4
1.3
316.31
253.36
u/ml
0.42
16
91
152
1242
1.27
1.91
1.4
1.3
24.75
11.37
u/ml
0.79
52
472
5
12
4.18
1.82
1.6
1.3
75.20
68.00
ug/l
—
5
12
15
73
2.07
1.81
2.6
1.7
—
—
—
0
0
735
7065
1.29
1.80
39.5
16.4
29.39
24.97
mg/l
3.42
676
5850
289
2551
1.20
1.75
4.7
3.7
—
0.77
—
0
13
14
68
2.08
1.71
1.1
1.1
—
—
—
0
0
7
162
0.43
1.68
1.1
1.7
—
—
—
0
0
8
31
2.60
1.66
2.4
1.8
—
—
—
0
0
8
31
2.60
1.66
2.9
1.6
—
—
—
0
0
13
62
2.11
1.66
1.1
1.1
—
—
—
0
0
16
83
1.95
1.65
1.4
5.3
11.89
10.22
%
0.69
16
83
32
205
1.58
1.64
1.5
1.2
—
—
—
0
0
293
2602
1.19
1.64
4.5
3.4
6.43
7.78
mmol/l
6.55
240
2196
747
7212
1.28
1.64
41.5
19.7
3.97
3.98
mmol/l
0.61
737
7056
5
133
0.37
1.62
1.2
1.1
—
—
—
0
0
14
261
0.53
1.60
1.4
1.1
0.94
0.91
g/l
0.13
14
261
11
50
2.22
1.57
1.5
1.6
75.64
80.94
umol/l
0.31
11
50
7
27
2.61
1.51
1.4
2.0
42.17
39.44
g/l
—
7
27
16
86
1.88
1.51
2.2
2.2
—
—
—
0
0
9
37
2.45
1.48
1.1
1.0
1468.44
1560.05
miu/ml
—
9
37
65
491
1.35
1.47
1.5
1.3
211.99
196.17
u/ml
0.07
59
457
22
132
1.68
1.47
1.2
1.1
—
—
—
0
0
16
87
1.86
1.46
1.3
1.2
—
—
—
0
0
744
7201
1.25
1.44
41.6
19.5
139.08
139.70
mmol/l
7.37
735
7058
18
103
1.76
1.41
1.1
1.2
—
—
—
0
0
7
29
2.43
1.39
1.3
1.4
—
—
—
0
0
28
182
1.56
1.38
4.4
4.9
—
—
—
0
0
30
199
1.53
1.36
3.5
2.0
942.49
1842.00
u/l
0.57
12
74
16
90
1.79
1.33
1.9
1.4
—
—
—
0
0
6
24
2.51
1.30
1.2
1.0
—
—
—
0
0
9
43
2.10
1.30
13.8
3.6
0.67
0.88
index
—
9
43
6
133
0.45
1.29
1.2
1.1
—
—
—
0
0
5
18
2.79
1.28
2.6
2.2
—
—
—
0
0
22
138
1.61
1.27
3.5
2.9
9.31
8.55
pmol/l
0.09
22
138
575
5463
1.16
1.25
4.6
4.2
15.08
14.80
pmol/l
1.85
529
5003
8
36
2.23
1.24
1.6
1.1
390.09
149.82
iu/ml
—
8
36
30
204
1.49
1.24
1.3
1.1
—
—
—
0
0
59
755
0.77
1.19
1.3
1.5
—
—
—
0
0
96
789
1.24
1.19
2.4
4.4
322.23
23.45
ug/l
0.47
75
654
189
1660
1.18
1.18
5.9
4.9
—
—
—
0
0
44
326
1.37
1.16
1.2
1.3
—
—
—
0
0
275
3020
0.87
1.15
1.9
1.9
1.54
1.35
mmol/l
1.40
242
2554
78
630
1.26
1.13
1.6
1.7
—
—
—
0
0
5
114
0.44
1.13
1.2
1.1
—
—
—
0
0
144
1660
0.84
1.12
2.9
3.1
0.62
0.77
ug/l
1.61
97
1062
7
32
2.20
1.08
5.0
3.4
31.26
33.31
umol/l
—
7
24
7
33
2.13
1.05
1.1
2.1
—
—
—
0
0
26
370
0.69
1.05
1.1
1.1
—
—
—
0
0
7
35
2.01
1.00
11.0
7.3
10.54
458.56
ug/l
—
7
25
18
115
1.58
1.00
2.7
2.4
—
—
—
0
0
9
49
1.85
0.98
1.1
1.1
—
—
—
0
0
5
23
2.18
0.98
3.2
3.0
—
—
—
0
0
15
92
1.64
0.97
2.4
2.8
4.31
4.05
mmol/l
1.13
15
92
15
92
1.64
0.97
2.4
2.8
101.93
105.11
mmol/l
0.95
15
92
15
92
1.64
0.97
1.8
1.6
—
—
—
0
0
26
182
1.44
0.97
1.2
1.2
—
—
—
0
0
568
5913
0.88
0.96
41.0
20.3
14.18
13.62
%
12.58
561
5841
27
191
1.43
0.95
1.9
1.9
3.88
5.05
iu/l
0.22
13
72
6
29
2.08
0.89
1.0
1.5
8.83
1.07
%
—
6
23
18
119
1.52
0.88
1.2
1.2
3.75
3.38
u/ml
—
8
52
6
30
2.01
0.87
2.8
2.9
21.98
295.80
ug/l
—
6
25
649
6682
0.88
0.84
7.4
6.5
39.29
39.41
mmol/mol
0.12
610
6259
40
310
1.30
0.84
1.4
1.4
25.66
25.41
iu/l
0.02
34
256
756
7700
0.84
0.83
50.5
25.0
129.22
135.75
g/l
23.61
751
7613
46
364
1.28
0.83
2.2
1.7
0.32
0.34
mg/l
0.11
25
169
756
7699
0.85
0.82
50.2
24.8
7.09
6.76
e9/l
3.95
745
7533
35
267
1.32
0.82
8.8
2.1
—
—
—
0
0
6
32
1.88
0.82
1.0
1.1
—
—
—
0
0
6
32
1.88
0.82
1.0
1.1
—
—
—
0
0
756
7698
0.85
0.81
50.1
24.8
4.35
4.50
e12/l
11.25
744
7532
756
7698
0.85
0.81
51.7
25.4
39.00
40.51
%
12.31
751
7605
268
2476
1.12
0.81
4.3
4.2
12.74
9.39
mg/mmol
0.63
174
1551
109
948
1.17
0.80
1.3
1.3
—
—
—
0
0
756
7695
0.85
0.78
50.0
24.7
90.73
91.19
fl
1.72
751
7610
7
124
0.56
0.78
1.4
1.6
—
—
—
0
0
756
7694
0.85
0.78
50.3
24.8
254.94
246.61
e9/l
2.29
745
7547
227
2084
1.12
0.77
1.5
1.4
—
—
—
0
0
6
34
1.77
0.76
1.0
1.5
57.67
60.04
%
—
6
25
47
378
1.26
0.76
1.2
1.2
—
—
—
0
0
14
91
1.55
0.75
2.5
2.7
1.20
1.19
mmol/l
0.29
14
91
12
75
1.61
0.75
3.8
2.8
—
—
—
0
0
528
5072
1.11
0.75
4.4
4.2
—
6734.73
—
0
15
29
219
1.34
0.74
1.2
1.4
174.08
229.53
miu/ml
0.40
12
102
18
125
1.45
0.73
1.7
1.3
—
—
—
0
0
663
6799
0.89
0.72
5.5
5.1
5.97
5.96
mmol/l
0.06
604
6237
9
56
1.61
0.72
5.1
2.7
39.89
36.07
mg/l
—
9
42
5
26
1.93
0.70
3.2
2.8
—
—
—
0
0
7
121
0.58
0.67
1.4
1.5
—
—
—
0
0
26
197
1.33
0.66
4.3
3.3
1.53
1.58
mmol/l
0.13
26
191
20
145
1.39
0.66
3.5
3.3
0.93
0.87
nmol/l
0.31
15
122
11
70
1.58
0.65
1.2
2.4
—
—
—
0
0
22
164
1.35
0.63
4.7
3.5
6.29
7.57
mmol/l
2.03
22
159
12
79
1.53
0.63
2.3
1.4
—
—
—
0
0
259
2426
1.10
0.60
3.6
3.5
63.19
52.89
mg/l
0.31
175
1569
11
72
1.53
0.59
1.2
1.1
—
—
—
0
0
11
72
1.53
0.59
1.0
1.3
877268.33
286958.27
e6/l
—
6
48
38
309
1.24
0.59
2.3
2.8
—
—
—
0
0
15
106
1.42
0.58
1.7
1.2
—
—
—
0
0
35
283
1.25
0.57
8.8
2.1
—
—
—
0
0
8
54
1.49
0.57
1.3
1.3
—
—
—
0
0
35
286
1.23
0.53
9.0
2.1
—
—
—
0
0
41
347
1.19
0.46
2.0
2.3
—
—
—
0
0
94
848
1.12
0.46
1.4
1.4
—
—
—
0
0
104
945
1.11
0.45
2.2
2.5
130.53
115.33
ug/g
0.32
80
774
34
284
1.21
0.44
8.7
2.1
—
—
—
0
0
27
220
1.23
0.44
1.9
1.4
247.68
286.74
ug/g
0.54
19
123
5
31
1.62
0.43
1.6
1.2
5.29
6.66
mmol/l
—
5
31
0
18
0.00
0.40
0.0
6.7
—
5.31
—
0
18
0
18
0.00
0.40
0.0
2.3
—
17.98
—
0
18
16
124
1.30
0.39
1.3
1.2
—
—
—
0
0
5
36
1.39
0.38
1.6
1.6
—
3328.00
—
0
5
80
725
1.11
0.38
2.6
2.4
12.39
13.21
nmol/l
0.37
71
655
738
7464
0.92
0.35
18.2
12.1
26.81
26.68
u/l
0.07
718
7260
11
83
1.33
0.32
1.5
1.2
—
—
—
0
0
33
286
1.16
0.31
9.8
2.0
—
—
—
0
0
14
113
1.24
0.26
3.0
1.5
—
—
—
0
0
14
113
1.24
0.26
3.0
1.5
—
—
—
0
0
14
113
1.24
0.26
3.0
1.5
—
—
—
0
0
14
113
1.24
0.26
3.0
1.5
—
—
—
0
0
33
291
1.14
0.26
1.0
1.1
—
—
—
0
0
30
338
0.88
0.23
1.4
1.7
—
—
—
0
0
5
40
1.25
0.22
1.4
2.1
52.74
112.67
ng/l
—
5
40
0
11
0.00
0.21
0.0
1.0
—
17.55
—
0
11
72
769
0.93
0.21
1.6
1.5
—
—
—
0
0
6
48
1.25
0.20
3.2
1.6
—
—
—
0
0
272
2792
0.96
0.19
5.1
5.4
5.95
2.60
ug/l
0.67
243
2501
7
59
1.19
0.18
1.0
1.4
—
—
—
0
0
8
71
1.13
0.16
1.4
1.1
—
—
—
0
0
32
349
0.91
0.16
1.1
1.1
—
128.73
—
0
11
17
149
1.14
0.15
1.5
1.4
108.53
214.91
pmol/l
0.64
17
144
10
83
1.21
0.15
1.0
1.1
—
—
—
0
0
46
491
0.93
0.14
1.3
1.2
—
—
—
0
0
658
6533
1.03
0.12
6.0
5.2
1.75
1.92
mu/l
3.24
613
6023
10
86
1.16
0.11
1.8
1.7
—
—
—
0
0
730
7265
1.03
0.10
28.6
14.7
—
—
—
0
0
20
183
1.10
0.10
2.0
2.3
114.00
104.94
ug/min
0.04
13
105
18
165
1.09
0.08
1.5
1.4
—
—
—
0
0
18
166
1.09
0.08
1.1
1.2
—
—
—
0
0
33
314
1.05
0.07
2.5
3.7
779.85
4330.40
u/ml
0.57
26
272
50
488
1.03
0.03
1.2
1.2
104.67
148.85
u/ml
0.29
19
199
21
217
0.97
0.01
16.5
12.2
—
—
—
0
0
8
81
0.99
0.00
1.3
1.1
—
—
—
0
0
5
50
1.00
0.00
1.0
1.0
—
—
—
0
0
0
6
0.00
-0.00
0.0
1.0
—
—
—
0
0
7
77
0.91
-0.00
1.1
1.2
—
—
—
0
0
0
6
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
7
0.00
-0.00
0.0
1.7
—
396.57
—
0
7
0
8
0.00
-0.00
0.0
5.1
—
0.18
—
0
8
6
61
0.98
-0.00
1.3
1.2
78.67
99.70
pmol/l
—
6
61
0
5
0.00
-0.00
0.0
1.8
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.8
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.0
—
86.30
—
0
5
0
5
0.00
-0.00
0.0
1.4
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.4
—
—
—
0
0

Mortality – FinRegistry

↥

Association

Association between endpoint G6_PARDIPLE and mortality.

Females

Parameter HR [95% CI] p-value
G6_PARDIPLE 3.284 [2.85, 3.78] < 0.001
Birth year 0.99 [0.98, 1.0] 0.022

During the follow-up period (1.1.1998 — 31.12.2019), 1018 out of 2755 females with G6_PARDIPLE died.

Males

Parameter HR [95% CI] p-value
G6_PARDIPLE 3.353 [2.93, 3.84] < 0.001
Birth year 0.983 [0.97, 0.99] < 0.001

During the follow-up period (1.1.1998 — 31.12.2019), 1463 out of 3289 males with G6_PARDIPLE died.

Mortality risk

Mortality risk for people of age

years, who have G6_PARDIPLE.

N-year risk Females Males
1 0.264% 0.544%
5 1.408% 3.501%
10 3.74% 7.817%
15 7.163% 14.977%
20 12.565% 24.983%

Relationships between endpoints

↥

Index endpoint: G6_PARDIPLE – Paraplegia, diplegia of upper limbs

GWS hits: -

Endpoint
Case Overlap
Survival Analysis
Genetic Correlations
Genetic Signals
N (Jaccard index)
HR [CI]
rg [CI]
Hits
Coloc Hits
FinRegistry
FinnGen
FinRegistry
FinnGen
FinnGen
loading spinner Loading data